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Abstract 
Cataracts are the commonest cause of preventable blindness in the world.  During 
surgery the natural lens is replaced with a polymeric intraocular lens (IOL), leaving the 
capsular bag in situ.  The most common postoperative complication is scarring which is 
known as posterior capsule opacification (PCO).  PCO occurs when residual lens 
epithelial cells (LECs) dedifferentiate and migrate onto the previously cell free posterior 
capsule.  By modifying the IOL surface properties we can manipulate the cellular 
response.  BioInteractions Ltd. is an innovative supplier of biomaterials, which aim to 
minimise, the host response, and provided the materials for this study.  The aim of this 
study was to evaluate potential IOL coatings to reduce PCO.  This can either be achieved 
by enabling a monolayer of LECs to attach to the posterior surface of the IOL, thus 
sandwiching the IOL to the capsular bag, or prohibiting cell attachment to the IOL 
entirely. 
 
Materials and Methods 
Various coatings were investigated incorporating: functional groups of poly ethylene 
glycol (PEG), sulphates, sulfonates, glycosaminoglycans (Heparin, (HEP) hyaluronic aid, 
(HA) and chondroitin sulphate (CS)) and zwitterionic monomers (10-30%).  Ways to 
prevent dedifferentiation was also evaluated.  LECs were seeded onto all coatings and 
monitored for a period of 7 – 14 days in cell culture.  LECs were examined 
morphologically, cell nuclei were counted and growth curves were plotted.  Water 
contact angle (CA) measurements were taken to measure the wettability of the coatings.  
Scanning electron microscope (SEM) analysis was performed to examine the topography 
of the coating.  White light interferometry (WLI) analysis was conducted to analysis the 
surface roughness.  Dedifferentiation of LECs and the use of TGFβ3 to neutralise or 
prevent dedifferentiation were also investigated. 
 
Results and Discussions  
Coatings with a greater number of water-based layers were the most hydrophilic, and 
did not offer the appropriate cell binding sites required to promote cell attachment.  In 
general, little cell attachment was observed on HEP and HA coatings provided by 
  v 
BioInteractions Ltd., cell attachment varied on CS coatings provided by BioInteractions 
Ltd.  When HA and CS were covalently bound onto amine coated coverslips a reduction 
in cell attachment was observed.  The LEC response varied across different ratios of 
zwitterionic monomer within the coatings.  Zwitterionic coatings were not cytotoxic to 
LECs and surface analysis demonstrated no clear link between wettability and roughness 
compared to cell attachment.  Addition of transforming growth factor beta 2 (TGFβ2) 
was chosen as a successful dedifferentiation model.  Addition of TGFβ3 had little 
influence at reversing dedifferentiation however it may offer some protection against 
differentiation.  PCR analysis showed a change in regulation of collagens, integrins, 
matrix metallopeptidase and fibronectin 1 genes, when LECs were incubated with 
TGFβ2, TGFβ3 or untreated (control LECs).  These genes may play important roles in 
PCO. 
 
Conclusions 
Incorporation of functional groups influenced the cellular response, however the 
coatings with more water-based layers prohibit cell attachment.  The cellular response 
varied depending on GAG type and the conformation of GAG on the surface coating.  HA 
and CS bound to amine-coated coverslips prohibited cell attachment at higher 
concentrations, indicating their potential to prohibit LEC attachment.  There was no 
clear link between wettability and cell attachment on the novel zwitterionic coatings.  
The ratio of zwitterionic-component:arylic-based monomer(s) influenced cell 
attachment.  TGFβ2 successfully dedifferentiated LECs.  Further work is required to 
understand the influence of TGFβ3 on dedifferentiation.  
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1. Introduction 
 
This thesis is concerned with synthetic materials designed to replace the natural lens in 
the human eye.  This is a cross-disciplinary research area requiring an understanding of 
materials and medical devices, the anatomy and properties of the tissues of the eye and 
the interactions at the material/biological environment interface. 
 
1.1 Biomaterials 
A biomaterial can be defined as, “Any substance, other than a drug, or combination of 
substances, synthetic or natural in origin, which can be used for any period of time, as a 
whole or as a part of a system which treats, augments, or replaces any tissue, organ or 
function of the body.” [1] 
 
Biomaterials are used as part of medical devices and implants throughout the body, for 
example, hip joint replacements, heart valves replacements, vascular stent implants and 
ocular implants.  Within the eye there are a vast number of biomaterials being used to 
regain or enhance vision and combat degenerative diseases associated with vision loss 
[2].  For these devices and implants to perform to their best they need to be 
biocompatible.  Biocompatibility refers to, ”A material that does not lead to an acute or 
chronic inflammatory response and that does not prevent a proper differentiation of 
implant-surrounding tissue.” [1] 
 
For implantable devices there will inevitably be some tissue reaction due to the surgery, 
however a biomaterial with a good biocompatibility should not elicit an adverse 
biological response.  Key to controlling the biocompatibility of a material or device is 
understanding the cell surface interactions. 
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1.2 Cell Surface Interactions 
Cell/surface interactions can be broken up into two areas, firstly proteins binding to the 
surface and secondary cells binding to the proteins.   
 
When a material is implanted into the biological environment proteins (long sequences 
of amino acids) rapidly interact with that implant surface and will, most often, adsorb 
onto the surface [3-6].  Protein adsorption occurs within seconds to minutes, long 
before any cells arrive and settle on the surface [7].  The multitude of proteins in the 
biological environment competes for surface binding.  This was first described by 
Vroman and is known as the Vroman effect.  Vroman outlined that initial protein 
adhesion is firstly mediated by highly mobile smaller proteins, generally derived from 
plasma.  Proteins then compete to bind to the surface and these smaller proteins are 
replaced by larger proteins.  As the proteins adsorb to the surface conformational 
changes within the protein occur which result in the formation of a strong bond to the 
surface [8].  This adsorbed protein layer can be influenced by the surface properties of 
the material such as surface charge, chemistry, wettability and roughness.  The cellular 
response to this surface, in terms of cellular attachment, proliferation, morphology and 
phenotypic changes, is then dependent on this folding and unfolding of proteins at the 
interface of an implant and the biological environment, and the interfacial forces 
between the two [3, 6, 9-11].   
 
Cells bind to these proteins via specific cell surface receptors, particularly integrins [7, 
12-13] (Figure 1.1).  Integrin binding will only occur if the adsorbed protein layer displays 
the correct amino acid sequences [6-7].  Since the conformation of the adsorbed protein 
is directly influenced by the implant surface properties different surfaces may result in 
variations in protein conformation and thus different cellular responses [4, 7, 14-16].  
One of the major integrins to support cells binding is α5β1, fibronectin receptor.  
Underwood et al demonstrated fibronectin confirmation differences between tissue 
culture treated polystyrene and untreated polystyrene.  Treated polystyrene displayed a 
greater number of the arginine-glycine-aspartic acid (RGD) binding sites compared to 
untreated polystyrene [15].  Grinnell et al previously reported similar results with tissue 
culture treated polystyrene and bacteriological polystyrene. Although radiolabelling 
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showed there was more fibronectin binding to bacteriological polystyrene than treated 
polystyrene, there was more anti-fibronectin antibody on treated polystyrene, 
suggesting different fibronectin confirmation on each surface. Fibronectin confirmation 
on treated polystyrene provided binding sites enabling cellular spreading [14].  
 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
These cell-surface interactions are complex and the surface properties can alter this 
response, this is explained in more detail throughout this chapter in the context of 
replacement lenses. 
  
Figure 1.1: Schematic of the cell/surface interface and binding of a cell to the protein adlayer.  A. 
Proteins adsorbed onto the surface of an implant.  B. Integrin binding point.  This will only occur if the 
correct amino acids sequence is presented to the integrin by the protein conformation.  Adapted from 
personal communications with R.L.Williams. 
A. 
B. 
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Protein 
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Integrin 
Lipid Bilayer 
Material 
Material 
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1.3 Anatomy of the Eye 
The eye is split up into two compartments, the anterior chamber (from the lens to the 
cornea) which houses the aqueous humour, and the posterior segment (from the lens to 
the back of the eye) which houses the vitreous humour (Figure 1.2).  The clear anterior 
surface of the eye is known as the cornea and the white of the eye is called the sclera.  
Light enters the eye through the cornea, which contributes to approximately 70% of the 
total refractive power of the eye [17].  Behind the cornea sits the coloured iris and the 
opening known as the pupil.  Light is then refracted through the aqueous and the pupil 
until it meets the lens.  The lens is responsible for fine focusing of light onto the retina 
(discussed further in section 1.6).  Light continues through the vitreous and an image is 
formed on the retinal photoreceptors at the back of the eye.  The optic nerve carries this 
information to the brain allowing us to see the image formed on the back of the eye [2, 
18-20].  
 
Figure 1.2: Schematic of the anatomy of the eye.  Light enters the eye through the transparent anterior 
surface, known as the cornea.  The white tissue at the periphery is known as the sclera.  Light is refracted 
by the cornea through the aqueous humour (A) in the anterior segment.  It continues through the 
coloured iris and the pupil until it meets the lens.  Light then travels through the vitreous (B) until it 
reaches the retina at the back of the eye.  Adapted from V.Kearns et al [21] 
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1.4 Anatomy of the Lens 
The lens comprises of a collagen-like glycoprotein capsular bag.  This collagen 
membrane encases the lens and is attached to the ciliary muscle via fibres called the 
zonules (Figure 1.3), enabling accommodation (1.6).  The anterior diameter is three 
times the size of the anterior–posterior thickness and the anterior surface is always less 
curved than the posterior side.  The front and back intersections are termed the poles 
and the edge rim is called the equator.  In the developed undisturbed lens, lens 
epithelial cells (LECs) are arranged in a single cuboidal monolayer, and are confined to 
the anterior surface of the capsule bag.  Mitosis of LECs occurs at the equator region 
where lens fibres are formed (Figure 1.3) [20, 22-23].   
 
 
 
 
 
 
 
 
 
 
  
Figure 1.3: Schematic of a cross-section of the lens.  The outer membrane is called the capsular bag.  LECs 
reside on the inner anterior surface of this capsular bag and are arranged in a single cuboidal monolayer.  
Beneath these cells lie the lens fibres.  Mitosis of LECs and fibres occurs at the equator region.   Zonules 
are attached to the equator area of the lens and in turn are attached to the ciliary muscle, both are 
responsible for accommodation.  
Lens Fibres 
Capsular Bag LEC Monolayer Pole
s 
Equator 
Zonules 
Ciliary 
Muscle 
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1.5 Development of the Lens 
At the 4mm embryo stage in humans the lens placode is formed from the surface 
ectoderm, which is in direct contact with the neural ectoderm, which forms the optical 
vesicle.  At this stage the optical vesicle is formed from a single layer of cuboidal cells.  
At the 5mm embryo stage invagination of the lens placode occurs to form the lens pit, 
the optical vesicle also invaginates to form the optical cup.  By the 9mm embryo stage 
the lens placode has further invaginated inside the optic cup and finally separates from 
the surface ectoderm.  After separation from the surface ectoderm the lens appears as a 
hollow sphere approximately 0.2mm in diameter, with a single layer of columnar cells 
outlining the wall.  A basal wall envelops the vesicle and a thin basal lamina is 
synthesised that thickens to form the lens capsule. 
 
Between the 10mm – 13mm embryo stages the lens changes from circular to an oval-
like shape.  Differentiation of the columnar cells on the posterior surface of the lens 
capsule also takes place.  Cells elongate to form the first lens fibres with their nuclei 
nearer the anterior surface.  At this point fibres are straightest and longest at the poles, 
they decrease in length at the equatorial region where they merge into the cuboidal 
cells of the anterior wall.  These original fibres move towards the centre with time and 
are known as the nucleus.  All new fibre cells are produced from the equator region and 
encapsulate the nucleus (original fibres), which become known as the cortex (Figure 
1.4).  When a cell at the equator region slowly differentiates into a fibre it elongates 
with the anterior stretching towards the anterior epithelium and posterior towards the 
posterior wall [18-19, 24-26].  
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Figure 1.4: Schematic of the development of the lens fibres. A new lens cell at the equator slowly 
differentiates into a fibre and elongates with the anterior stretching towards the anterior epithelium 
and posterior towards the posterior wall until it eventually encapsulates the cortex.  Adapted from 
V.Kearns et al [21] 
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This process continues throughout life meaning the lens grows with age and older fibres 
become compacted towards the centre, losing their nuclei (Figure 1.5).  The central 
nucleus region becomes sclerosed and less transparent with age [18-19, 24]. 
 
 
 
There are some physiological differences in the lens between men and women, for 
example a man’s lens is heavier.  Women seem to be less prone to cataracts (1.7) below 
the age of fifty compared to men, however this is reversed above the age of fifty 
suggesting some hormonal influence [27]. 
 
 
1.6 Accommodation and Disaccommodation 
Objects at different distances can be focused onto the retina by changing the refractive 
power of the eye.  To do this the geometry of the lens changes, either by increasing or 
decreasing its angle of curvature, known as accommodation or disaccommodation 
respectively.  The ciliary muscle plays a key role in this process.  It is attached anteriorly 
Figure 1.5: Photograph demonstrating age related differences in lenses.  A. Young lens donor – Lens is 
smaller, more transparent and paler in colour when compared to an older lens.  B. Older lens donor – Lens is 
bigger, less transparent and darker in colour, due to the natural aging process of the lens. 
A. B. 
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to the sclera spur and posteriorly to the choroid.  As previously mentioned the ciliary 
muscle is attached to the lens capsule via the zonules [20, 28-29].     
 
1.6.1 Accommodation  
To focus on a near object the ciliary muscle contracts, moving forward and inward.  This 
means the zonules relax and the lens becomes more spherical.  This thickens the lens 
axially and narrows it equatorially.  Both the anterior and posterior surfaces increase in 
curvature, with the posterior still remaining steepest.  The posterior surface is prevented 
from moving backwards due to the vitreous humour.  The anterior surface moves 
forward towards the cornea.  These changes contribute to increasing the refractive 
power of the eye (Figure 1.6) [20, 28-30]. 
 
 
 
 
 
 
 
 
 
1.6.2 Disaccommodation  
To focus on an object in the distance the sequence is reversed, and the ciliary muscle 
relaxes.  The tissue to which the ciliary muscle is anchored to pulls the ciliary muscle 
posteriorly and outward, flattening the ciliary muscle along the scleral surface.  This 
Figure 1.6: Schematic detailing the process of accommodation.  The ciliary muscle contracts moving 
forward and inward, meaning the zonules are relaxed and the lens becomes more spherical.  The 
anterior chamber decreases and images close up are brought into focus. 
Ciliary 
Muscle 
Zonules 
Anterior Chamber 
Lens 
Sclera 
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means the zonules are in tension which in turn stretches and flattens the natural lens, 
reducing its curvature.  The posterior surface remains fixed and the anterior surface 
retracts from the cornea.  These changes contribute to decreasing the refractive power 
of the eye (Figure 1.7) [20, 28-30]. 
 
 
 
 
  
 
 
 
 
1.6.3 Changes with Age 
The ability to change the refractive power of the natural lens by accommodation 
gradually diminishes with age [18-19].  This process starts to occur from as early as the 
second decade of life.  Meaning objects must be held further away from the eye to be 
clearly visualised.  This degradation is known as presbyopia, which means “old eye”.  
Whilst the true reason behind this is not fully understood, several reasons have been put 
forward which are believed to contribute to the degeneration process.  Such as 
alterations in the elasticity of the Bruch’s membrane becoming more rigid with age, 
meaning the ciliary muscle cannot move forward properly when it contracts.  Another 
proposed reason for presbyopia is that the curvature of the lens increases with age, 
which decreases the anterior chamber space.  The lens nucleus also hardens with age.  
Figure 1.7: Schematic detailing the process of disaccommodation.   The tissue area to which the ciliary 
muscle is anchored to pulls the muscle posteriorly and outward, flattening the ciliary along the sclera, 
meaning the zonules are in tension which in turn stretches and flattens the lens.  The anterior chamber 
increases and images far away are brought into focus. 
 
Ciliary 
Muscle 
Zonules 
Anterior Chamber 
Lens 
Sclera 
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In addition the vitreous loses its viscous properties becoming more liquid-like affecting 
the compression abilities it has on the posterior surface of the lens, thus allowing the 
lens to move posteriorly when the ciliary contracts.   All of these factors have been 
attributed to presbyopia [18-19, 24, 30]. 
 
1.7 Cataracts 
A cataract is characterised by opacification of the natural lens (Figure 1.8), which if left 
untreated can lead to blindness.  Our most dominant sense is considered to be our 
vision, therefore the loss of sight can be very debilitating [31].  There are many factors 
that have been associated with the risk of developing cataracts, such as: UV radiation 
[32], smoking [33], alcohol [34], diet and diabetes [35].  Cataracts can also be congenital, 
caused by trauma or old age.  Senile cataracts are a natural ageing process of the 
crystalline lens [36], and result from a change in structure of the proteins [18, 23, 28, 37-
38].  The lens fibres are full of proteins and approximately one third of the lenses weight 
is accounted for by these proteins.  One of the major proteins present within the lens is 
alpha crystallin, which gives the lens its clarity and refractive power [39].  These 
proteins, some of which are insoluble, increase in size and molecular weight with age 
and can aggregate together.  The lens loses transparency with age as a result of these 
insoluble protein aggregates, increasing light scatter and glare, leading to cataract 
formation [20, 38, 40]. 
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Figure 1.8: Micrographs demonstrating age related cataracts in patients whose pupils have been 
dilated.  A. Photograph of a cataract viewed via a slit lamp in a patient at the Royal Liverpool 
Hospital just before theatre, their pupil has been dilated and clouding on the left-hand side of the 
pupil can be observed where the light is shining in.  B. Photograph of a denser age-related cataract, 
again the patient’s pupil has been dilated.  In the NHS cataracts are removed much earlier 
(photograph A) than this late stage.  National Eye Institute Reference#EDA13 [41] 
A. 
B. 
Dense white 
cataract 
Peripheral 
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Cataracts are the leading cause of preventable blindness worldwide (Figure 1.9).  The 
most common form of cataracts is the senile cataract, which greatly reduces the quality 
of the patient’s life.  In 2000 Minassian et al constructed a model to calculate the 
current cataract rates and predict the backlog of cataract operations.  The backlog of 
vision impairing cataracts was predicted at 2.36 million in England and Wales (aged 65 
and older) [42].  Across the world there are an estimated 20 million people affected by 
cataract related blindness.  The World Health Organisation (WHO) has launched a 
campaign, Vision 2020, to eliminate avoidable blindness.  This aims to increase the 
volume of cataract surgery to 32 million per annum globally by 2020 [43]. 
 
 
 
 
 
 
 
Figure 1.9: Pie-chart to demonstrate disease related blindness as a percentage of total blindness in 2002.  
Cataracts are the leading cause of preventable blindness worldwide, and this number is only due to 
increase by the year 2020, with 51% of total blindness being attributed to cataracts.  Information taken 
from World Health Organisation – “Global data on visual impairments 2010” [44].  
 
Cataract 
  
14 
Chapter 1: Introduction 
1.7.1 Surgical Treatment  
Cataracts are treatable with a simple ophthalmic operation known as cataract surgery.  
In brief the cataractous lens is removed and replaced with a synthetic polymer lens to 
regain vision, known as an intraocular lens (IOL) (Figure 1.10).  IOL’s are made from a 
variety of materials and differ in terms of shape and design (1.9.3).   
 
 
 
 
 
 
 
In the developed world this surgery is performed at an earlier stage before total 
blindness occurs.  Whereas in developing countries surgery is performed at a far later 
stage if resources are available.  Cataract surgery is performed on an outpatient basis 
and takes approximately 30 minutes. It is the most commonly performed ophthalmic 
procedure worldwide, meaning the healthcare budget to manage this condition is 
significant [42, 45-47].   
Figure 1.10: Micrographs demonstrating four types of IOL designs.  IOLs vary in terms of the material, 
IOL shape and haptic design.  A. Acrysof® IOL, B. Acrysof® IOL with UV filter, C. Rayner C-Flex® IOL and D. 
Artisan anterior chamber IOL.  
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In cataract surgery a small incision, of approximately 3 mm, is first made in the limbal 
region of the eye, where the clear cornea meets the white sclera (Figure 1.11-A).  This 
small incision allows for rapid visual recovery and minimises surgical induced 
astigmatism.  A continuous circular capsulorhexis (CCC) is then made in the anterior 
capsule, allowing the surgeon access to the lens fibres.  The opaque natural lens is 
disintegrated by phacoemulsification which uses ultrasonic waves to break up the lens 
matter (Figure 1.11-B).  Lens fibres are removed by irrigation/aspiration leaving the 
capsular bag in situ, which is made up of all of the posterior capsule and most of the 
anterior capsule.  A polymer IOL, (Figure 1.11-C) is then folded and implanted through 
the capsulorhexis.  The IOL slowly unfolds within the capsular bag (Figure 1.11-D).  The 
arms of the IOL, known as haptics, secure the IOL in place and allow vision to be 
restored [2, 25, 48].  An injected viscoelastic material aids the cataract extraction 
method by protecting the endothelial inner surface of the cornea, increasing the depth 
of the anterior chamber allowing room for instruments, and absorbing ultrasound 
energy [2]. 
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Prior to the use of IOLs the whole cataractous lens was removed and nothing was 
inserted inside the eye, therefore thick glasses were required to attempt to correct 
vision.  Sir Harold Ridley was the first person to implant an IOL (the Ridley IOL) made 
from poly methyl methacrylate (PMMA), in 1950.  This material was selected based on 
observations of pilots during World War II who got pieces of the canopy (made from 
Figure 1.11: Schematic demonstrating the process of cataract removal and implantation of an IOL.  A. 
Small incision is made in the limbal region, where the clear cornea meets the white sclera. B. Removal of 
the cataract by phacoemulsification, C. Polymer IOL and D. IOL unfolded inside the capsular bag to 
restore vision.  Adapted from Healthwise Inc [49].  
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PMMA) lodged into their eye.  This seemed to cause little inflammatory response and 
was transparent, therefore was chosen as the first IOL material.   Originally the whole 
lens and capsular bag were removed known as intracapsular cataract extraction (ICCE), a 
PMMA anterior chamber (AC) fixed IOL was then implanted.  Since then the surgical 
procedure has evolved and improved (1.9.1) [30]. 
 
The Ridley IOL was very bulky and mechanically difficult to fixate in the eye, and was 
eventually discontinued.  This led to an influx of improvements to the PMMA IOL 
suggested by other surgeons at the time.  PMMA remained the dominant material 
choice until the 1990’s, when advancements in materials meant foldable IOLs emerged 
(Figure 1.12).  These materials can be grouped into three groups, hydrophilic acrylate 
(predominantly poly hydroxyethyl methacrylate, pHEMA) hydrophobic acrylate 
(phenylethyl methacrylate PEMA and phenylethyl acrylate PEA) and silicone (poly 
dimethyl siloxane PDMS) [30]. 
 
 
 
 
 
  
Figure 1.12: Chemical structure of available IOLs.  A. PMMA, B. PHEMA, C. PEMA/PEA and D. PDMS. 
Diagram courtesy of R.L. Williams. 
A. B. C. D. 
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1.8 PCO 
There are some postoperative complications associated with scarring after implantation 
of an IOL, of which posterior capsule opacification (PCO) (Figure 1.14) is the most 
common [50].  The usual physiological monolayer of LECs on the anterior capsule causes 
no clinical problem, however the capsule remains a stage for cellular adhesion and 
migration [51].  During cataract surgery LECs on the anterior capsule and the lens fibres 
are removed via phacoemulsification and irrigation/aspiration, however the nature of 
the surgery means it is very difficult to remove all cells [51].  PCO occurs when residual 
LECs, normally present on the anterior capsule, migrate onto the previously cell free 
posterior capsule, in response to the surgical trauma caused and implantation of an IOL 
[52].   These cells then dedifferentiate into fibroblast-like cells causing the posterior 
capsular bag to wrinkle, causing light scattering (Figure 1.13), distorting the light path to 
the back of the eye.  
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The trauma caused during surgery induces cytokine release such as elevated levels of 
transforming growth factor beta (TGFβ), causing changes in LEC phenotype and 
morphology  [53].  TGFβ is usually present in the inactive form in aqueous humour, and 
is activated after surgery as part of the natural wound healing response [54-55].  The 
isoform most abundant in the eye is TGFβ2.  It is known that LECs secrete TGFβ2 post 
operatively [56], causing dedifferentiation of LECs, meaning modifications in their 
Figure 1.13: Schematic of PCO development.  A. Residual LECs on the anterior capsule following 
surgery and IOL implantation. B. Migration of LECs onto the previously cell free posterior capsule, 
where cells dedifferentiate into fibroblast-like cells and cause wrinkling of the posterior capsule, which 
results in loss of vision.  Adapted from personal communications with R.L. Williams 
A. 
B. 
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structure to produce different proteins, such as  α smooth muscle actin ( αSMA) [56-58].   
αSMA is expressed by myofibroblast-like cells which are thought to be responsible for 
excessive contractile forces, causing capsular wrinkling [59].  The protein and 
morphological changes provoke repair and regeneration of LECs and fibres known as 
Elschnig’s pearls [60-61] and Soemmering's Ring [5, 61].  As well as the surgical trauma, 
the degree of PCO is also affected by the material, surface properties and shape of the 
IOL [10, 62].  This process occurs post operatively but PCO (Figure 1.14) may take several 
years to develop [24, 63].    
 
 
 
 
 
PCO rates vary between studies [64]. Schaumberg et al demonstrated this and pooled all 
published rates for PCO for different materials together.  The overall (95% confidence 
limits) incidence of PCO rates for years 1, 3 and 5 were, 11.8% (9.3–14.3%), 20.7% (16.6–
24.9%) and 28.4% (18.4–38.4%) respectively [46, 65].  Boureau et al reported a PCO 
Figure 1.14: Photograph demonstrating a donor eye with IOL implant and early PCO formation.  Early 
fibrosis was observed as scar tissue at the periphery.  As well as development of Soemmering's Ring.  
Fibrous scar tissue 
Development of 
Soemmering ring 
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rates for three square edge design IOLs, Acrysof SA6S0 (Alcon, n=250), AR40E (Advanced 
medical optics, n=254) and XL-Stabi (Zeiss-loltech, n=263) in a retrospective study 
conducted by 10 ophthalmology centres in France.  PCO occurred in 13.1% Acrysof 
SA6S0 IOLs, 23.3% in 4AR40E IOLs and 45.4% in XL-Stabi IOLs, three years 
postoperatively.  Based on data from the year 2005 Boureau et al calculated the total 
budget for post-capsulotomy complications for all cataract interventions was €18.5 
million for the Acrysof SA6S0 IOLS, €12 million for AR40E IOLs and €21.4 million XL-Stabi 
IOLs [66]. 
 
1.8.1 Surgical Treatment  
There are no therapeutic agents available to prevent PCO, therefore a second operation 
is required using an Nd:YAG (neodymium doped yttrium aluminium garnet) laser, known 
as a capsulotomy.  This procedure involves burning a hole through the posterior capsule 
to regain a clear light path to the back of the eye.  This can lead to further complications 
such as retinal detachment, damage to the IOL, increase in intraocular pressure and 
corneal oedema.  In addition to the risk factors involved with capsulotomy it also poses a 
significant cost factor on the healthcare system, severely limiting its use in developing 
countries.  A better understanding is therefore required to improve the outcome of 
cataract surgery [25, 66-69].   
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1.9 Current Research to Prevent PCO 
There are various routes being investigated to eliminate the clinical significance of PCO 
and these are all interlinked.  These include surgical technique, the use of therapeutic 
agents and IOL design either in terms of their shape or materials (Figure 1.15). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.9.1 Surgical Techniques  
Initially research was undertaken to improve surgical techniques by minimising the 
amount of injury caused and reducing the inflammatory response [25].  Firstly, research 
was aimed at improving the fixation and location of the IOL.  Several AC IOLs emerged 
between the years 1952 – 1962, however inflammation due to abrasion of the cornea 
and uvea meant they were abandoned.  Iris supported designs soon followed in 1957 – 
1973.  These had round loops on the side of the IOL to suture them into place, and were 
made from different materials to the IOL optic.  Complications occurred with these IOLs 
≥6 years postoperatively, including decompensation of the cornea, as well as iris erosion 
and dislocation of the IOL.  AC IOLs were revisited in the 1970 – 1980’s with the 
introduction of haptics made from PMMA or other biomaterials, however the outcome 
was still unfavourable resulting in inflammation and glaucoma.  This led to posterior 
Figure 1.15: Schematic demonstrating routes being investigated to eliminate the clinical burden of PCO.  
Research areas are all interlinked. 
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chamber (PC) fixated IOLs with “J” shaped haptics, originally being positioned behind the 
iris and in front of the capsule, in an area called the sulcus.  These IOLs led to iris chafing, 
decentration of the IOL if one haptic accidently fell into the bag and PCO [30, 52].  
Further improvements to “C” shaped haptics and opening the capsular bag by 
capsulorhexis, meant reliable implantation of PC IOLs to the current position, known as 
“in the bag” capsular fixation [30, 52].  Firstly this prevents irritation to other tissue and 
secondly it creates an IOL optic barrier, forcing the IOL and the posterior capsule 
together, eliminating space for cell migration.  Another area of improvement has been 
the decrease in capsulorhexis size,  to create a tight fit for the IOL and to minimise 
interaction with the aqueous humour [70-71]. 
 
In addition, the inflammatory response can be minimised by decreasing the incision size 
and taking care to enhance cortical clean-up of residual LECs.  Peng et al studied the 
benefits of using hydrodissection, coupled with phacoemulsification and 
irrigation/aspiration.  The process of hydrodissection requires injecting saline in-
between the capsular bag and lens, creating a fluid stream around the lens making 
phacoemulsification quicker and easier.  Peng et al proved on autopsy eyes that 
hydrodissection accompanies the elevation of the lens away from the capsular bag, 
enhancing cortical clean up.  This process has also been shown to decrease surgical time 
[48, 70].   
 
Improvements to surgical technique can minimise the amount of trauma caused, and 
inevitably the wound healing response.  This is crucial as it has been shown that the 
wound healing response provokes changes in LEC signalling which increases proliferation 
rates, extracellular matrix (ECM) deposits, capsular contraction and differentiation, thus 
leading to PCO [60, 72].  As mentioned earlier TGFβ2 levels are elevated post operatively 
[56] inducing  αSMA expression, causing wrinkling and distortion to the capsular bag 
[59].  These intracellular and extracellular changes to LECs are thought to be a cause of 
PCO [56, 73].  Therefore research has been carried out to reduce TGFβ2 either in terms 
of minimising the initial wound healing response, or by using drugs to prevent TGFβ2 
secretion (1.12) [56, 74]. 
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1.9.2 Drug Release  
Drugs have been administered during and after cataract surgery with the aim of 
reducing inflammation and PCO. Typically inflammation is controlled by administering 
eye drops or injections, but some researchers have investigated the use of IOLs as a 
system for drug delivery [25, 75-78].  Pharmacological agents are being used to kill 
remaining LECs left behind after surgery, however there is a worry that any drug aiming 
to cause cell death could be toxic to other areas of the eye [51, 67, 71].  This is why 
pharmacological agents being tested have not left the laboratory stage or at most the 
animal testing phase [71].  Pharmacological agents currently being tested include, 
antimetabolites (for example methotrexate, mitomycin C and 5-FU), anti-inflammatory 
and immunological substances.  A common problem for these pharmacological agents is 
the sustained release and contact of the drug to the appropriate area of the eye.  
Pandey et al combined the use of 5-FU with an intracapsular ring to prevent contraction 
and inhibit LEC proliferation.  The results were mixed and indicated the intracapsular 
ring may prevent central PCO by inhibiting LEC growth inward, but the pharmacological 
effects of 5-FU were not demonstrated [72].  
 
The drug daunorubicin has been applied to IOL’s and successfully reduced PCO by 50% in 
an animal study, however corneal endothelial side effects were reported, indicating this 
antimetabolite would not be suitable for clinical use [79]. 
 
Using IOLs to minimise the post operative infection has also been studied via soaking 
hydrophilic acrylic IOLs in gatifloxacin and moxifloxacin antibiotics for 24 hours.  IOLs 
were implanted into rabbits.  The results showed higher concentrations of drugs were 
delivered for a prolonged period of time to the target area, than the amount of drug 
delivered with the use of antibiotic drops [80-81].  This area has potential for future IOL 
development [51]. 
 
The Surodex implant is a biodegradable polymer implant, inserted inside the anterior 
chamber at the same time as cataract extraction, and slowly releases the steroid 
dexamethasone to reduce to post operative inflammation [51, 82].  Tan et al showed 
that implantation of the Surodex decreased anterior flare, examined by flare meter, up 
to 30 days postoperatively when compared to conventional 0.1% dexamethasone eye 
  
25 
Chapter 1: Introduction 
drops [76].  In another study Tan et al implanted 2 Surodex drug delivery systems per 
eye and found that flare was only significantly lower than 0.1% dexamethasone eye 
drops control until the 15 days postoperative time point.  Surodex treatment did reduce 
ocular discomfort, photophobia and lacrimation [77].  Both studies reported that no 
significant difference in corneal endothelial cell loss between Surodex and 
dexamethasone treatment 1 year after surgery [76-77].  Wadood et al also reported that 
there was no difference in corneal endothelial cell numbers, however they found no 
difference in flare or subjective assessment of inflammation between Surodex or 
dexamethasone treated eyes [78]. 
 
1.9.3 IOL Design 
Biocompatibility of IOLs can be broken down into two research themes, biological and 
mechanical compatibility.  Biological compatibility can be assessed by the degree of 
adhesion of macrophages, giant cells and LECs to the IOL [52].  Mechanical compatibility 
can be determined by the fit of the IOL inside the capsular bag and influence of IOL 
shape has on LEC migration.  Mechanical compatibility can therefore be broken down 
into two components, IOL material and IOL shape.  Due to the overlap between the two 
research themes biological compatibility will be discussed in both these sections.   
 
1.9.3.1 IOL Material 
In the beginning of the 1980’s Starr Inc. introduced the first foldable silicone IOL made 
from a proprietary poly-siloxane [52].  The formulation was then developed over the 
next 15 years and other companies introduced lenses with different refractive indexes, 
mechanical properties and UV protection.  Complications with silicone IOLs arose such 
as unfolding rapidly in a spring like motion and adhesion of silicone oil to the back of the 
IOL, if it was required as a tamponade agent in the future.  pHEMA has extensively been 
used for contact lenses due to its wettability properties, the same material was later 
applied to IOLs, however fixation was difficult and complications arose after 
capsulotomy with Nd:YAG laser.  In 1994 Alcon introduced the Acrysof® IOL, a new soft 
hydrophobic copolymer of phenylethyl acrylate and phenylethyl methacrylate, with a UV 
absorbing filter.  A much thinner design meant it could be inserted inside a smaller 
incision of just 3mm, the IOL also unfolded slowly reducing inflammation and remaining 
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centred.  There have been several modifications from the three-piece foldable IOL with 
PMMA “C” shaped haptics, inserted with forceps, to the injectable one-piece IOL with 
integral haptics made for the same material as the optic [31].  
 
It is known that IOL material and surface properties, such as wettability can influence 
the severity of the postoperative cellular response, and the development of PCO [67].  
Wettability refers to the spreading of a liquid on a solid surface.  If the water droplet was 
very rounded on a surface there would be a low interaction with the surface and it 
would be more hydrophobic, than if the water droplet was highly spread across the 
surface and would be termed hydrophilic (Figure 1.16).   
 
 
 
 
 
 
 
 
 
 
 
 
The wettability is influenced by the surface and interfacial tension.  A high surface 
tension would pull the water droplet across the surface to try and reduce the tension.  
The surface tension is countered by the interfacial tension at the surface/liquid 
interface, which pulls the water droplet away from the surface.  In terms of IOLs there 
has been much controversy over cell attachment and wettability, and the argument of 
hydrophobic vs. hydrophilic IOLs to prevent PCO [83].  This controversy is highlighted in 
the studies of Yao et al and Schroeder [84-85].   
 
A. B. 
Figure 1.16: Photograph demonstrating wettability of a surface on A.  A more hydrophobic surface with a 
higher contact angle and B. A more hydrophilic surface with a lower contact angle.  Photograph courtesy 
of K.G. Doherty. 
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Yao et al investigated two types of silicone IOLs, one foldable IOL and one surface 
modified foldable IOL with phospholipid monomers, to make it more hydrophilic.  The 
wettability of both was evaluated using contact angle analysis.  This measures the angle 
between the water droplet and the surface, to give it a degree of wettability.  LECs were 
also seeded onto the surfaces and the results show lower cellular attachment on the 
modified silicone IOLs, indicating a more hydrophilic IOL would be best suited for 
reduction of PCO [84].  Schroeder et al performed a similar study investigating adhesion 
of fibronectin on varying hydrophilic IOLs, as it is thought that fibronectin increases 
cellular attachment and thus PCO.  Again contact angle measurements were taken.  The 
results showed more hydrophilic IOLs had more fibronectin attached.  This indicates a 
more hydrophobic IOL would be best suited for reducing fibronectin attachment and 
therefore PCO.  These two studies contradict each other and add to the case that there 
is still no clear link between wettability and PCO [85]. 
 
Deposits on IOLs either in terms of cell type, such as fibroblasts, macrophages or LECs or 
ECM macromolecules can lead to an inflammatory response [86].  Lauren et al and Saika 
et al have examined LEC secretion of different collagen types [87] and how this is 
influenced by the material [86].  LECs have been shown not only to secrete their specific 
basement membrane protein, collagen type IV, but also type I and III in bovine LECs 
when left for a long period in tissue culture (up to 10 months).  These results indicate 
that in long term culture LEC secretion of collagen changes phenotype [87].  Saika et al 
later found traces of type I collagen on PMMA IOLs explanted from human eyes along 
with cells having the appearance of macrophages and giant cells.  In one particular case 
fibrous deposits where found encasing the lens haptics with a thin membranous deposit.  
This fibrotic tissue appeared to have many cellular components included cell debris and 
some macrophages, however no fibroblastic cells were identified.  As fibrotic tissue is 
generally long lasting conclusions were made that fibrosis was formed immediately after 
surgery as a wound healing response, and by the time of the analysis the fibroblast cells 
were absent [86].   
 
Mullner et al reviewed four different IOLs in terms of their inflammatory responses.  
LEC, Small round, fibroblast-like, epithelioid, and giant cells were all examined as these 
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cells play an important role in postoperative inflammation and the foreign body 
reaction.  The four IOLs studied were, Hydroview™ (hydrophilic hydrogel IOL), AcrySof® 
(hydrophobic acrylic IOL), MemoryLens (hydrophilic acrylic IOL) and CeeOn 920 
(hydrophobic silicone IOL).  Mullner et al observed that different IOL materials alter the 
cellular reaction.  Small round and fibroblast-like cells were seen on all IOL groups, and 
decreased in numbed between 7 – 30 days.  These cells increased in number at 90 days 
in the AcrySof® (hydrophobic) and MemoryLens (hydrophilic) groups.  Epithelioid and 
giant cells can be used as an indicator of the biocompatibility of an IOL material, due to 
the fact they are found in eyes with a prolonged inflammatory reaction.  The number of 
these cells between the four groups was not significantly different.  In conclusion, the 
Hydroview (hydrophilic acrylic) group had the highest incidence of LECs numbers but the 
lowest incidence of epithelioid and giant cells (after 180 days).  The AcrySof® 
(hydrophobic acrylic) group had the lowest incidence of LEC’s (after 180 days), but the 
highest incidence of epithelioid and giant cells (after 90 days). The CeeOn 920 
(hydrophobic silicone) group had the lowest incidence of all cells after 180 days.  This 
indicates variations in material and cellular attachment, and in particular, wettability 
may influence epithelioid and giant cell attachment [88].   
 
Tognetto et al compared three different types of HEMA IOLs manufactured with 
different methacrylate copolymers (Hydroview H60M, ACR6D and Stabibag) in 73 
patients for their biocompatibility on the anterior surface.  The anterior surface was 
analysed for small rounded cell attachment and anterior capsule opacification, up to 180 
day postoperatively.  The results showed a greater percentage of Stabibag IOLs had 
small rounded cells adhered during the first month, however ACR6D group had the 
largest percentage of anterior capsule opacification during the first month and at 180 
days postoperatively. Although all IOLs were based on HEMA with different 
methacrylate copolymers variations in terms of the wound healing response were 
observed, it is therefore believed that the chemical composition leads to this wound 
healing response [89].   
 
As previously mentioned αSMA is expressed by myofibroblast cells and gives an 
indication of a wound healing and inflammatory response to implantation of an IOL.  
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Mahelokova et al examined the expression of αSMA on different culture substrates.  
LECs proliferation and αSMA expression was examined on collagen I, collagen IV, 
microscope glass slides and uncoated polystyrene dishes.  The authors concluded that 
the substrate influenced attachment, proliferation and expression of αSMA in LECs [90].     
Therefore αSMA could also be used to examine how substrates affect the 
dedifferentiation of LECs. 
 
1.9.3.2 IOL Shape 
Alcon’s Acrysof® IOL was the first IOL to utilise a square edge design.  This is designed to 
create a barrier eliminating space and applies more pressure on the posterior capsule, 
due to the 900 angle, sandwiching the posterior capsule to the IOL (Figure 1.17). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.17: Schematic of round and square-edge designed IOLs: A. Round-edge IOL does not cause a bend in 
the posterior capsule so room is still available for LEC migration from the equator region onto the previously 
cell-free posterior capsule.  B. Square-edge design IOL creating a bend in the posterior capsule and applying 
pressure to the posterior capsule creating a tight fit. Minimal space for LEC migration is present maintaining 
cell free posterior capsule. 
A. 
Round Edge 
B. 
Square Edge 
  
30 
Chapter 1: Introduction 
Based on a rabbit study Nishi et al. showed that PCO levels were significantly lower in 
the square edge hydrophobic acrylic (AcrySof®) IOL compared to silicone and PMMA 
round edged IOLs.  Capsular bags were examined 2, 3 and 4 weeks after implantation 
[91].  Oshika et al found similar inhibition of PCO with the square edge Acrysof® IOL [92].  
It was later shown by Nishi and Nishi that it was the square edge design of a PMMA and 
an Acrysof® IOL that could prevent migration of LECs.  The benefit resulting from the 
square edged IOL was illustrated using a rabbit model with a follow up time of 3 weeks 
[93].  Peng et al demonstrated this square edge barrier effect in human pseudophakic 
autopsy eyes.  PMMA, silicone and hydrophobic acrylic (AcrySof® IOL) were studied.  
Square edge Acrysof® IOLs blocked LEC growth on the posterior capsule in more cases, 
when compared to square edge PMMA IOLs.  Silicone IOLs could not hinder LEC growth 
[94].  Ayaki et al later showed that the finishing of experimental 3-piece hydrophobic 
acrylic elastomer IOLs influenced the level of PCO, in a rabbit model.  When IOLs had 
been tumbled and polished it led to significantly more PCO due to the edge being more 
curved than no finishing of the edge.  Ayaki et al also evaluated the level of PCO 
between three clinical IOLs, Acrysof® MA30BA, Sensar® AR40 and CeeOn® 911.  The 
round edge Sensar® IOL had significantly more PCO amongst the clinically available IOLs.  
Supporting the theory that sharp edge acrylic IOLs are superior to round edge 
equivalents [95].  In a further rabbit study by Nishi et al no differences were seen in PCO 
rates when comparing two square edge design IOLs, the hydrophobic acrylic IOL (Alcon 
AcrySof® MA60BM) and the 3-piece silicone IOL (Pharmacia CeeOnTM 911) [96].  
Leading them to believe the shape was key to reducing the effect of migrated LECs and 
PCO rather than IOL material.   
 
The Acrysof® IOL has been shown to have some adhesive properties, which encourages 
LEC  adhesion in a single monolayer, which bonds the IOL to the capsule [22].  Linnola et 
al proposed the sandwich theory as an explanation for the variable PCO formation with 
different IOLs.  The sandwich theory was presented in 1997 and explains that during 
cataract surgery a CCC is performed to allow the IOL to be implanted.  The remaining 
anterior capsule bonds to the surface of the IOL directly, or as a result of the remaining 
LECs.  This leaves the anterior capsule clear and seals the IOL onto the capsular bag.  
LECs proliferate from the equator region onto the posterior capsule where they meet 
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the 900 edge of the IOL, which partly hinders and directs the proliferating cells to form a 
monolayer, thus creating a bond to the posterior capsule (Figure 1.17).  Since only a 
monolayer of LECs are present on the posterior capsule the capsule remains clear, in the 
same way the anterior capsule does. Some of these cells later die as a result of increased 
pressure on the posterior capsule, ageing and poor nutrition.  Linnola later showed that 
not only does the Acrysof® IOL allow LEC attachment but also ECM attachment.  The 
adhesion of fibronectin, vitronectin, laminin and collagen type IV to Acrysof®, hydrogel, 
silicone and PMMA IOLs was investigated in pseudophakic human autopsy eyes.  
Fibronectin is a major glycoprotein and is found in the body where firm binding is 
required.  Fibronectin was the most dominant ECM molecule present on all IOLs.  
Fibronectin strongly adheres to collagen, therefore the collagen capsular bag severed as 
a mediator to attach the IOL to the posterior capsule.  Results from pseudophakic 
autopsy eyes showed a sandwich-like structure consisting of, the posterior capsule, 
fibronectin, LECs, fibronectin and IOL, or with the posterior capsule bond to the IOL 
directly via fibronectin.  This bond prevents further in-growth of LECs onto the posterior 
capsule, suggesting fibronectin is produced before LECs proliferate.  This was seen 
significantly more in the Acrysof® group than in the hydrogel, silicone or PMMA IOLs [22, 
97-101].  Linnola et al noted that there was a greater amount of vitronectin adhered to 
Acrysof® than PMMA and silicone IOLs [98].  Johnson also found more fibronectin 
adsorbed onto Acrysof® than PMMA lenses with saturation occurring within 2 hours at 
50µg/ml [5].  
 
The IOLs described in this IOL design section have been monofocal IOLs which mean 
they do not correct for visual inaccuracies.  There have, however, been recent 
developments towards toric multifocal and accommodative IOLs in the past ten years, 
yet these still suffer from PCO [102-104].  These can vary in terms of their design and 
shape [105-106].  In addition IOLs are also being used in refractive surgery to correct 
myopia or hyperopia in a phakic eye (with natural lens), as an alternative to laser surgery 
or correction via contact lenses or glasses [107-108].  Due to this the demand on IOLs as 
ophthalmic implants is vast, therefore complications associated with IOL shape and 
material and their effect on PCO, needs to be fully understood for the field to progress 
and advance [31].  
  
32 
Chapter 1: Introduction 
1.10 Polymers for Controlling Cellular Response 
Covalent binding allows modification of a surface without affecting the bulk materials, 
and achieves a stable bond between the added functional group, and the biomaterial 
surface.  This offers a wide scope for attaching various functional groups to a surface 
offering chemical stability.  Functional groups often employed in covalently bounding 
include hydroxyl (-OH), amine (-NH2), amide (-CONH2) and carboxyl (-COOH) groups.  
There has been much use of poly(ethylene glycol) (PEG) in biomaterials applications via 
covalent binding.  PEG is hydrophilic and as a result has the ability to decrease non-
specific binding of proteins and cellular adhesion. It also has non-toxic and non-
immunogenicity properties, therefore has been added to several biomaterials.  This can 
be achieved via direct covalent binding to the hydroxyl group present at either end of 
PEG.  Covalent binding can be achieved by utilising various coupling agents such as, N-
hydroxysuccinimide (NHS) and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC).  
NHS increases electron attraction and reacts to activate carboxylic acid groups to 
promote amide bonds.  EDC is also used to activate carboxylic acid increasing their 
reactivity towards amines and hydroxyl groups, it promotes coupling reaction and 
therefore efficiency [109].  
 
Danion et al bound PEG onto pHEMA contact lenses with the aim of immobilising 
ophthalmic drugs.  Hydroxyl groups present on the surface of the contact lenses were 
activated via coupling reagent N,N’-disuccinimidyl carbonate (DSC).  Poly-(ethylenimine) 
(PEI) was added to the surface of the contact lenses to encourage amine groups.  PEG 
was grafted onto the PEI layer using NHS carbodiimide reaction.  Intact liposome layers 
preloaded with a fluorescent dye were bound onto the anterior and posterior surface of 
the contact lenses, to monitor the release for the later purpose of drug delivery.  
Release of the fluorescent dye showed good stability of the intact liposomes when 
stored for up to a month at 4°C [110].  mPEG is the mono-functionalised derivative of 
PEG and reduces unwanted crosslinking, but still retains the beneficial properties of PEG.  
BioInteractions Ltd. bound mPEG onto soft contact lenses to reduce protein adhesion 
and spoiling via a coupling agent, 1,1’-carbonyldiimidazole (CDI).  This again activates 
carboxylic acid groups and forms esters between carboxylic acid and PEG [109].  Various 
studies have investigated the potential of PEG to reduce protein adsorption and platelet 
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and cell adhesion [111-115].  Kim et al investigated the cellular adhesion effect on PEG 
grafted onto PMMA IOLs by implantation using a rabbit model.  Results showed a 
significant reduction in cellular adhesion, indicating the potential of PEG to decrease 
cellular debris and formation of foreign body reaction and PCO [114].   
 
PEI has been used for various biomaterial applications to induce cellular attachment and 
proliferation [116-117].  Lakard et al examined the potential of several amine-based 
polymers polyethyleneimine (PEI), polypropyleneimine (PPI), polypyrrole (PPy) and poly( 
p-phenylenediamine) (PPPD), as an alternative to poly-L-lysine, which is commonly used 
as an adhesive molecule. Rat neuronal cells were investigated for their adhesive, 
proliferative and morphological properties on the above polymers.  PEI and PPI both 
encouraged a higher number of cellular attachment compared to PPy and PPPD, with 
typical morphological growth, indicating their use as an adhesion molecule for 
biomaterial surfaces [118].  PEI has also been shown to encourage cellular attachment 
in, human embryonic kidney cells, rat pheochromocytoma cells and human fibroblast 
cells [119]. 
 
As mentioned early the surface chemistry can control cellular adhesion via protein 
adsorption, however, as polymeric surfaces can undergo conformational 
rearrangements in responses to environmental conditions, work has been carried out to 
produce a defined and controlled substrates [120-122].  Cells are reported to have 
greater adhesion to surfaces containing COOH and NH2 functional groups, than those 
with CH3 and OH groups [122].  Amine groups have therefore been added to various 
substrates for the purpose of encouraging cellular attachment and growth [123-124].  
Keselowsky et al demonstrated conformational differences in adsorbed fibronectin and 
varying cellular adhesion onto four self assembled monolayers (SAMs).  Four functional 
end groups, CH3 (nonpolar hydrophobic surface), OH (neutral hydrophilic surface), COOH 
(negatively charged surface) and NH2 (positively charged surface) were investigated.  
Fibronectin was adsorbed onto the different SAMs at various concentrations and 
measured.  More fibronectin was adsorbed onto positively charge NH2 and least on 
neutrally charged OH SAMs.  A centrifugation cellular adhesion assay was performed 
and SAMs were coated with a range of fibronectin densities.  The results showed that 
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cells adhered strongly to OH SAMs at lower fibronectin density.  NH2 and COOH SAMs 
had comparable cellular adhesion at intermediate fibronectin densities and CH3 SAMs 
had comparable cellular adhesion only at high fibronectin densities.  These results 
demonstrate the surface chemistry affects the fibronectin adsorption and cellular 
adhesion strength between SAMs [3].  Lee et al examined human erythroleukemia 
(K100) cellular adhesion onto COOH, NH2, and CH3 SAMs.  NH2 SAMs had a significantly 
higher number of adhered cells compared to COOH and CH3 [122], Indicating that 
properties such as the surface charge and functional group govern cellular behaviours. 
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1.11 Glycosaminoglycans 
Glycosaminoglycans (GAGs) are long chains of polysaccharide units that are synthesised 
in the Golgi apparatus[125].  Their linear sugar chains can be sulphated at various points 
[126-127].  They are found in the ECM and on cell surfaces themselves.  GAGs are known 
to be involved in cell cycle regulation due to their rigidity and integrity, which allows for 
cell migration, proliferation and differentiation, particularly with epithelial cells.  They 
also have the ability to bind to growth factors, and can be covalently attached to a 
protein to form a proteoglycan.  If GAG functionalised surfaces could encourage a 
desired protein adsorption layer they could be utilised to manipulate cell behaviour 
[128-130]. 
 
Heparin (HEP) is derived from heparan sulphate and is widely used in anticoagulation 
drugs.  HEP is stored in the granules of mast cells and when realised prevents clotting.  
Heparin is widely used after surgery to prevent clotting especially where mobility is 
hindered [126]. 
 
Hyaluronic acid (HA) otherwise known as hyaluronan is the only GAG that is not 
sulphated, meaning it cannot be covalently bound to other proteins [9].  It is not 
covalently linked to a core protein unlike other GAGS and is said to be the simplest GAG 
[126].  Rather than being synthesized in the Golgi, HA is produced in the plasma 
membrane by hyaluronan synthase [126].  HA is found in the ECM and is responsible for 
cellular behaviours such as promoting proliferation, along with cell-cell and cell-matrix 
adhesion [129-133].  HA has a long mobile molecular chain with a high molecular weight 
and is highly negatively charged [126].  It has the capacity to bind one part HA to 100 
parts water.  HA takes the form of a hydrated hydrogel like substance and in the body is 
used as a space filler, providing structural support [126].  During embryonic 
development epithelial cells secrete HA to create space for new cells to proliferate 
[126].  It is present in the vitreous at 0.02 – 1mg/cm3 [128, 131], the aqueous at ~1.1-
1.14 µg/ml [130, 134], the lens as well as other places in the body such as synovial fluid 
and cartilage.  HA is used in ophthalmology, as a constituent in eye drops, to promote 
corneal wound healing and in the viscoelastic material used in cataract surgery.  The 
viscoelastic material protects the inner surface of the cornea, retains the cornea space 
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and allows the surgeon room to operate and insert instruments [9, 126, 128-133].  If 
immobilised in the appropriate way with the right configuration HA could be a non-
fouling polymer, inhibiting protein and cellular adhesion [9].  
 
Chondroitin sulphate (CS) is another major GAG that is present within the ECM, and has 
similar responsibilities for regulating cell behaviour as HA.  Sulfation of CS can occur in 
two positions, chondroitin-4-sulfate (C4S) and/or chondroitin-6-sulfate (C6S).  They both 
contain carboxylated and sulphated charged groups within the disaccharide unit, and 
can either occur separately or together depending on the tissue [126].  CS is present in 
the anterior capsule but diminishes with age [135].  CS is also sometimes used in these 
viscoelastic products to aid cataract surgery [2]. 
 
As the capsular bag has structural and physiological changes with age Winkler et al 
examined the basal membrane of the anterior capsule for proteoglycans, in patients 
that had senile cataracts.  To explore these age dependent changes four removed 
anterior capsulorhexis explants were received from people with senile cataracts (aged 
between 67 – 87).  Four younger donors were used as a control, two who suffered from 
congenital cataracts (aged one and two) and two who suffered from perforating eye 
injuries (both aged 20).  Biochemical and immunological analysis was used to examine 
distribution of heparin, chondroitin-6-sulphate and dermatan sulphate across the full 
thickness of young and senile anterior lens capsules.  This showed the capsule to have a 
complex composition of proteoglycans, the most dominant being heparin, but 
chondroitin sulphate was also present.  GAGs appeared as a thin lamina layer in the 
control (younger) anterior capsulorhexis explants.  Heparin stained very strongly. 
Chondroitin-6-sulphate and dermatan sulphate were also present but with a less 
prominent layer in the humoral surface (outer surface which is in contact with the 
aqueous).  In senile cataract anterior capsulorhexis explants heparin appeared distorted 
and not heterogeneous in the humoral surfaces.  In both senile and young lens 
capsulorhexis explants heparin was most prominent when lens epithelial cell loss had 
occurred (clean up of LEC during surgery).  This demonstrates the changes in GAG 
distribution with age across the capsular bag, with the most prominent GAG being 
Heparin [135]. 
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GAGs have been used with several cell types to tailor the cellular response by 
encouraging or preventing cellular attachment [136-138].  Heng et al characterises 
human umbilical vein endothelial cell (HUVEC) adhesion and proliferation on HA, HEP 
and CS, using either poly-L-lysine or chitosan as an underlying layer.  Significant 
differences in the percentage of cellular adhesion were seen at early time points on the 
different underlying layers, however these became insignificant at later time points.  HA 
resulted in the least amount of cell proliferation regardless of the underlying layer.   HEP 
and CS encouraged a similar amount proliferation by day 10 with no significant different 
between the GAGs.  These results indicate the three GAG coatings produce different 
cellular growth profiles with HUVEC.  Coatings functionalised with HEP and CS could 
encourage endothelial cellular attachments [137].  Contrasting results were seen in 
dermal fibroblasts.  Attia et al examined the cellular response on polysulfone substrates 
bound with HA and CS.  CS did not promote cellular adhesion whereas HA encouraged 
cellular adhesions and supported proliferation, meaning the cellular type and underlying 
layer may influence cellular attachment [138]. 
 
Uygun et al investigated if GAGs on chitosan membranes could increase the growth of 
mesenchymal stem cells (MSC).  Six GAGs, HEP sodium, heparin, CS4, CS6, HA and 
dermatan sulphate (DS), at six different ratios, 0.04, 0.08, 0.1, 0.2, 0.5 and 1.0mg 
GAG/mg chitosan, were chosen to examine their influence on MSC proliferation, 
spreading and differentiation.  The GAGs were immobilised onto chitosan membranes in 
one of two ways. In the first method GAGs were added onto chitosan membranes 
overnight at 4°C then covalently linked to the chitosan membrane using EDC solution, 
for 24 hours at room temperature (referred to as immobilisation followed by covalent 
binding, ICB).  In the second method GAGs were activated using EDC solution for 15 
minutes then added to chitosan membranes for 24 hours at room temperature (referred 
to as direct covalent immobilisation, DCI).  Presence of the GAGs on the surfaces were 
determined by staining with toluidine blue, the amount of GAG bound to a surface was 
determined by using safranin-O dye and determined indirectly by measuring the 
reaction solution and the wash solution.  More GAGs were immobilised onto the 
surfaces via the ICB method than the DCI method.  As the concentration of GAG 
increased so did the level of GAG immobilised onto a surface, there was only slight 
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variations between GAGs.  The DCI method had more variation in terms of bound GAG 
ranging between 39.9 – 92.1%.  The ICB method produced swollen and rough surfaces 
regardless of GAG type that did not allow cells to attach, whereas the DCI method 
produced smooth surfaces.  On the DCI method for all GAG types cell growth was 
increased with the increasing concentration of GAG.  C4S produced the highest cell 
density at 1 mg/mg.  The morphology of the cells were examined by fluorescent staining 
for phalloidin and vinculin, a focal adhesion protein which if present at the ends of actin 
fibres suggests integrin involvement in cellular adhesion.  Heparin, HS, C4S and HA 
showed significant levels of cell spreading from phalloidin staining and had some 
vinculin present inside the cell.  MSCs on C6S and DS were less spread and had 
disorganised actin fibres.  Whereas the actin fibres of HA and C4S were aligned and 
similar to tissue culture plastics, vinculin was also found at the end of these actin fibres 
indicating integrin involvement.  This study gives an indication as to how cell behaviour 
and adhesion can be controlled with different GAG types and concentration [139]. 
 
D’Sa et al examined LECs response to HA coatings. HA was immobilised onto 
atmospheric pressure plasma modified polystyrene substrates. Amine groups were 
added to the coatings via silinisation.  HA was covalently bound to the surface at 1mg/ml 
and 3mg/ml via carbodiimide coupling reaction using EDC/NHS agents.  The results 
showed a significant reduction in LECs attachment at 24 hours and 48 hours post 
seeding, indicating HA exists in a confirmation that could provide a steric layer to 
inhibiting cellular attachment [9]. 
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1.12 Transforming Growth Factor Beta 
Within the lens TGFβ2 plays a role in dedifferentiation and capsular wrinkling [140-141], 
it is realised postoperatively as part of the natural wound healing response (Figure 1.18) 
[56-58].  It can also lead to the expression of ECM proteins such as fibronectin [142] 
which is associated with PCO [143].  There are three isoforms of the TGFβsuper-family, 
TGFβ1, TGFβ2 and TGFβ3, they all contribute to cell proliferation, migration, 
differentiation and apoptosis.  They share between 70 – 80% homology and signal using 
the same cell surface receptors, however, depending on the cell type, they display 
different and sometimes opposing effects in vivo.  TGFβs are unable to send signalsto 
the cell nucleus without first binding to a receptor.  TGFβs are expressed in an inactive 
form and must attach to these receptors before a signal is passed through the cell 
cytoplasm to the nuclei.  In detail, the inactive part contains propeptide and latent TGFβ 
binding protein (LTBP).  Either proteolysis or pH regulation activates TGFβ, which allows 
it to bind to type 2 receptor (TβR-II) on the cell membrane, and recruits type 1 receptor 
(TβR-I) in the cell cytoplasm.  Further phosphorylation of TβR-I by TβR-II activates 
SMAD2 and SMAD3, which transmits TGFβ signals to the nucleus (Figure 1.18) [24, 143]. 
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Figure 1.18: Schematic demonstrating the process of TGFβ activation and signalling (in the context here 
of a lens epithelial ell (LEC)).  Latent TGFβ contains TGFβ propeptide and LTBP.  It is activated by 
proteolysis or pH regulation, which allows it to bind to type 2 receptor (TβR-II) and recruits type 1 
receptor (TβR-I).  Further phosphorylation of TβR-I by the TβR-II activates SMAD2 and SMAD3 which 
transmits TGFβ signals to the nucleus.  Depending on the cell type transcript factors turn genes on/off, 
in the example here of a LEC fibronectin is up regulated after TGFβ2 activation.   Adapted from Hao et al 
[143].  
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The effect TGFβ has on LECs and fibres are distinctively different, for example, TGFβ is 
required to promote normal differentiation events in lens fibres, whereas in LECs TGFβ is 
associated with the fibrosis seen after cataract surgery [24, 142].  TGFβ1 was first 
studied in rat LECs in vitro by Lui at al.  They showed that cultures incubated with 
20ng/ml of TGFβ1 underwent rapid elongation and accumulation of ECM, capsular 
wrinkling and cell death.  Whilst all three isoforms have the potential to cause these 
changes within the eye, TGFβ2 is the most abundant and the most potent [140, 144].  
 
Hales et al reported opacities or plaques of abnormal cells across the anterior capsule 
when whole rat lenses were cultured with 5ng/ml of TGFβ2.  Cuboidal epithelial cells 
usually present on the anterior capsule had been replaced with spindle shaped 
multilayer cells, with areas of contraction.  Lenses treated with TGFβ2 had positive 
expression of αSMA, laminin and collagen type I, components not usually present or 
associated with the LECs.  Control samples showed no positive staining for these 
molecules [141].  Lovieu et al performed a similar study where similar ECM and 
cytoskeleton markers were present, including the addition of collagen type III and 
fibronectin [145].   
 
Wormstone et al has contributed to research on TGFβ2 secretion using a human 
monoclonal antibody neutralising TGFβ2, called CAT 152 [56, 74].  Wormstone found 
that when capsular bags from donor eyes were incubated in vitro with 10ng/ml of 
TGFβ2 and 10µg/ml of CAT 152 capsular bags did not show any contractile effects or 
light scatter.  Capsules appeared severely wrinkled when CAT 152 was not present.  CAT 
152 suppressed TGFβ2 induced expression of αSMA and fibronectin, compared to 
capsular bags incubated with TGFβ2 in the absence of CAT 152 [146].  Further studies 
examining TGFβ2 signalling in LEC line FHL124 also supported this.  LECs were cultured in 
5% serum for 3 days and serum starved for 2 days before exposure to experimental 
conditions for 24 hours.  Experimental conditions were medium supplemented with 
10ng/ml TGFβ2 with and without CAT 152 (0.1-10µg/ml).  CAT 152 again successfully 
inhibited contractile induced behaviour of TGFβ2 and αSMA expression [147].  
Wormstone et al also showed that even short term exposure of LECs to TGFβ2 (2 days) 
induces long term morphological changes and a fibrotic response, characterised by up-
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regulated expression of αSMA, 28 days later [74].  This is in agreement with Hales et al 
conclusions on rat LECs [58]. 
 
There has been much recent research in the role of TGFβ3 in cleft palate and wound 
healing. Cleft palate is the failure of palatal midline epithelial seam (MES) cells to fuse 
during development, meaning the epithelium never forms a single confluent palatal 
mesenchymal structure.  TGFβ3 has been shown to regulate these interactions and is 
expressed abundantly by the palatal medial edge epithelial (MEE) cells [143, 148].  In 
cleft palate the expression of TGFβ3 is significantly reduced.  In a study using TGFβ3 null 
mice cleft palate occurred in 100%, therefore is believed to be critical for the adhesion 
and fusion of the MEE cells [143].  This was also reported by other authors [148-151].  In 
vitro Brunet et al used neutralising TGFβ1, 2 and 3 antibodies to block their activity.  This 
showed that by blocking TGFβ3 activity normal palate development was disrupted, and 
by 72 hours the MEE had not adhered and the midline seam had not fused.  When 
antibodies specific to blocking TGFβ1 and TGFβ2 were used no effect on palate fusion 
was observed and cultures appeared similar to untreated controls [152].  This shows 
that TGFβ3 is critical in palatal fusion and therefore may play a role in epithelial 
monolayer formation [143]. 
  
Scar free wound healing in skin is seen in early embryos but not in adults.  Cowin et al 
characterised TGFβ's in fetal and adult wounds.  TGFβ1 and TGFβ2 were seen at low 
levels in fetal wounds, TGFβ3 was expressed in the epidermis of fetal skin.  All three 
isoforms were present in adult wounds.  However when adult wounds were treated with 
TGFβ3 there was noticeable improvements or even scar free wound healing.  It was 
concluded that TGFβ3 produces a regenerative healing response in epithelia, potentially 
leading to scar free healing [153], whereas TGFβ1 and TGFβ2 have been associated with 
fibrotic scarring [143, 153-155]. 
 
TGFβs were also investigated by Karamichos et al, to encourage corneal fibroblasts to 
deposit ECM in a similar manner seen during stromal development.  TGFβ1, TGFβ2 or 
TGFβ3 was added to the growth media at a concentration of 0.1ng/ml.  All isoforms 
increased cell number and ECM production when compared to control (no TGFβ).  
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TGFβ1 and TGFβ2 caused expression of collagen III and α-smooth muscle actin, however 
this was not seen in TGFβ3 cultures.  TGFβ3 stimulated matrix alignment and seemed to 
mimic the natural cornea, whereas TGFβ1 and TGFβ2 demonstrated a fibrotic response.   
TGFβ3 is currently being used in several studies to reduce scar tissue in skin.  Shah et al 
showed that TGFβ3 greatly reduces scar formation.  Incisions were made in the 
subcutaneous skin of rats.  Incisions were injected with varying concentrations of TGFβ1, 
TGFβ2, TGFβ3, anti-TGFβ1 and anti-TGFβ2.  Control wounds were either left untreated 
or injected with PBS 0.1% BSA.  Rats injected with TGFβ1, TGFβ2 and controls had stiff 
white scarring four months post treatment.  Rats injected with anti-TGFβ1 and anti-
TGFβ2 had a marked reduction in scar formation.  Rats treated with TGFβ3 had reduced 
deposition of collagen type I and III and fibronectin compared to controls, and wound 
site showed little to no scarring.  This demonstrates specific isoform roles of TGFβ in scar 
formation [156].   
 
There is therefore the possibility to use TGFβ3 as a tool to reduce scaring elsewhere in 
the body.  One company called “Ronova” introduced a pharmaceutical agent containing 
TGFβ3 known as “Jusitva™”.  The aim of “Jusitva™” was to prevent and reduce scar 
formation.  Clinical trials in over a 1000 patients have been performed.  Occelston et al 
reported successful results for the phase I and II UK clinical trials with 34 month follow 
ups, no safety or tolerability issues were reported.  Appearance of scar tissue was 
evaluated by both the surgeons and histological analysis.  Scarring was significant 
improvement when wound margins were injected with “Jusitva™” compared to a 
placebo, causing a prevention and reduction of scarring and fibrotic response [157].   
 
Further evaluation of “Jusitva™” in a phase III EU trail however proved unsuccessful 
when primary and secondary endpoints were not met.  Primary endpoints were 
evaluated based on photographic assessment 12 months postoperatively.  Photographs 
were evaluated by an independent panel and graded against the Global Scar 
Comparison Scale.  Secondary endpoints used the same Global Scar Comparison Scale 
but were evaluated by the patients themselves and the clinical investigator.  Over 350 
patients were recruited from the EU and two concentrations of “Jusitva™” were 
evaluated, 200ng and 500ng/100ul/linear cm of wound margin, administered twice 
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following wound closure and 24 hours later [158].  These results were surprising after 
the success of phase I and II trails.  This opens up more questions than answer, and 
curiosity about what is happening at the gene level and what interaction TGFβ3 has on 
wound healing. 
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1.13 Novel BioInteractions Ltd Materials 
The level of PCO is dependent on the material therefore possible surface modifications 
can be considered to control cell attachment and aim to tailor the cellular response.  As 
previously mentioned cells interact with the surface of the IOL, therefore the 
biocompatibility is primarily influenced by this surface.  Characteristics such as 
wettability, surface chemistry and surface topography can greatly affect the 
biocompatibility.  Modifications to the surface properties can influence the cellular 
response, without changing the bulk material [83].  This was the approach taken with 
BioInteractions Ltd.  Using BioInteractions Ltd. techniques and expertise potential 
coatings for IOLs were developed and examined. 
 
The materials tested in this PhD have been supplied by BioInteractions Ltd who are 
based at Reading University.  Their focus is on producing specialised coatings for a range 
of cardiovascular devices and catheters, providing non-thrombogenic, anti-
thrombogenic and drug delivery opportunities.  These coatings aim to minimise human 
host response which causes protein deposits, inflammation and fibrosis, inevitably 
resulting in device failure and patient discomfort.  Their technology uses a layer by layer 
technique to build up the coatings with desirable functional groups to tailor a desired 
cellular response for a given application.  BioInteractions Ltd. wished to expand their 
coatings and expertise to ophthalmic implants.   
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1.14 Hypothesis and Aims 
The hypothesis for this PhD was that PCO can be prevented by surface modified coatings 
for potential IOLs, to control the cell-surface interactions, without affecting the bulk 
material. 
 
There are two ways that this can be approached:  
1. Firstly, LECs are less likely to cause any adverse scarring if they maintain their 
phenotype.  If a surface coating (of an IOL) could encourage a monolayer of LECs 
to grow that could sandwich the back of the IOL to the capsular bag, this would 
maintain a clear light path to the back of the eye. 
2. Secondly, if a surface coating (of an IOL) could inhibit cell migration, it would 
prevent wrinkling and contraction of the posterior capsule, therefore 
maintaining a clear light path to the back of the eye. 
 
The aims of this project were: 
1. To evaluate the surface properties and LEC response to existing BioInteractions 
Ltd. coatings (001, 002, 003, 004 and pHEMA) and use these results to suggest 
new coatings that could be developed to produce the desired effect. 
2. To investigate if glycosaminoglycans could be attached to a material and used as 
coatings for IOLs to influence the cellular response.   
3. To investigate the influence of surface wettability and topography of coatings 
with zwitterionic characteristics on cell attachment. 
4. To establish a model for dedifferentiation of LECs and, particularly, the role of 
TGFβ2 and TGFβ3 in LEC dedifferentiation and investigate if manipulation of the 
levels of these cytokines could be used to reduce the scarring response 
following cataract surgery.  
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2. Material and Methods 
 
2.1 Material Coatings and Techniques 
This section outlines the material coatings provided by BioInteractions Ltd. and the 
experimental techniques used to evaluate them. 
 
2.1.1 Material Coatings 
Polymer surface coatings provided by BioInteractions Ltd. were built up using a layer by 
layer technique.  All the coatings provided by BioInteractions Ltd. are listed in the table 
below, grouped into experiments along with details of the cell staining method and 
surface analysis performed on each group (Table 2-1).  Coatings and experimental 
procedures will be explained further in the relevant sections to follow. 
 
Table 2-1:  Coatings provided by BioInteractions Ltd., cell line used, duration and experimental procedures   
Experiment Group Coating Name Cell Line Duration  Staining Surface Analysis 
Group One 
polyethylenimine 
(PEI) + 
anticoagulation 
polymers 1 
001 
FHL124 7 days 
Mayer’s 
haematoxylin and 
live/dead assay 
N/A 
004 
pHEMA 
Group Two 
PEI + 
anticoagulation 
polymers 2 
001 
FHL124 14 days 
Propidium Iodide 
(PI) and Phalloidin  
Contact angle, 
scanning electron 
microscopy (SEM) 
and white light 
interferometry 
(WLI) 
002 
003 
Group Three 
Glycosaminoglycan 
(GAG) polymers 
Hyaluronic 
acid 
N/N100
3A 
14 days 
4′,6-Diamidino-2-
phenylindole 
dihydrochloride 
(DAPI), Phalloidin 
and alpha-smooth 
muscle actin ( 
αSMA) 
Contact angle, 
SEM and WLI 
Chondroitin 
sulphate 
Heparin 
Group Four 
Zwitterionic 
Polymers 
F 
N/N100
3A 
7 days 
DAPI, Phalloidin,  
αSMA and 
resazurin 
Contact angle, 
SEM and WLI 
G 
H 
I 
J 
K 
L 
M 
 
  
Polymer coatings provided by BioInteractions Ltd. grouped into experiments 1 - 4.  For each group the 
coating codes are present, details of what cell line was used, duration of each experiment, what staining 
was performed and what surface analysis techniques were used.  All coatings were sterilized for 5 minutes 
at 150J/cm
2
 using CL-1000 ultraviolet crosslinker (UVP) prior to use. 
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2.1.2 Cell Culture Techniques 
All cell culture was carried out using a class II microbiology hood.  Microbiology hoods 
were cleaned with virkon (Du Pont) and 70% ethanol (University of Liverpool’s Chemistry 
Department).  All cell vessels were purchased from Greiner Bio One and cells were 
cultured in the incubator at 37°C at 5% CO2.  All phosphate buffered solution (PBS, 
Oxoid) used was calcium and magnesium free.  Three cell lines were used throughout 
this study (Table 2-2).  Cells were maintained in minimum essentials medium eagles 
(MEME, Sigma Aldrich) supplemented with either, fetal calf serum (FCS, Biosera) or 
rabbit serum (RS, Sigma Aldrich) and 1 % L-Glutamine (L-Glut, 200mM, Sigma Aldrich).  
  
Table 2-2: Details of the three cell lines used throughout this PhD project 
Cell 
Type 
Code Origin Culture 
Conditions 
Human-
LEC 
FHL124 kindly donated by Dr John Reddan of 
Oakland University, MI, USA 
MEME + 5% FCS 
+ L-Glut  
Human-
LEC 
B3  kindly donated by Barbara Pierscionek 
of University of Ulster, Coleraine, 
Northern Ireland 
MEME + 10% FCS 
+ L-Glut 
Rabbit-
LEC 
N/N1003A 
 
kindly donated by Dr John Reddan of 
Oakland University, MI, USA 
MEME +8% RS + 
L-Glut 
 
 
 
Cells were fed every 2 – 3 days by removing around ⅔ of medium from the flask or well 
and replacing with fresh medium.  Cells were checked at the same time under the phase 
contrast microscope, Diaphot (Nikon) for abnormal growth and infections.  All cell lines 
became confluent within a week.  Once cells became confluent FHL124 LECs were 
passaged at a 1:3 ratio, B3 and N/N1003A LECs were passaged at a 1:5 ratio.  To passage 
cells all culture medium was removed from the flask or well and cells were washed with 
PBS.  A solution of 0.5mg/ml porcine trypsin and 0.2mg/ml EDTA (trypsin, Sigma Aldrich, 
UK) in PBS was used.  Enough solution was added to cover the base of the vessel and 
cells were incubated for ~4 minutes at 37°C.  Cells were then removed from the 
Table details human and rabbit LEC lines used, including code names, where they were obtained from, 
what culture medium was used and the concentration of serum that was used. 
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incubator and viewed under the microscope to ensure all cells had dislodged.  The 
trypsin was quenched in medium containing serum, transferred to a universal and 
centrifuged at 1000 RPM (180g) for 5 minutes.  Once finished the supernatant was 
discarded (cell freezing or cell counting was performed if necessary sections 2.1.3 and 
2.1.4).  The pellet was resuspended in fresh medium and split at the appropriate ratios 
mentioned above into new flasks or wells, and placed in the incubator.  FHL124’s were 
kept to approximately passage 25, B3 and N/N1003A LECs were kept to approximately 
passage 45.  All cells lines were stained for cytokeratin, as a marker for epithelial cells, 
and alpha B-crystallin to characterise their phenotype (2.1.17). 
 
2.1.3 Freezing and Retrieval of LECs 
Freezing down cells was routinely carried out to create a stock of cells that could be 
used at a later date.  Cells were removed using trypsin and centrifuged, as detailed 
above.  The pellet was suspended in 900µl of fresh MEME containing 20% FCS or 20% RS 
(depending on the cell type) and transferred to a cryovial.  100µl of cryopreservation 
medium, dimethyl sulphoxide (DMSO, Sigma Aldrich, UK), was added gradually in a 
swirling motion to mix the solution.  Cryovials were labelled and then placed in the 
isopropanol container, “Mr Frosty®”, (Nunc International, UK) and stored in a -80°C 
freezer.  This provided a repeatable cooling rate of -1°C/minute before transferring the 
cyrovials into the liquid nitrogen dewar, (at -196°C) for long term storage.  Cells were 
retrieved by warming a cryovial in the water bath (37°C) for a couple of minutes until 
thawed.  Cell solution was then transferred into a universal containing 10 - 15ml of fresh 
warm medium containing serum, to dilute the DMSO.  Cells were then centrifuged 
(2.1.2), however this time all resuspended cell solution was transferred into one flask. 
 
2.1.4 Seeding Cells 
Throughout this PhD cells were seeded at a known density per cm2 onto tissue culture 
treated polystyrene (TCPS) plates and surface coatings provided by BioInteractions Ltd. 
and monitored for a period of days.  To do this a haemocytometer was used to count 
the cells.  Cells were lifted from the flask using trypsin (outlined above in section 2.1.2) 
and centrifuged.  Cells were resuspended in fresh medium and 20µl of the cell solution 
was pipetted into the haemocytometer.  Cell counts were taken from the four corner 
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grids of the haemocytometer chamber.  The total number of cells was averaged to give 
the number of cells/ml.  Based on the required seeding density and area of the well cells 
would be seeded into, the volume of cell solution per well was calculated.  The 
remaining volume of medium needed per well was then calculated.  The total volume of 
cell solutions needed for all wells for the experiment was calculated, and added to the 
correct volume of fresh medium in a glass bottle and mixed well prior to seeding.  Using 
a multivolume dispenser pipette, 1ml of the cell/medium solution was added into each 
well of a 24 well plate.  This volume varied slightly depending on the size of the plate 
used for each experiment.  Plates were placed in the incubator.  Representative phase 
contrast micrographs were taken throughout the study starting at day one and cells 
were fed every 2 – 3 days.     
 
2.1.5 Seeding Density Growth Curve 
A cell growth curve is a way of establishing the general growth pattern at different time 
intervals for a particular cell type.  To determine the optimum seeding density for 
FHL124 LECs, a seeding density growth curve was set up in a 24 well plate.  Initially three 
seeding densities were tested, 1x103/cm2, 1x104/cm2 and 1x105/cm2.  Four wells per 
concentration were set up, cells were counted on days 1, 4, 7 and 10.  Cells were 
counted using a haemocytometer.  This was then repeated at seeding densities, 
5x103/cm2 and 1x104/cm2, however this time cells were fixed, micrographed and cell 
nuclei were counted.  In order to visualise the nuclei, cells were stained with 100% 
Mayer’s haematoxylin (Leica Biosystems, UK, section 2.1.9).  Three random micrographs 
per well were taken using the inverted phase contrast microscope, images were 
analysed using ImageJ cell counter plug-in, by placing a marker on each cell to count 
cells per field of view (2.1.7).  Cells were considered to be mononuclear, therefore each 
nuclei counted corresponded to one cell.  The chosen seeding density was used for 
other cell lines to compare cell growth across all surface coatings. 
 
2.1.6 Serum Growth Curve 
The optimum serum concentration was not known for FHL124 LECs therefore a serum 
growth curve was set up using a similar method as detailed in 2.1.5.  Cells were seeded 
onto 24 well plates at a seeding density of 1x104/cm2.  The following serum 
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concentrations were tested, 5%, 10% and 20% FCS.  FHL124 LECs were fixed on days 1, 3 
and 4 with absolute methanol (Fisher Scientific, UK) and stained with Mayer’s 
haematoxylin (2.1.9).  Again three random images were taken per well using the 
inverted phase contrast microscope, and cells were counted using ImageJ cell counter 
plug in (2.1.7). 
 
2.1.7 Image Analysis for Coated Surfaces 
In order to analyse average cell growth on coatings, cells were stained with Mayer’s 
haematoxylin and micrographed using the Diaphot inverted phase contrast microscope 
(Nikon, UK), or fluorescently stained with Propidium Iodide (PI) or 4′,6-Diamidino-2-
phenylindole dihydrochloride (DAPI) and micrographed using the Axiovert 200 inverted 
microscope (Zeiss, UK).  To achieve an average cell count per field of view, three 
micrographs per well were taken with an x10 objective, or four micrographs with an x20 
objective.  For seeding density (2.1.5) and serum (2.1.6) studies random micrographs 
were taken.  For material coating studies micrographs were taken in approximately the 
same area each time to compare cell growth across coatings (Figure 2.1).  As the 
material coating should be homogenous one micrograph was taken near the centre, one 
to the left and one to the right.  Cells were considered to be mononuclear, therefore 
each nuclei counted corresponded to one cell.  Nuclei were counted and then averaged 
across all wells of the same coating for that time point.   
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Cells were counted using ImageJ version 1.45S software package (National institute of 
Health, USA) in one of two ways.  Either by using the cell counter plug-in to place a 
marker on the cell when clicked and count the total markers, or a macro configured to 
count cells automatically by converting the image to binary and counting the particles 
larger than 40 pixels. 
 
2.1.8 Harvesting Human Primary LECs 
Human donor globes were either retrieved from The Manchester Eye Bank or The Royal 
Liverpool University Hospital, following local ethical approval and conforming to the 
Human Tissue Act (2004).   Donor globes reached the laboratory within 48 hours post 
mortem.  All dissections were carried out in a class I dissection hood.  The dissection 
hood was cleaned, along with any equipment that was needed.  In order to retrieve the 
lens the whole globe was cut along the equator and the anterior segment removed.  The 
zonules were careful cut and the lens, with the capsular bag intact, was lifted free and 
placed on a piece of filter paper (Whatman, UK).  The paper allowed the lens to remain 
stable whilst performing a capsulorhexis.  A small amount of MEME or PBS was added to 
stop the capsular bag from becoming tacky and sticking to the paper.  A 25 gauge needle 
Figure 2.1: Schematic to illustrate the photographed area of each well for the purpose of cell counting.  The 
squares represent the approximate positions of photographed area in a well of a 24-well plate. As the 
coating should be homogenous three micrographs were taken in approximately the same area in each well.  
One in the centre, one to the left hand side and one to the right hand side. 
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(Sherwood Medical, UK) was attached to a 1ml syringe and was bent at 2 right angles to 
produce a step-shaped needle (Figure 2.2).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Using this needle a small nick was made in the capsule and a capsulorhexis was 
performed (Figure 2.3).  The lens was hydrodissected away from the capsular bag with a 
similar procedure to cataract surgery.  The remaining bag was removed from the filter 
paper and placed into a well of a 6 well plate epithelial side down, along with the 
removed anterior capsulorhexis explant.  The sample was incubated at 37°C with a small 
amount of MEME supplemented with 20% FCS, 1% L-Glut, 1% penicillin streptomycin 
(Pen-Strep, 10,000 units penicillin and 10mg streptomycin/ml, Sigma Aldrich) and  1% 
Amphotericin B (fungizone, 250μg/ml Sigma Aldrich).  More medium was added 1-2days 
later when the capsular bag explant had settled and adhered to the well.  Cells were fed 
every 3 – 4 days, by removing half the medium and replacing with fresh medium.   
 
 
 
 
Figure 2.2: Schematic of the bent needle used to perform capsulorhexis.  A 25 gauge needle attached to a 
1ml syringe.  The needle was bent in a step-shape to help perform a capsulorhexis on a human donor lens.   
Syringe 
Needle 
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Performing the capsulorhexis and hydrodissecting the lens out of the capsular bag can 
be very difficult and was not always successful.  As this method was inefficient a 
variation to the technique was made after a nick in the capsular bag had been made 
with the needle (Figure 2.4-A).  Using this nick a small section of the anterior capsule 
was cut away.  Using this hole in the anterior capsule, cuts were made towards the 
equator of the capsule using a pair of small surgical scissors (Figure 2.4-A).  These 
cuts/flaps were peeled back with a pair of forceps to reveal a flower shape (Figure 2.4-
B).  The lens was hydrodissected out from the centre and the capsular bag was placed in 
a Petri dish as described above. 
Figure 2.3: Schematic to demonstrate how a capsulorhexis was performed.  A. First a nick was made in 
the centre of the lens capsule.  This was dragged down and towards the right in an anticlockwise 
motion.  B.  The anti clockwise circular motion was continued up and round to a 12 o’clock position. C. 
The circular motion was followed down to meet to original 6 o’clock position, completing the 
capsulorhexis. 
A. B. 
C. 
  
55 
Chapter 2: Material & Methods 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1.9 Mayer’s Haematoxylin 
Cells were stained with Mayer’s haematoxylin for the purpose of visualising cell nuclei, 
using the following protocol: 
1. Removed medium from wells  
2. Rinsed cells three times with PBS 
3. Fixed cells with absolute methanol (Fisher Scientific, UK) for 5 minutes at 4°C 
4. Removed methanol 
5. Rinsed cells a further three times with PBS  
6. Added Mayer’s haematoxylin (1%) for 4 minutes 
7. Removed Mayer’s haematoxylin and rinsed cells with water for approximately a 
minute until the water ran clear  
8. Added 250µl of PBS to each well to achieve a clearer micrograph  
 
2.1.10 Methylene Blue 
Cells were stained with methylene blue (Sigma Aldrich, UK) for the purpose of visualising 
cell nuclei, using the following protocol: 
Figure 2.4: Schematic displays an alternative method performed to remove the lens from the capsular 
bag.  A. First a nick was made in the centre of the lens capsule.  A pair of scissors where then used 
underneath this nick and small cuts were made towards the equator.  B. These cuts/flaps were peeled 
back to reveal a flower shape and expose the lens.  Meaning the lens could be removed from the 
capsular bag. 
A. B. 
  
56 
Chapter 2: Material & Methods 
1. Removed medium from wells  
2. Rinsed cells three times with PBS 
3. Fixed cells with absolute methanol (Fisher Scientific, UK) for 5 minutes at 4°C 
4. Removed methanol 
5. Rinsed cells a further three times with PBS  
6. Added methylene blue (0.05 wt%) for 2 minutes 
7. Removed methylene blue and rinsed cells with water for approximately 1 
minute until the water ran clear  
8. Added 250µl of PBS to each well to achieve a clearer micrograph  
 
2.1.11 Toluidine Blue 
Toluidine blue (Sigma Aldrich, UK) was used to stain for the presence of 
glycosaminoglycan (GAGs) on coatings, using the following protocol: 
1. Toluidine blue (0.1 w/v% in deionised water) was added to GAG coatings for 5-
10 minutes 
2. Removed toluidine blue and coatings were rinsed with water  
3. Micrographs were taken of the stained coatings  
 
2.1.12 Resazurin 
A resazurin (Sigma Aldrich, UK) assay was used to assess the metabolic activity of LECs, 
using the following protocol: 
1. Stock resazurin (1mg/ml) in MEME medium was made up and kept for up to six 
months at 4° in foil  
2. Removed medium from wells  
3. Make up 10% resazurin working solution in medium and add to LECs 
4. Incubate for 3 hours at 37° 
5. Aliquot 100µl of 10% resazurin from wells into a black 96 well plate in triplicate 
6. Discard of remaining resazurin and rinse cells with PBS before adding fresh 
medium 
7. Read plate on a fluorescence plate reader at 530 excitation/590 emission 
wavelengths 
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2.1.13 Propidium Iodine 
Propidium Iodine (PI) (Sigma Aldrich, UK) is a nuclear stain which binds to the DNA inside 
nuclei and fluoresces red (excitation 491-496nm; emission 636-642nm).  To stain with PI 
the following protocol was used: 
1. Removed medium from wells  
2. Rinsed cells three times with PBS 
3. Fixed cells with either methanol or 10% neutral buffered formaldehyde (NBF, 
BIOS Europe ltd) at room temperature for 10 minutes 
4. Removed fixative  
5. Rinsed cells a further three times with PBS  
6. PI solution (100µl Ribonuclease (RNase, Sigma Aldrich), 895µl PBS and 5µl PI) 
was added to cells (not in direct light) and left for 5 minutes at room 
temperature on a laboratory rocker 
7. Removed PI and rinsed cells three times with PBS 
8. Refilled wells with PBS so cells did not dry out 
 
2.1.14 DAPI  
DAPI (Invitrogen, UK) is another nuclei stain which fluoresces blue (excitation 350nm; 
emission 470nm).  To stain with DAPI the following protocol was used: 
1. Removed medium from wells  
2. Rinsed cells three times with PBS 
3. Fixed cells with either methanol or NBF   
4. Removed fixative 
5. Rinsed cells a further three times with PBS  
6. A working stock was made (1µl of DAPI to 2999µl of PBS) and was used at a 1:10 
ratio stock:PBS 
7. DAPI was added (out of the light) and left for 5 minutes at room temperature on 
a laboratory rocker 
8. Removed DAPI and rinsed cells three times with PBS 
9. Refilled wells with PBS so cells did not dry out 
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2.1.15 Phalloidin 
Phalloidin (phalloidin 488 (excitation 495nm; emission 518nm), Invitrogen, UK) is a 
cytoskeleton stain that stains f-actin fibres in a cell and was used to examine the cells 
morphology.  To stain with phalloidin the following protocol was used: 
1. Removed medium from wells  
2. Rinsed cells three times with PBS 
3. Fixed with NBF   
4. Removed fixative 
5. Rinsed cells a further three times with PBS  
6. Permeabilised cells with 1% Triton X (Sigma Aldrich, UK, diluted in PBS) for 5 
minutes at 4°C 
7. Removed Triton x and rinsed cells three times with PBS   
8. phalloidin was added (out of the light) at a concentration of 1:40 made up in 
0.1% Tween 20 (Sigma Aldrich, UK, diluted in PBS) for 30 minutes at room 
temperature on the laboratory rocker.    
10. Removed phalloidin and rinsed cells three times with PBS (nuclei staining was 
performed at this stage) 
11. Refilled wells with PBS so cells did not dry out 
 
2.1.16 Live/Dead Assay 
A live dead assay (Invitrogen, UK) was used as a staining method to give an indication of 
how a coating or environment affected the cells.  Live cells were stained green and dead 
cells stained red, using the following protocol: 
1. Removed medium from wells  
2. Rinsed cells three times with PBS 
3. Live/Dead solution was made up of calcein-AM (green) at 1:500(PBS) and 
ethidium homodimer-1 (red) at 1:200 
4. Each solution was added (out of the light) simultaneously and left for 30 minutes 
at 37°C   
5. Live/Dead assay solution was removed and cells were rinsed three times with 
PBS 
6. Refilled wells with PBS so cells did not dry out and imaged immediately 
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2.1.17 Primary and Secondary Antibody Staining 
Cells have been stained with various antibodies.  These include various cytokeratin as an 
epithelial marker to characterise the cell phenotype, alpha B-crystallin protein (Abcam) 
as an additional characterisation method and alpha smooth muscle actin (αSMA, Abcam, 
UK) as a marker for dedifferentiated LECs ( 
Table 2-3).   
 
Table 2-3: Details of antibodies used throughout the PhD project 
Antibody Clone Concentration 
Mouse monoclonal pan cytokeratin (CK 4, 5, 6, 8, 
10, 13 & 18) (Santa Cruz, Insight biotechnology, 
UK) 
C11 1:100 
Mouse monoclonal pan cytokeratin (CK 8 & 18) 
(Abcam, UK) 
NCL-5D3 1:100 
Mouse monoclonal cytokeratin (19) (Dako, UK) RCK108 1:100 
Mouse monoclonal pan cytokeratin (1, 2, 3, 4, 5, 
6, 7, 10 ,13, 14, 15, 16 & 19) (Dako, UK) 
AE1/AE3 1:100 
Mouse monoclonal pan cytokeratin (5, 6 8, 17 & 
probable 19) (Dako, UK) 
MNF116 1:100 
Mouse monoclonal alpha B-crystallin (Abcam, UK) 1B6.1-3G4 1:100 
Mouse monoclonal αSMA ( Abcam, UK) 1A4 1:100 
 
 
Antibody staining was performed following the below protocol: 
1. Removed medium from wells  
2. Rinsed cells three times with PBS 
3. Fixed with either methanol or NBF   
4. Removed Fixative  
5. Rinsed cells a further three times with PBS 
6. Permeabilised cells with 1% Triton X (Sigma Aldrich, UK, diluted in PBS) for 5 
minutes at 4°C 
7.  Removed Triton x  and rinsed cells three times with 0.1% Tween 20   
8. Blocked cells with 10% goat serum (Sigma Aldrich, UK) diluted in PBS:1% bovine 
serum albumin, (BSA, Sigma Aldrich, UK) for 30 minutes at 37oC  
9. Primary antibody and negative control mouse IgG (Dako, UK) was added at 
1:100 (PBS:1%BSA) overnight on a laboratory rocker at 4oC (out of light)  
Table detailing primary antibodies, antibody clone and the concentrations used at. 
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10. Removed antibody and rinsed cells thoroughly with 0.1% Tween 20   
11. Alexa Fluor® secondary antibodies (Invitrogen, UK) were added (out of light) at 
1:100 or 1:250 (PBS:1%BSA) for 1 hour at 37°C    
12. Removed secondary and rinsed cells thoroughly with PBS:Tween 20 
13. Performed phalloidin (2.1.15) and/or nuclei staining (2.1.13 or 2.1.14, optional) 
14. Refilled wells with PBS so cells did not dry out and imaged immediately 
 
2.1.18 Surface Analysis 
Several surface analysis techniques were used throughout this PhD, including contact 
angle measurement (CA) analysis, scanning electron microscopy (SEM) and white light 
interferometry (WLI).   
 
2.1.18.1 Contact Angle 
The wettability of coatings was determined by measuring the CA at the surface/liquid 
interface by dispensing a small water bead onto a sample, using the DSA 100 (KRÜSS 
GmbH, Germany).  Throughout this PhD the sessile drop technique was used for 
measuring static CA.  This involved dispensing a drop from a syringe and using a 
goniometer to capture an image. 
 
The DSA 100 has two set ups for dosing different sized water beads, a macro and a 
piezo-electric system, the principle is the same for each set up.  Both set ups have been 
used during this PhD.  When the macro set up was used a 2 µl drop size was chosen and 
nine points per sample were measured, in three rows of three across the sample, 
completed in triplicate.  In the piezo-electric set up water was dispensed through a piezo 
dosing unit and the voltage and pulse width determine how much water was dispensed.  
A voltage of 80V and a pulse of 200µs was selected which gave roughly 720pl – 960pl 
drop size.  Again nine readings per sample were taken in triplicate.  A circle profile 
function was fitted to all water droplets. The CA was determined by measuring the angle 
of intersection between the baseline (surface of sample) and this circle profile. 
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2.1.18.2 Scanning Electron Microscopy 
Scanning electron microscope (SEM) analysis was performed using the LEO 1550 (Zeiss, 
UK) to examine the topography of the coatings provided by BioInteractions Ltd. this was 
particularly useful in checking for homogeneous coatings.  Coated coverslips were 
placed onto SEM stubs before chromium coating using the EMI TECH K575X (Quorum 
Technologies, UK) to make them conductive.  Each sample was coated twice with 
chromium to give a coating thickness of roughly 200nm.  Three to five random areas of 
the sample were micrographed per magnification.  This was performed in triplicate. 
 
2.1.18.3 White Light Interferometry 
White light interferometry (WLI) analysis was performed using the WYKO NT3300 
profilometer (VEECO, USA).  Samples were chromium coated first to make them 
reflective.  The same samples that were used for SEM were also used for WLI analysis.  
To examine the roughness and how uniform the coating was, 3 – 5 random areas of the 
sample were analysed per magnification (x50 and x100).  This was performed in 
triplicate. 
 
2.1.19 Statistical Analysis 
All graphs are presented with mean average ± 1 standard deviation (SD).  All statistical 
analysis was performed using IBM SPSS V.20 statistics software.   One-way ANOVA was 
used to measure the statistical significance followed by Dunnett’s T3 or Tukey’s post hoc 
test, depending whether homogeneity of variances were significantly different or not 
significantly different, respectively.  Statistical significance was assumed when p<0.05. 
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2.2 Anticoagulation Polymers Coatings – 1 
For material coatings in group one, two and three (Table 2-1) the chemistry was quite 
similar and the base polymer for all was polyethylenimine (PEI).  The preparation of PEI 
is outlined below. 
 
All solutions were made up in ultra-pure water to an end volume of 500ml.  All washes 
were performed using deionised water.  All solutions were mixed well and the pH was 
checked as the pH can greatly affect the charge and amine groups present.  The 
following mixtures were made up: 
 
(1) PEI mixture (BioInteractions Ltd. UK)   was used at 4% by adding 20g of PEI was 
added to 500ml of ultra-pure water (pH 10).  The basic polymer absorbs carbon 
dioxide and reduces the pH so it was covered with foil (for approximately 15 
minutes), until ready to be used. 
(2) Polymer B (BioInteractions Ltd. UK) was a mixture of sulphates, sulfonates and 
polyethylene glycol (PEG) with no heparin.  Sodium tetraborate buffer 
(BioInteractions Ltd. UK)   was used with this polymer (pH 8.5).  1.25g of polymer 
B was added to 500ml of ultra-pure water. 
(3) Both mixtures were crosslinked with glutaraldehyde (25% solution pH 6.5, 
BioInteractions Ltd. UK.  1.5ml was added to the 500ml of ultra-pure water.  
Once mixed the solution was stored at 4oC until it was ready to use. 
 
After all solutions were made up PEI was polymerised into 24 well plates by adding 
1ml/well of solution (1) for 5 minutes at room temperature, then plates were rinsed 
three times with water.  Followed by 1ml/well of solution (2) for 5 minutes at room 
temperature, and again rinsed three times.  1ml /well of cross linking agent (3) was then 
added for a final 5 minutes at room temperature and again rinsed three times.  Wells 
were rinsed a final time with ultra-pure water before plates were left to dry in the oven 
at 40oC for 1 hour.  Coverslips were made in the same way for surface analysis, by 
submersing the coverslips in a Petri dish containing each solution for 5 minutes.  Care 
was taken to make sure they did not overlap, to provide an even coating and reduce 
scratches.  Coverslips were placed in clips and stacked in a rack to dry in the oven. 
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The additional layers on top of the PEI vary in terms of the functional groups present 
and end charge, dictating how the polymer interacts with the cells.  Although the base 
chemistry for coatings in group 1 and group 2 was the same each coating has a slightly 
different composition.  Each coating contains three components, heparin, negative 
charged sulphates and hydrophilic PEG chains, each of these components plays a specific 
role within the coating (Figure 2.5).  
 
 
 
Coating 001 was a two layer water based polymeric coating, it has a positively charged 
primer layer which is PEI and can bind to both hydrophobic and hydrophilic surfaces.  
The second copolymer layer is negatively charged containing PEG which enhances 
hydrophilicity and laminar flow, sulphates and sulfonates to repel cells and heparin to 
confer anti-thrombogenic properties.  Coating 004 is similar to 001 and only varies in 
terms of the number of layers and thus the amount of functional groups, PEG and 
heparin.  Poly HEMA (pHEMA) is a 2-hydroxyethyl methacrylate which functions as a 
Figure 2.5: Schematic of the base chemistry for coatings 001, 002 and 003.  Each coatings varies slightly 
in terms of the number of layers but all contain PEI base then additional PEG, sulphates, sulfonates and 
heparin groups which are designed to repel cell and protein attachment.  Adapted from BioInteractions 
Ltd [159]. 
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hydrogel and has been previously used in clinic for IOL materials and therefore used as a 
control. 
 
2.2.1 Cell Growth Study 
Coatings were tested in a preliminary qualitative manner to optimise the coating 
process and cell culture techniques.  Coatings 001, 004 and pHEMA were synthesized 
onto glass coverslips (13mm diameter) and directly into 24 well plates.  FHL124 LECs 
were seeded on coated coverslips (13mm diameter) at 1x104/cm2.  Six coverslips per 
coating were set up, and LEC attachment and growth was monitored for a total of 7 
days.  In addition LECs were seeded into a coated 24 well plate (eight wells per coating).  
LEC attachment and growth was evaluated whilst in culture for a total of 11 days.  
Uncoated TCPS wells served as a control in both studies to examine typical LEC growth 
and attachment in culture.  For both studies representative phase contrast micrographs 
were taken throughout the study starting at day 1 and cells were fed every 2 – 3 days. 
 
2.2.2 Cell Staining 
Coated coverslips were fixed at day 7 with methanol for 5 minutes and stained with 
Mayer’s haematoxylin (2.1.9), to visualise the cell nuclei and cytoplasm of the cell.  
Coated wells were fixed at day 11 and a live/dead assay (2.1.15) was carried out. 
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2.3 Anticoagulation Polymers Coatings – 2 
Coating 002 has the same composition as 001 but has been lightly crosslinked using 
glutaraldehyde.  Coating 003 is similar to coating 002 but has a total of five water based 
high molecular weight polymer layers.  Similar to 002 more functional groups are 
present, when compared to 001, and it too has been lightly crosslinked with 
glutaraldehyde to confer stability (Figure 2.6).  
 
 
  
 
 
 
 
 
 
 
 
2.3.1 Cell Growth Study 
Coatings from group 2 (001, 002 and 003) were synthesized directly into 24 well plates, 
and examined for a longer time period of 14 days.  Plates were fixed at days 1, 4, 7, 10 
and 14.  FHL124 LECs were seeded at 1x104/cm2 into six coated wells per coating for 
each time point.  Uncoated TCPS wells served as a control.  Representative phase 
contrast micrographs were taken throughout the study starting at day 1, and cells were 
fed every 2 – 3 days.   
Figure 2.6: Schematic of multi-layered coating 003 provided by BioInteractions Ltd.  Due to 003 having 
five layers more functional groups were present, including heparin, sulphates and PEG.  Adapted from 
BioInteractions Ltd. 2010 
Key: 
 
Functional 
group 
Crosslinkage 
Includes: Heparin, Sulphates, 
Sulfonates and PEG 
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2.3.2 Cell Staining 
At the various time points (days 1, 4, 7 10 and 14) cells were fixed with NBF and stained 
with PI (2.1.13) and phalloidin (2.1.15).  The average cell growth on each coating per 
time point was calculated by counting the cell nuclei using ImageJ cell counter plug-in. 
 
2.3.3 Surface Analysis 
CA measurements were taken using the macro system (2.1.18.1).  Nine CA 
measurements were taken across each sample, repeated in triplicate.  Coatings were 
also examined under the SEM (2.1.18.2).  A wide area of the sample was viewed and 3 – 
5 representative micrographs of the coating were taken, again repeated in triplicate.  
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2.4 GAG Coatings 
Three methods of synthesising GAG coatings were investigated to examine if the cellular 
response was affected by the GAG itself or how the GAG was bound to the surface.  The 
three methods were: firstly, BioInteractions Ltd. polymer GAG coatings (2.4.1), secondly, 
GAGs dissolved in medium then adsorbed onto various substrates (2.4.2) and thirdly, 
covalently bound GAGs onto amine coated coverslips (2.4.3).  Adsorbed GAG coatings 
and bound GAG coatings only examined hyaluronic acid (HA) and chondroitin sulphate 
(CS) as the response of heparin (HEP) was well established and no further evaluation 
was required. 
 
2.4.1 BioInteractions Ltd. Cell Polymer Coatings 
BioInteractions Ltd. synthesised HEP, HA and CS, using a proprietary method, directly 
into 24 well plates, each plate contained all three GAGs (eight wells per coating).  An 
additional uncoated TCPS plate was used as a control.   
 
2.4.1.1 Cell Growth Study 
N/N1003A LECs were seeded onto GAG polymer coatings and TCPS at a seeding density 
of 1x104/cm2.  Representative phase contrast micrographs were taken throughout the 
study starting at day 1 and cells were fed every 2 – 3 days.  Cells were fixed at days 1, 4, 
and 7 with NBF. 
 
2.4.1.2 Cell Staining 
GAGs plates were fixed with NBF on days 1, 4, 7 10 and 14.  Cells were stained with 
phalloidin (2.1.15), to examine the cytoskeleton, αSMA (2.1.17) to view myofibroblast 
cells and give an indication of dedifferentiation and DAPI (2.1.14) to stain the nuclei.  
Three micrographs per well were taken using an x10 objective.  The average cell growth 
on each coating at each time point was measured by counting cell nuclei using a 
configured macro to count cells in ImageJ.  
 
2.4.1.3 Surface Analysis 
Polystyrene coverslips were coated with HEP, HA and CS for the purpose of surface 
analysis.  The piezo-electric system was used for CA measurements (2.1.18.1), 9 points 
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per sample were measured, repeated in triplicate.  Their topography was investigated 
using SEM (2.1.18.2) and WLI (2.1.18.3).  Five areas per sample were analysed on WLI at 
x50 objective, repeated in triplicate.   
 
2.4.1.4 Time Lapse Microscopy 
GAGs coatings were also examined using the IncuCyte time lapse microscopy (Essen 
BioScience) for a total of 14 days, micrographs were taken every hour to build up a video 
of still micrographs.  Micrographs were taken in the exact same location each time using 
a motorised stage and software.   
 
2.4.2 Adsorbed GAG Coatings 
Five variations of the adsorbed GAG assay were studied to optimise the conditions 
(Table 2-4).  These included varying the: concentration of HA and CS (0.01mg/ml, 
0.1mg/ml, 1mg/ml, 5mg/ml and 10mg/ml), incubation times (3 hours and 24 hours), 
temperatures (4°C and 37°C) and substrates (TCPS plastic, PEI base polymer and 
polystyrene coverslips (PS, Goodfellow, UK, roughly cut 10mm x 10mm).  In addition HA 
and CS were added to the cell culture medium.  
  
Table 2-4: To detail the various incubation times and optimisation of the soluble GAG assay. 
# Incubation Time Concentrations Substrates 
1 
 
3 hour incubation at 37oC  
– GAGs rinsed off 
0mg, 0.01mg, 0.1mg, 1mg, 5mg 
and 10mg – 500µl p/w 
Base polymer, 
TCPS & PS 
2 
 
3 hour incubation at 37oC  
– GAGs not rinsed off 
0mg, 0.01mg and 0.1mg and 
1mg – 500µl p/w 
Base polymer, 
TCPS and PS 
3 24 hour incubation at 
37oC – GAGs not rinsed 
off 
0mg, 0.01mg and 0.1mg and 
1mg – 500µl p/w 
Base polymer and 
TCPS 
4 24 hour incubation at 4oC 
– GAGs not rinsed off 
0mg, 0.01mg and 0.1mg and 
1mg – 500µl p/w 
Base polymer and 
TCPS 
5 GAG added in medium 0mg, 0.01mg and 0.1mg and 
1mg – added in medium  
Base polymer, 
TCPS and PS 
 
 
 
 
 
The above table presents all adsorbed GAG assays tested, numbered 1-5.  Various incubation times and 
concentrations were tested to optimise the process of binding the GAGs to the different substrates. 
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HA and CS were dissolved in medium and mixed well prior to adding either 500µl or 
1000µl per/well to the substrates at the above concentrations, temperatures and time 
periods.  HA and CS were removed and wells were either rinsed with fresh medium or 
not before seeding N/N1003A LECs.  To replicate the same environment as the polymer 
GAG coatings provided by BioInteractions Ltd. HA and CS were adsorbed onto the base 
polymer, as this was the base material present in the polymer GAG coatings.  LECs 
seeded straight onto the base polymer in the absence of any GAG served as a positive 
control.  To confirm if the HA and CS encouraged cell growth or the base polymer, LECS 
were seeded onto PS coverslips either in the presence or absence of adsorbed GAG.  
LECs seeded onto PS in the absence of any GAG served as a negative control as PS does 
not encourage cell growth.  LECs were also seeded onto TCPS in the presence or absence 
of adsorbed GAG.  LECs seeded onto TCPS in the absence of any GAG served as a control. 
 
2.4.2.1 Cell Growth Study 
N/N1003A LECs were seeded onto the adsorbed coatings (4 wells per GAG 
concentration) at a seeding density of 1x104/cm2.   Cells were fed every 2 – 3 days and 
monitored for a total of seven days.  Base polymer, PS and TCPS wells with the absence 
of GAGs served as controls.  Representative micrographs were taken on days 1, 4 and 7.  
Micrographs were taken from the same well in roughly the same area at each time point 
so cell growth could be monitored throughout the study. 
 
2.4.2.2 Quantifying the Amount of GAG Present 
Toluidine blue was used at 0.1% w/w in distilled water to assess whether the GAG was 
present (2.1.11).  Toluidine blue was added to adsorbed GAG coatings for 5 minutes and 
then removed and rinsed with water.  If HA and CS were present the coated wells or 
coverslips stained blue. 
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2.4.3 Bound GAG Coatings 
HA and CS were immobilised onto modified 13mm glass coverslips (Agar Scientific, UK) 
coated with amine functionality by silinisation.  GAGs were bound onto glass coverslips 
following the below protocol: 
1. 10% 3-aminopropyl-triethoxysilane (APTES, Sigma Aldrich, UK) was made up in 
isopropanol 
2. Glass coverslips were placed inside 24 well plates (4 coverslips per 
concentration). 
3. APTES (10%) solution was mixed well then pipetted onto glass coverslips and left 
for 10 minutes 
4. Coverslips were washed thoroughly with isopropanol 
5. APTES coated coverslips were left to air dry overnight  
6. 3mg/ml, 1mg/ml and 0.1mg/ml of HA and CS were dissolved in a solution of 
0.01M 2-(N-morpholino)ethanesulfonic acid (MES, Sigma Aldrich, UK) buffer   
7. GAGs were added to a reaction solution of 0.05M N-hydroxysuccinimide (NHS, 
Sigma Aldrich, UK)/0.2M 1-ethyl-3(3-dimethylaminopropyl) carbodiimide 
hydrochloride (EDC, Sigma Aldrich, UK) sequentially, made up in MES buffer, to 
activate the GAGs 
8. Activated GAG solutions were stirred for 1 hour at room temperature  
9. 1ml of activated GAG solution was added to amine coated coverslips overnight 
at room temperature on a laboratory rocker 
10. The following morning bound GAG coverslips were washed with double distilled 
ultrapure water (Sigma Aldrich, UK) throughout 24 hours, 2 – 3 changes of water 
were made  
11. 24 hours later the distilled water was removed and bound GAG coverslips were 
left to air dry for two hours in a class II biological hood 
12. Bound GAG coverslips were used in cell culture the same day  
13. Prior to seeding cells the coverslips were UV sterilised for 5 minutes at 
1500J/cm2 
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2.4.3.1 Cell Growth Study 
N/N1003A LECs were seeded onto the bound GAG coatings (four wells per 
concentration) at a seeding density of 1x104/cm2 for a total of 7 days.  Amine coated 
coverslips, glass coverslips and untreated TCPS wells served as controls.  Representative 
micrographs were taken on days 1, 4 and 7.  Micrographs were taken from the same 
well in approximately the same area at each time point so cell growth could be 
monitored throughout the study.  On day 7 cells were fixed at methanol for 5 minutes at 
4°C and stained with methylene blue (2.1.10) to visualise the LECs attachment and 
growth. 
 
2.4.3.2 Quantifying the Amount of GAG Present 
Additional bound GAG coverslips were synthesised and stained with toluidine blue 
(2.1.11) to determine the presence of HA and CS. 
 
2.4.3.3 Surface Analysis 
Additional bound GAG coverslips were synthesised for the purpose of contact angle 
analysis.  The piezo-electric system was used for CA measurements (2.1.18.1), 9 points 
per sample were measured, repeated in triplicate.   
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2.5 Zwitterionic Polymers 
Six novel zwitterionic coatings (F–K) and three control coatings (L–N) were synthesized 
directly onto 24 well plates at BioInteractions Ltd. (Table 2-5). 
 
Table 2-5: Composition details of zwitterionic coatings 
Coating  Novel Zwitterionic Polymer Composition  
F  90% butyl methacrylate 
10% novel zwitterionic monomer 
G  80% butyl methacrylate  
20% novel zwitterionic monomer 
H  70% butyl methacrylate  
30% novel zwitterionic monomer 
I  58% hydroxypropyl methacrylate  
31% hexyl methacrylate  
11% novel zwitterionic monomer 
J  50% hydroxypropyl methacrylate  
30% hexyl methacrylate  
20% novel zwitterionic monomer 
K  50% methoxyethyl methacrylate  
30% hexyl methacrylate  
20% novel zwitterionic monomer 
L 100% poly (butyl methacrylate) 
M 90% butyl methacrylate 
10% 2-methacryloyloxyethyl - phosphorylcholine (MPC) 
N 70% butyl methacrylate 
30% 2-methacryloyloxyethyl - phosphorylcholine (MPC) 
 
 
 
2.5.1 Cell Growth Study  
Four wells per coating were synthesised, F-K coatings were in one plate and L-N coatings 
were in an additional plate.  N/N1003A LECs were seeded on coated wells at 1x104/cm2, 
uncoated TCPS wells served as a control.  Representative phase contrast micrographs 
were taken throughout the study starting at day 1 and cells were fed every 2 – 3 days.  
Cells were fixed at days 1, 4 and 7 with NBF. 
 
 
Composition of zwitterionic coatings and ratios of zwitterionic monomer: 
comonomer(s) used. 
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2.5.2 Cytotoxicity Assay 
To test whether the coatings were prohibiting cell attachment via the chemistry and not 
because the coatings were leaching toxic material into the medium, a cytotoxicity assay 
was performed, following BS EN ISO 10993-5:2009 using the extraction method.  To do 
this medium was added directly to coatings F-N and incubated at 37° for 48 hours.  In 
addition medium was added to polystyrene coverslips (blank) and TCPS wells (negative 
control) and incubated at 37° for 48 hours.  N/N1003A LECs were seeded at 5x104/cm2 
onto 24 well TCPS plates for 24 hours.  Medium from the sub confluent LEC monolayer 
was removed and replaced with medium from the coatings and control wells.  5% DMSO 
was added to four wells of sub confluent LECs and served as a positive control to kill the 
LECs.  LEC metabolic activity was monitored at days 1 and 3 by a resazurin (Sigma 
Aldrich, UK) assay.  To do this medium was removed and replaced with medium 
containing 10% resazurin (in the dark).  Cells were incubated for 3 hours at 37°.  After 
this time 100µl of the medium containing resazurin was aliquoted from each well into a 
black plate in triplicate.  The plate was read on the FLx800 microplate fluorescence plate 
reader (Bio-Tek Instruments INC., UK) at 530 excitation/590 emission wavelengths.   
 
2.5.3 Toxicity Assay 
An additional toxicity assay was performed to observe if unattached cells from coatings 
F-N could be removed from the coated wells, seeded into fresh TCPS wells and attach, 
spread and grow as usual.  LECs were seeded onto the coated wells and left for two 
hours to attach, TCPS served as a control.  After two hours medium with floating cells 
were removed from coated wells and reseeded onto fresh 24 well plates.  As some cells 
attach to coatings J, L and N the original plates were kept and these wells were refilled 
with fresh medium, meaning any cells that had adhered in the two hours could continue 
to grow.  The metabolic activity was assessed using resazurin again on days 1 and 4.  
 
2.5.4 Cell Staining 
Zwitterionic plates were fixed with NBF on days 1, 4 and 7.  Cells were stained with DAPI, 
(2.1.14) and phalloidin (2.1.15).  To assess LEC growth three micrographs per well were 
taken and the cell nuclei was counted using a macro set up in ImageJ.  The average cell 
growth of each coating at each time point was calculated. 
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2.5.5 Time Lapse Microscopy 
Zwitterionic coatings were examined using the IncuCyte time lapse microscopy (Essen 
BioScience) for a total of 7 days.  Micrographs were taken every hour to build up a video 
of still micrographs.  Micrographs were taken in the exact same location each time.   
 
2.5.6 Surface Analysis 
Contact angle measurements were taken using the piezo-electric system (2.1.18.1), 9 
points per sample were measured, repeated in triplicate.  The topography of the 
coatings was also examined using SEM (2.1.18.2) and WLI (2.1.18.3).  For WLI 4 areas per 
sample were analysed x50 and four at x100 magnification. 
 
2.5.7 Bulk Materials 
Coating F was copolymerised with pHEMA and synthesised as a bulk material.  Contact 
lens moulds were used as IOL moulds were not available.  The bulk material was cured 
using UV light.  PHEMA contact lenses were used as a control.  Contact lenses were 
placed in 13mm diameter cell crowns to hold the lens in place inside a 24 well plate. 
N/N1003A LECs were seeded at 1x104/cm2 for seven days.  To compare the bulk material 
to the gold standard, LECs were also seeded onto Acrysof (Alcon) acrylic IOLs.  Untreated 
TCPS wells served as a control.  Phase contrast micrographs were taken during the seven 
days in culture.  On day 7 cells were fixed with methanol for 5 minutes and cells were 
stained with methylene blue (2.1.10) to visualise the cell attachment, morphology and 
growth.   
 
An additional control of C-Flex (Rayner) pHEMA IOL was separately tested to compare 
LEC response to bulk material pHEMA provided by BioInteractions Ltd.  LECs were 
seeded on Acrysof IOLs to repeat and confirm cellular response.  Uncoated TCPS wells 
were used as a control.  Cells were seeded at 1x104/cm2 for 7 days.  Phase contrast 
micrographs were taken during the 7 days in culture.  On day 7 cells were fixed with 
methanol and cells were stained with methylene blue.   
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2.6 Dedifferentiation Model and TGFβ3 Assay 
The effect TGFβ3 (Invitrogen, UK) had on N/N1003A LECs was examined prior to 
examining the effect TGFβ3 had on dedifferentiated LECs.  
 
2.6.1 Rabbit Serum Assay 
The optimum serum concentration for growing and maintaining N/N1003A rabbit LECs is 
8% rabbit serum (RS).  Prior to the use of TGFβ3 a serum concentration study was 
conducted to analyse N/N1003A LECs and establish the lowest serum concentration that 
would sustain proliferation.  Based on the literature two approaches were taken to 
analyse the reduced serum concentrations.  Firstly by reducing the serum concentration 
from the start and seeding cells at 1x104/cm2 in 2%, 0.5% and 0% RS, four wells per 
serum concentrations were analysed.  Cells were fixed at different time points, days 1, 4 
and 7.  Secondly by seeding cells at 1x104/cm2 in medium containing optimum 8% RS for 
a period of time (either 24hours and 72 hours), serum starving the cells for 24 hours, 
prior to reducing the serum to 2%, 0.5% and 0%.  Plates were fixed at days 1, 4 and 7 
after cultured in experimental conditions.  Medium supplemented with 8% rabbit serum 
served as a control for all studies.  The nuclei were stained with PI, four micrographs per 
well were taken on an x20 objective, cells were counted using a macro in ImageJ.     
 
2.6.2 Dedifferentiation Model 
To test the hypothesis that TGFβ3 could reverse or prevent the effect of 
dedifferentiation a model to dedifferentiated LECs was investigated. To quantify 
dedifferentiation LECs were stained with αSMA.  Optimisation of αSMA antibody was 
carried out on human coronary artery smooth muscle cells (HCASM, Promocell, UK).  
Dedifferentiating LECs were examined via culturing LECs in three different scenarios, 
detailed below. 
  
2.6.2.1 PMMA 
Poly methyl methacrylate (PMMA) was originally the material of choice for IOLs but has 
since been replaced with improved IOL materials, because LECs dedifferentiated and 
contracted on this material causing PCO.  N/N1003A LECs were seeded at 1x104/cm2 
onto PMMA (The Plastic Shop, UK) roughly cut 11mm by 11mm and placed in a 12 well 
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plate.  Six coverslips per time point and four time points (days 1, 4, 7 and 14) were 
examined.  At each time point cells were fixed with NBF and stained for αSMA (2.1.17).   
 
2.6.2.2 Scratch Assay 
A scratch assay was performed to try and replicate the trauma caused postoperative in 
cataract surgery.  N/N1003A LECs were seeded at 1x104/cm2 into a 6 well plate and 
maintained until a monolayer of cells was formed.  A scratch was made through the 
centre of the well with a 1ml pipette tip.  Re-growth of cells in the scratched area was 
monitored on days 1, 4 and 7 (post scratch).  At each time point cells were fixed with 
NBF and stained for αSMA (2.1.17).   
 
2.6.2.3 TGFβ2 Dose Dependant Study  
TGFβ2 is elevated postoperatively as part of the natural wound healing response causing 
dedifferentiation.  This causes the posterior capsule to scar and wrinkle leading to PCO.  
N/N1003A LECs were seeded at 1x104/cm2 into a 24 well plates and grown for 72 hours 
in MEME containing 8% RS then serum starved for 24 hours before changing to 
experimental medium.  Experimental medium was MEME (2% RS + L-glut) containing, 
1.5ng/ml, 3ng/ml or 10ng/ml of TGFβ2.  Six wells per concentration per time point were 
examined.  Plates were fixed on days, 1, 4 and 7, (post experimental medium) and 
stained for αSMA (2.1.17).   
 
2.6.3 Optimisation 
TGFβ2 was repeated using more concentrations, 3ng, 5ng, 6.5ng, 8ng and 10ng/ml 
TGFβ2, following the same procedure outlined above (2.6.2). 
 
2.6.4 TGFβ3 Dose Dependant Study 
To investigate the influence TGFβ3 had on LECs morphology and phenotype a dose 
dependent study was evaluated for 7 days.  The concentrations (10ng, 1ng, 100pg and 
10pg/ml) and time exposure of TGFβ3 (1 hour, 24 hours or 7 days) were varied.  
N/N1003A LECs were seeded into 24 well plates at 1x104/cm2 in MEME containing 8% RS 
for 72 hours then serum starved for 24 hours, before removing all medium and changing 
to the various TGFβ3 experimental conditions.  These included adding 300µl of MEME 
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containing 10ng, 1ng, 100pg and 10pg /ml TGFβ3 and 2% RS for 1 hour at 37oC, adding 
500µl of MEME containing 10ng, 1ng, 100pg and 10pg /ml TGFβ3 and 2% RS for 24 
hours, or 1ml of MEME containing 10ng, 1ng, 100pg and 10pg /ml TGFβ3 and 2% RS for 
7 days.   Control wells were seeded and maintained in exactly the same way but with the 
absence of any TGFβ3.  Cells were fed every 2-3 days with the corresponding medium.  
Micrographs were taken during the 7 days from the same well in roughly the same area 
so the cell growth and morphology could be monitored.  On day 7 cells were fixed with 
NBF and stained with αSMA (2.1.17).  Dedifferentiation was semi-quantitatively 
analysed by measuring the area of αSMA staining as a percentage of the total field of 
view, this was achieved by programming a macro on ImageJ. 
 
2.6.5 Dedifferentiation Model 
The dedifferentiation model and TGFβ3 were studied in conjunction with each other to 
determine if TGFβ3 could reverse or prevent dedifferentiation (Figure 2.7). 
  
 
 
 
 
 
Figure 2.7: Flow chart to demonstrate the principle of using the dedifferentiation model in conjunction with 
TGFβ3.  To test the hypothesis that TGFβ3 could either reverse dedifferentiation (left hand side) or prevent 
dedifferentiation (right hand side). 
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To test the hypothesis that TGFβ3 could reverse dedifferentiation, TGFβ3 was added to 
already dedifferentiated cells, following the same procedure as previously described.  
Briefly N/N1003A were seeded at 1x104/cm2 and cultured in MEME containing 8% RS for 
72 hours, serum starved for 24 hours, before switching to MEME containing 2% RS with 
5ng/ml TGFβ2 to dedifferentiate the LECs for 4 days.  On day 4 MEME was changed and 
cells were treated with TGFβ3 at the same concentrations and time exposures as 
previously described (2.6.4) for a further four days.  This involved either removing all 
medium containing TGFβ2 and adding 300µl-500µl of medium containing various 
concentrations of TGFβ3 for either 1 or 24 hours at 37oC, or half the medium containing 
TGFβ2 was removed and replaced with MEME 2% RS containing various concentrations 
of TGFβ3 for the remaining four days.   At the end of the experiment plates were fixed 
with NBF and stained to examine the expression of αSMA (2.1.17).  Dedifferentiation 
was analysed by measuring the area of αSMA staining as a percentage of the total field 
of view, this was achieved by programming a macro on ImageJ.  To test the hypothesis 
that TGFβ3 could prevent dedifferentiation, TGFβ3 was added for four days prior to 
dedifferentiating cells with TGFβ2 for the remaining four days, following the same 
procedure as described above.   
 
2.6.6 Flow Cytometry 
As the method to analyse αSMA expression was semi quantitative, flow cytometry was 
used to determine a quantitative method to sort a population of LECs.  N/N1003A LECs 
were seeded into three 25cm2 flasks at 1x104/cm2.  LECs were either treated with MEME 
containing 2% RS with no TGFβ2, or MEME containing 8% RS for 72 hours then serum 
starved for 24 hours, followed by experimental conditions of MEME containing 2% RS 
with 5ng/ml TGFβ2 for four days.  Cells were fed on day 2 with the appropriate medium.  
The flow cytometry was operated by Dr Stuart Marshal Clarke, University of Liverpool.  
To prepare the cells for flow cytometry cells were stained as described in section 2.1.17, 
however as a suspension of cells was required cells were fixed, washed, permeabilised 
and stained in suspension in 1.5ml eppendorfs.   Centrifugation was performed between 
each step to remove supernatant and wash cells.  To determine the usability of flow 
cytometry as a method for quantification 8 vials of LECs were prepared, 4 vials of 
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untreated LECs (no TGFβ2) and 4 vials of LECs treated with TGFβ2, with the following 
staining conditions:   
 
1. LECs + PBS + PBS (unstained cells) 
2. LECs + negative mouse IgG + secondary Alexa Fluor® 488  (negative control) 
3. LECs + primary  αSMA + secondary Alexa Fluor® 488 (stained cells) 
 
Each vial contained a minimum of 500,000 cells suspended in 0.5ml PBS: 1% BSA.  Cells 
were stained with 500µl of primary and secondary antibodies (1:100).   
 
2.6.7 RT2-PCR Assay 
The difference in gene expression between untreated B3 LECs (no TGFβ2) and LECs 
treated with various TGFβ2 and TGFβ3 conditions were evaluated, using the 
extracellular matrix and adhesion molecules RT² profiler PCR array (QIAGEN, UK), which 
examined 84 genes involved in cell-cell and cell-matrix interactions (appendix 1).  
Housekeeping genes were incorporated onto the plate to ensure the procedure had 
been successful.  B3 LECs were seeded at 1x104/cm2 in a 24 well plate and treated with 
MEME 10% FCS for 72 hours, cells were then serum starved for 24 hours before 
changing to experimental conditions.   
 
Experimental conditions were either:  
1. MEME containing 2% FCS for four days 
2. MEME containing 2% FCS with 5ng/ml TGFβ2 for four days 
3. MEME containing 2% FCS with 10ng/ml TGFβ3 for four days followed by MEME 
containing 2% FCS with 5ng/ml TGFβ2 for the remaining four days (2.6.5) 
 
Cells were fed every 2-3 days with the appropriate medium.  RNA was extracted using 
RNeasy extraction kit (QIAGEN, UK).  Cells were lysed using buffer RLT (10µl β-
mercaptoethanol/1ml Buffer RLT).  For each experimental condition four wells were 
pooled.  Further DNA was removed following the optional DNase digestion steps.  The 
total RNA was read using the BioPhotometer Plus (Eppendorf).  A total of 1µg/ml RNA 
for each condition was converted into 102µl cDNA synthesis reaction following RT² 
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profiler PCR array protocol (Qiagen).  cDNA was mixed with 1350µl SYBR green 
mastermix and 1248 µl RNase-free water.  Using a multi channel pipette 25µl of cDNA 
solution was aliquoted into the PCR array 96 well plate.  Plates were centrifuged for 60 
seconds before reading plates on the Light Cycler 480 (Roche).   
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3. Results 
 
3.1 Material Coatings and Techniques 
This section will examine results from characterising LEC phenotype, seeding density 
growth assay, serum assay and techniques to harvest native LECs. 
 
3.1.1 Cell Culture Techniques 
Cytokeratin antibody staining was carried out to characterise the cell phenotype.  
Various cytokeratin antibodies were tested (Table 3-1).  In addition N/N1003A’s were 
stained for alpha B-crystallin protein (clone 1B6.1-3G4, anti-mouse, Abcam).   
 
Table 3-1:  Antibody clones used to stain FHL124, B3 and N/N1003A LECs  
Cell Line Clone Cytokeratins 
FHL124 C11 anti-mouse, Santa Cruz 4, 5, 6, 8, 10, 13 and 18 
B3  C11 anti-mouse, Santa Cruz 4, 5, 6, 8, 10, 13 and 18 
N/N1003A C11 anti-mouse, Santa Cruz 4, 5, 6, 8, 10, 13 and 18 
NCL-5D3 anti-mouse, Abcam 8 and 18 
RCK108 anti-mouse, Dako 19 
AE1/AE3 anti-mouse, Dako 1, 2, 3, 4, 5, 6, 7, 10 ,13, 14, 15, 16 and 19 
MNF116 anti-mouse, Dako 5, 6 8, 17, and probably 19 
 
 
  
  
Table demonstrating cytokeratin antibody clones used in immunocytochemistry, details of the supplier 
and specific cytokeratins to which they bind. 
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FHL124 LECs were stained with pan cytokeratin, clone C11.  Cytokeratin staining was 
present illustrating positive epithelial cell expression (Figure 3.1).  Intensity of stain was 
independent of concentration used. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 3.1: Fluorescent micrographs demonstrating cytokeratin (green, clone C11) and PI (red) staining 
of FHL124 LECs.  At antibody concentrations of A. 1:200, B. 1:250, C. 1:400 and D. Negative mouse IgG 
control at a concentration of 1:100.  Intensity of stain was independent of concentration of antibody 
used. 
 
A B 
C D 
100µm 
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B3 LECs were also stained with pan cytokeratin, clone C11.  Many B3 LECs stained 
positively for cytokeratin expression (Figure 3.2).  
 
   
 
 
 
No primary antibody was found that was specific to react with rabbit species, however 
several monoclonal cytokeratins specific to human were tested on N/N1003A LECs using 
ARPE-19 cells as a positive control.  None of the cytokeratins tested proved successful in 
staining rabbit LECs, N/N1003A’s.  Crystallins have been used as a method for proving 
lens epithelial cell phenotype [160-166].  Based on this N/N1003A LECs were stained for 
alpha B-crystallin (Abcam).  Rabbit LECs stained positive for alpha B-crystallin (Figure 
3.3).  
 
    
 
 
Figure 3.3: Fluorescent micrographs demonstrating positive alpha B-crystallin staining (green, clone 
1B6.1-3G4) and DAPI (blue) of N/N1003A LECs.  At a concentration of A. 1:100 and B. Negative mouse 
IgG control at a concentration of 1:100. 
 
A B 
Figure 3.2: Fluorescent micrographs demonstrating positive cytokeratin staining (green, clone C11) and 
PI (red) of B3 LECs.  At a concentration of A. 1:100 and B. Negative mouse IgG control at a concentration 
of 1:100.  
 
A B 
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3.1.2 Seeding Density Growth Curve 
To optimise tissue culture techniques a seeding density growth curve experiment was 
performed using FHl124 LECs to characterise their usual growth pattern at different 
seeding densities.  Firstly cells were counted using a haemocytometer.  Results showed 
that cells seeded at 1x103/cm2 did not contain enough cells to allow for accurate 
counting at early time points, i.e. no cells were present on the haemocytometer.  Cells 
seeded at 1x105/cm2 became confluent by approximately day 3 – 4 with cells having to 
be diluted to be counted accurately.  Therefore a different method for counting cells 
was explored.  Cells were fixed at different time points and stained with Mayer’s 
haematoxylin, for the purpose of counting cell nuclei (Figure 3.4).   
 
  
 
 
 
  
Figure 3.4: Phase contrast micrographs demonstrating FHL124 LECs stained with Mayer’s haematoxylin.  
At seeding density of A. 1x10
4
/cm
2
 day 4 and B. 5x10
3
/cm
2 
day 4 
100µm 
A. B. 
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For cells seeded at 1x104/cm2 there was a higher proliferation rate between days 1 – 4 
whereas most proliferation occurred between days 4 – 7 at 5x103/cm2 (Figure 3.5).  The 
number of cells began to plateau by day 7 for 1x104/cm2 seeded density.  Cells seeded at 
5x103/cm2 continue to divide at day 7 but at a slower rate.  Based on this a seeding 
density of 1x104/cm2 was chosen for FHL124, B3 and N/N1003A cell lines to observe cell 
growth on all coatings and any additional cell growth assays. 
 
 
 
 
 
 
 
 
  
Figure 3.5: Graph demonstrating FHL124 LEC seeding density growth curve of 1x10
4
/cm
2 
and 5x10
3
/cm
2
 
seeding densities.  Error bars equal ± 1 standard deviations.  1x10
4
/cm
2
 seeding density reached 
confluency by approximately day 4, whereas 5x10
3
/cm
2
 took approximately 7 – 10 days to reach 
confluency. 
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3.1.3 Serum Growth Curve 
A short experiment was set up to optimise the FCS concentration used with FHL124 cell 
line as this was not previously known.  From the previous study it was shown that the 
area of exponential growth for LEC seeded at 1x104/cm2 was between days 1 – 4 (Figure 
3.5), therefore cells were analysed on day 1, 3 and 4.  Little difference in cell growth 
between the FCS concentrations was observed, 5% FCS had a slight increase between 
days 3 – 4 (Figure 3.6).  All serum concentrations produced a similar growth curve.  At 
each time point there was no significant difference in cell numbers between serum 
concentrations, analysed by a one-way ANOVA Tukey’s post hoc test (p>0.05).  A serum 
concentration of 5% FCS was chosen for FHL124 LECs as it was the lowest level of serum 
FHL124 LECs needed to sustain proliferation and retain epithelial morphology.  
 
 
 
 
 
 
 
Figure 3.6: Graph demonstrates FHL124 LEC line serum (fetal calf serum, FCS) growth curve of 5% FCS, 
10% FCS and 20% FCS serum concentration.  Error bars equal ± 1 standard deviations.  All serum 
concentrations produced roughly the same amount of cell attachment per field of view by 4 days and 
were not significantly different (analysed using one way ANOVA with Tukey’s post hoc test). 
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The recommended serum concentration for B3 LECs was 10% FCS.  The optimum serum 
concentration for N/N1003A was known to be 8% RS [167-168].   
 
3.1.4 Harvesting Native Human LECs 
Harvesting native LECs from donor eyes was difficult, both in terms of availability of the 
eyes and the technique.  Cells grew at a slow rate and became difficult to dislodge with 
trypsin, resulting in fewer LECs than expected, even when wells were pooled together.  
Due to this experiments were not be repeated with native LECs as was desired.  Instead 
all experiments were carried out using cell lines.   
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3.2 Anticoagulation Polymers Coatings – 1 
Coatings from group 1 (001, 004 and pHEMA), were tested in a qualitative manner to 
optimise the process of the coatings and tissue culture techniques.  001, 004 and 
pHEMA coatings were synthesised onto glass coverslips (13mm diameter, Agar 
Scientific) and directly into 24 well plates.   
 
3.2.1 Cell Growth Study 
FHL124’s were seeded onto coated coverslips for a total of 7 days, and coated plates for 
a total of 11 days.  Phase contrast micrographs were taken of LECs on the different 
coatings whilst they were in culture (Figure 3.7), uncoated TCPS wells served as a 
control.  Most LECs on 001 and 004 were rounded with poor attachment.  Some 
attached cells had an elongated morphology.  Some defects with 004 were noted 
around the edges of the coated coverslips especially at later time points.  Some cells 
initially attached to the pHEMA coating however at later time points the cells had 
become rounded.  When FHL124 LECs were seeded onto coated wells micrographs 
showed a similar attachment and growth profile so data is not presented here. 
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Figure 3.7: Phase contrast micrographs demonstrating FHL124 LECs seeded onto coated coverslips from 
polymer group 1 (001, 004 and poly (hydroxyethyl methacrylate) (pHEMA)) and tissue culture 
polystyrene (TCPS) control at days 1, 3 and 7.  LECs on 001 were attached but were either elongated or 
rounded.  LECs observed on 004 were similar to 001.  LECs initially attached to pHEMA on day 1, but 
become rounded and loosely attached by day 3.  LECs attached and proliferated on TCPS control, with 
typical epithelial morphology and started to become confluent by day 7.   
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3.2.2 Cell Staining 
At day 7 samples were fixed with methanol for 5 minutes.  Methylene blue staining was 
performed on the coated coverslips and the wells the coverslips had been in and phase 
contrast micrographs were taken.  As the coated coverslips had hydrophilic gel-like 
properties 001, 004 and pHEMA absorbed the methylene blue, therefore visualising the 
cells proved difficult.  Nearly all cells had either detached or were washed off during 
fixation, cells that remained were rounded (Figure 3.8).    
 
 
 
 
 
 
 
The wells the coverslips had been in were also micrographed to examine if any cells had 
adhered to the well.  These gave an indication as to whether the coatings were 
cytotoxic, or leach toxic material into the medium.  FHL124 LECs adhered to the wells 
001 and 004 coverslips had been in (Figure 3.9), indicating the coatings were not 
cytotoxic to the cells.  LECs were well spread, produced small patches of cell growth and 
Figure 3.8: Phase contrast micrographs demonstrating methylene blue staining of FHL124 LECs seeded 
onto coated coverslips from polymer group 1 (001, 004 and poly (hydroxyethyl methacrylate) (pHEMA)) at 
day 7.  Coatings 001, 004 and pHEMA were a hydrophilic gel-like coatings which absorbed the dye, 
therefore visualising cells was difficult.  Cells that remained after washing and fixing were rounded on all 
three coatings. 
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appeared epithelial in morphology, similar to the TCPS control.  Coating 001 coverslips 
adhered to the plate which was a result of the material becoming tacky, due to the 
hydrogel-like nature of the coating.  A few LECs had attached around the edge of the 
well pHEMA coverslips had been in.  This was probably due to the fact that initially all 
LECs seemed to adhere to the pHEMA coverslips on day one, before becoming round 
and lifting off at later time points.  The cells that adhered to the TCPS control wells 
appeared epithelial in morphology and by day 7 were starting to produce a monolayer 
of LEC growth.  
 
 
 
 
 
 
 
 
 
 
Figure 3.9: Phase contrast micrographs demonstrating methylene blue staining of FHL124 LECs adhered 
to wells that contained 001, 004 and poly (hydroxyethyl methacrylate) (pHEMA) coated coverslips and 
tissue culture polystyrene (TCPS) at day 7.  LECs adhered to all wells indicating the coatings were not 
cytotoxic to the LECs.  Wells that previously contained 001, pHEMA and 004 showed confluent small 
patches of cell growth with epithelial morphology similar to the control. 
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LECs seeded onto coated wells were left in culture for 11 days and a live/dead assay was 
performed.  LECs on the coated wells appeared to have a slightly more rounded 
morphology than on the coverslips.  By day 11 cells had attached and formed a 
confluent monolayer of live (green) cells with only few dead (red) cells on the TCPS 
control (Figure 3.10).  Coating 001 showed a mix of live and dead cells, however the 
majority were dead.  Coating 004 and pHEMA absorbed the dye due to their surface 
properties, so there was a lot of background stain, making live/dead analysis difficult.  
When comparing coating 004 live/dead images to the phase contrast micrograph almost 
all LECs were rounded and dead.  Coatings 004 and pHEMA did not support cell 
attachment, the lack of attachment may be due to the coatings surface properties.  
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Figure 3.10: Fluorescent micrographs demonstrating Live/Dead assay of FHL124 LECs 
on control (tissue culture polystyrene (TCPS)) and 001, 004 and poly (hydroxyethyl 
methacrylate) (pHEMA) at day 11.  The control shows a confluent monolayer of live 
cells. 001 showed a mix of live (green) and dead (red) cells, however the majority were 
dead.  pHEMA and 004 absorbed the dye as they were both hydrogel-like coatings, the 
majority of cells were dead.   
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3.3 Anticoagulation Polymers Coatings – 2 
From this point on coatings were synthesised directly onto 24 well plates.  Coatings in 
group 2 were examined for a longer time period of 14 days.  
 
3.3.1 Cell Growth Study 
LECs were studied whilst in cell culture by taking phase contrast micrographs at each 
time point (Figure 3.11).  LECs responded differently to the various coatings shown via 
the amount of attachment and growth on 001, 002 and 003.  Interestingly, coatings 001 
produced more cell attachment and growth than in group 1 experiments, this may be 
due to improvements in the coating process and cell culture technique.  By day 14 small 
semi-confluent patches were observed on coating 001.  Coating 002 encouraged more 
LEC attachment and growth compared to 001.  Few LECs adhered and spread on coating 
003.  In general LECs attached to coating 003 were mainly rounded and not strongly 
adhered, however when cells did attach they were more elongated in morphology and 
did not look epithelial-like.  LECs grown on the TCPS control wells represented the 
typical growth pattern for this cell line.  LECs adhered to TCPS became confluent by 
around day 7 after this point some LECs rounded up due to lack of space. 
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Figure 3.11: Phase contrast micrographs demonstrate FHL124 LECs seeding onto coatings 001, 002, 003 
and control (tissue culture polystyrene (TCPS)) during cell culture at days 1, 3, 7, 10 and 14.  Cell 
attachment and growth varies on the various substrates.  Coating 001 allows some cell attachment and 
growth but not as much as coating 002.  By day 14 small patches of confluent cell growth were visualised 
on coating 002.  Coating 003 repelled cell attachment and the majority of cells were rounded on this 
coating, the cells that did attach do not appear epithelial-like and are elongated.  Cells seeded onto 
control TCPS showed typical LEC attachment and supported a monolayer of LECs by day 14. 
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3.3.2 Cell Staining 
Cells were stained with phalloidin-FITC (green) to view the f-actin filaments within the 
cytoskeleton and PI (red) to visualise the nuclei.  Coatings 001 and 002 had some cell 
attachment and were reasonably well spread, whereas 003 had few cells attached 
throughout the time in cell culture (Figure 3.12).  TCPS control was confluent by day 10 
and cells had become tightly packed, phalloidin staining demonstrated cells had an 
epithelial morphology. 
 
 
 
 
 
 
 
After all micrographs were taken cell nuclei were counted using ImageJ and a cell growth 
curve was plotted (Figure 3.13).  An area of exponential cell growth was observed 
between days 7 – 10 on TCPS, cell proliferation began to plateau after day 10.  Cell 
attachment and growth on coatings 001 and 002 were not significantly different 
(p>0.05).  Coatings did not produce a monolayer of cells in the time frame, however by 
Figure 3.12: Fluorescent micrographs demonstrating immunocytochemical staining of f-actin fibres 
(green) and nuclei (red) of FHL124 LECs seeded onto coatings 001, 002, 003 and control (tissue culture 
polystyrene (TCPS)) at day 10.  LECs at day 10 on 001 and 002 are reasonably well spread, with 002 
having more cell attachment.  Coating 003 had few cells if any attached by day 10.  TCPS control was 
confluent by day 10, cells were tightly packed and epithelial in morphology shown through F-actin fibre 
staining.  
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day 10 cell numbers started to increase, indicating LECs may have carried on 
proliferating if they were left in cell culture for longer.  Coating 003 had few cells 
attached if any during the 14 days in cell culture and was significantly different from all 
other coatings (p<0.05). 
 
 
 
 
 
 
 
 
3.3.3 Surface Analysis 
As the surface chemistry and properties are proprietary to BioInteractions Ltd. CA 
measurements were taken (Table 3-2) and coatings were analysed using SEM (Figure 
3.14).  The CA between all three coatings and PEI control was significantly different, 
ranging from an average of 29° to 68°.  Coating 003 had the lowest CA from 
Figure 3.13: Graph demonstrating LEC attachment and growth on 001, 002, 003 and tissue culture 
polystyrene control (TCPS) coatings during 14 days in cell culture.  Error bars equal ± 1 standard 
deviations.  TCPS wells represent the standard growth for this cell line, cells became confluent by day 
10.  Coatings 001 and 002 were similar to each other and produced a similar growth curve with large 
standard deviations.  Cell growth did increase from day 10, however a monolayer was not formed in 
this time period.  Coating 003 did not support cells attachment during the 14 days in cell culture. 
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BioInteractions coatings with a CA of approximately 35° and was more hydrophilic than 
coatings 001 (68°) and 002 (62°). 
 
Table 3-2: Demonstrates average contact angle (CA) measurements of coatings 001, 002, 003 and poly 
ethylinimine (PEI) base substrate. 
Coating Sample 1 Sample 2 Sample 3 Average 
001 71.1 ± 5.0 61.7 ± 5.5 70.1 ± 8.1  67.6±5.2 
002 59.9 ± 4.9 62.4 ± 3.2 63.4 ± 5.8 61.9±1.8 
003 31.9 ± 11.5 36.8 ± 6.1  36.8 ± 6.8 35.2±2.8 
PEI 29.3± 1.3 27.4± 4.1 31.3± 2.2 29.3± 3.1 
 
 
 
 
 
SEM analysis showed all three coatings to be featureless up to x400 magnification 
(Figure 3.14).  Some small particles were observed on the surface of a few samples, 
however this was most likely to be dust due to their size and distribution. 
 
 
Figure 3.14: Representative scanning electron microscopy (SEM) micrographs of A. Coating 001. B. 
Coating 002 and C. Coating 003.  All coatings appeared featureless and uniformly coated. 
CA measurements of coatings 001 and 002 were similar, however all coatings were significantly different.  
Error bars equal ± 1 standard deviations. * denotes significant difference were p<0.05.  Coatings 003 had a 
total of 5 water based layers and the CA measurement was more hydrophilic than 001 and 002. PEI had the 
lowest CA. 
* 
* 
* 
* 
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3.4 GAG Coatings  
BioInteractions Ltd. provided GAG polymer coatings containing heparin (HEP), 
Hyaluronic acid (HA) and chondroitin sulphate (CS).  Additionally GAG coatings were 
synthesised in house to examine if the cellular response was affected by the GAG itself 
or how it was present and bound to the surface. 
 
3.4.1 BioInteractions Ltd. Polymer Coatings 
Hep, HA and CS were synthesized directly in 24 well plates, an additional untreated TCPS 
plate was used as a control. 
 
3.4.1.1 Cell Growth Study   
HEP did not encourage cell attachment during the 14 day period (Figure 3.15).  HA 
produced a similar response however, small areas of cell attachment were observed 
randomly throughout some wells during the 14 days in cell culture.  CS encouraged a 
greater number of LECs attachment and growth than HEP and HA, however this was not 
equivalent to TCPS control.  By day 14 a monolayer of LECs was observed on TCPS. 
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Figure 3.15: Phase contrast micrographs demonstrating N/N1003A LECs attachment and growth on 
GAG polymer coatings, heparin (HEP), hyaluronic acid (HA), chondroitin sulphate (CS) and tissue culture 
polystyrene (TCPS) control, during the 14 days in cell culture.  HEP did not encourage cell attachment, 
HA produced a similar response however in some areas small patches of cells were observed.  CS 
encouraged LEC attachment and growth to a certain degree and TCPS enabled LECs to adhere and 
proliferate to achieve a confluent monolayer by day 14. 
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3.4.1.2 Cell Staining 
LECs were fixed and stained for αSMA to visualise myofibroblast-like cells, with 
phalloidin-FITC to visualise the f-actin fibres of the cytoskeleton and DAPI to visualise the 
nuclei (Figure 3.16).  No positive expression of αSMA was observed in LECs seeded onto 
HEP, HA, and CS, similar to TCPS control.  This indicates polymer GAG coatings do not 
encourage dedifferentiation into myofibroblast-like cells.  No cells were observed on 
HEP at day 14 (Figure 3.16-A).  Cells appeared rounded onto HA coatings (Figure 3.16-B).  
More cells were present on CS coating compared to HEP and HA coatings.  F-actin fibres 
were present in most cells seeded onto CS coating, however some cells had a rounded 
morphology (Figure 3.16-C).  LECs seeded onto TCPS control wells appeared to have a 
typical cobble-stone epithelial morphology with actin bands present around the 
periphery of the cells (Figure 3.16-D).    
 
 
 
  
 
Figure 3.16: Fluorescent micrographs demonstrating immunocytochemical staining of phalloidin (green) 
and DAPI (blue) of N/N1003A LECs on GAG polymer coatings A. heparin (HEP), B. hyaluronic acid (HA), C. 
chondroitin sulphate (CS) and D. tissue culture polystyrene (TCPS) control at day 14.  No cells were 
observed on HEP.  Few cells, if any, were attached to HA coating, cells had a rounded morphology.  More 
cells were observed on CS coatings, F-actin fibres were present in most cells.  TCPS wells enabled cell 
attachment with epithelial morphology and actin rings around the periphery on the cells. 
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Cell nuclei were counted and a growth curve was plotted (Figure 3.17).  Cells seeded 
onto TCPS became confluent by approximately day 7.  Cell growth on CS plateaued by 
day 10 however a monolayer of cell growth was not observed.  HA and HEP did not 
enable cell attachment during the 14 days in cell culture.  Significant difference was 
observed between all coatings on day 14. 
 
 
 
 
 
 
 
 
  
Figure 3.17: Graph demonstrating N/N1003A LEC growth GAG polymer coatings, heparin (HEP), 
hyaluronic acid (HA), chondroitin sulphate (CS) and tissue culture polystyrene (TCPS) control, during the 
14 days in cell culture.  Error bars equal ± 1 standard deviations.  Results showed that HEP and HA did 
not enable LEC attachment and growth, CS promoted some attachment and growth at a slower rate 
compared to TCPS control.   
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3.4.1.3 Surface Analysis 
TCPS and PEI had a significantly higher CA than the GAG coatings (Figure 3.18).  CAs for 
HEP, HA and CS were similar to each other and ranged between 23 – 25°, however the 
CA for CS was significantly lower than HEP (p=0.006).  Data were analysed using 
Dunnett’s T3 post hoc test.  
 
 
 
 
 
 
 
 
 
 
 
  
Figure 3.18: Contact angle measurements (CA) of polymer GAG coatings, heparin (HEP), hyaluronic acid 
(HA), chondroitin sulphate (CS), tissue culture polystyrene (TCPS) and poly ethylenimine (PEI).  Error bars 
equal ± 1 standard deviations.  * denotes significant difference were p<0.05.  HEP, HA and CS had similar 
CA ranging from 23-25°, meaning they had similar wettability properties, however HEP and CS were 
significantly different from each other.  TCPS and PEI control were slightly more hydrophobic and both 
were significantly different from all other coatings. 
 
* 
* 
* 
Significance  p<0.05 
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When coatings were viewed under the SEM, coatings appeared smooth and 
homogenous, at x5000 magnification (Figure 3.19).  Higher magnifications of x10000 
were taken but did not show anything different.   
 
 
 
 
 
 
 
To evaluate the topography of the coatings further WLI was performed to measure the 
surface roughness of the coating.  The roughness of all GAG coatings were relatively flat 
compared to TCPS and ranged from 10 – 12 nm (Figure 3.20).  TCPS and CS coatings 
were similar (p=1), as were HEP and HA (p=1), however, HEP and HA had a significantly 
lower roughness than both TCPS and CS.   Data were analysed using Dunnett’s T3 post 
hoc test. 
  
Figure 3.19: Representative scanning electron microscopy (SEM) micrographs of heparin (HEP), 
hyaluronic acid (HA), chondroitin sulphate (CS) and tissue culture polystyrene (TCPS).  All coatings 
appeared smooth and featureless. 
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3.4.1.4 Time Lapse Microscopy 
Time lapse microscopy analysis was performed on the coated GAG plates provided by 
BioInteractions Ltd (Appendix A).  HEP gave a different LEC response when monitored 
with time lapse microscopy.  Cells settled on HEP polymer coating between 3 – 4 hours.  
A high proportion of cells attached appeared to be rounded, this was more noticeable 
between day 0 – day 7 (approximately).  By day 14 a near confluent monolayer was 
reached, however cell morphology was elongated and not typical of LEC morphology.  
HA encouraged areas of cell attachment and growth, LECs proliferated during the 14 
days in cell culture.  LECs settled within 3 hours on CS polymer coating, small areas of 
cell growth were observed with some cells remaining rounded during the 14 days.  LECs 
settled within 30 minutes on TCPS control, cells spread and proliferated to form a 
confluent monolayer by day 14. 
 
Figure 3.20: Graph demonstrating average roughness (Ra) values for polymer GAG coatings, heparin 
(HEP), hyaluronic acid (HA), chondroitin sulphate (CS) and tissue culture polystyrene (TCPS). Error bars 
equal ± 1 standard deviations.  * denotes significant difference were P<0.05.  All coatings were relatively 
flat and smooth with similar Ra values in the range of 10 – 12 Ra, however HEP and HA were 
significantly different to CS and TCPS. 
* 
Significance  p<0.05 
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3.4.2 Adsorbed GAGs Coatings 
Five variations of the adsorbed GAG experiments were studied: 
1. 3 hour incubation at 37°C  – followed by a rinsing step 
2. 3 hour incubation at 37°C  – without a rinsing step 
3. 24 hour incubation at 37°C – without a rinsing step 
4. 24 hour incubation at 4°C – without a rinsing step 
5. GAG added to cell culture medium 
 
3.4.2.1 3 Hour Incubation at 37°C Followed by a Rinsing Step 
LECs were monitored in cell culture for a total of seven days and phase contrast 
micrographs were taken.   
 
When CS was adsorbed onto PEI base polymer for “3 hour incubation at 37°C followed 
by a rinsing step” cells attached and spread across all GAG concentrations during the 
seven days, similar to the PEI control (Figure 3.21).  There was a reduction in LEC 
attachment across all CS concentrations when compared to the PEI control on day 4, 
however by day 7 the majority of concentrations had produced a monolayer, similar to 
the PEI control.  10mg/ml CS had fewer cells attached by day 7 when compared to other 
concentrations.  When HA was adsorbed for “3 hour incubation at 37°C followed by a 
rinsing step” a similar LECs response was observed therefore the micrographs are not 
shown.   
 
LECs attached and spread to CS adsorbed coatings onto TCPS wells for “3 hour 
incubation at 37°C followed by a rinsing step", regardless of concentration.  LECs 
attachment to CS coatings was similar to TCPS control (Figure 3.22).  A decrease in cell 
attachment was observed on day 4 at 10mg/ml CS.  By day 7 typical epithelial 
cobblestone morphology was observed on TCPS control and all CS adsorbed coatings. 
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Figure 3.21: Phase contrast micrographs of cells on adsorbed chondroitin sulphate (CS) on 
polyethylenimine (PEI) base polymer for 3 hours incubation at 37°C followed by a rinsing step.  There was 
a reduction in LEC attachment across all CS concentrations at day 4 when compared to untreated PEI 
control.  However by day 7 monolayers had formed across most concentrations, similar to the control.  
10mg/ml had a slight decrease in LEC attachment by day 7. 
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Figure 3.22: Phase contract micrographs demonstrating cell attachment on chondroitin sulphate (CS) 
adsorbed onto tissue culture polystyrene (TCPS) for 3 hours incubation at 37°C followed by a rinsing 
step.  All CS concentrations produced a monolayer of LEC by day 7, similar to untreated TCPS control.  
By day 4 10ng/ml CS had less cell attachment, but this had recovered by day 7. 
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CS did not encourage LEC attachment when adsorbed onto PS coverslips for “3 hour 
incubation at 37°C followed by a rinsing step”, regardless of concentrations, similar to PS 
coverslips control (Figure 3.23). 
 
 
Figure 3.23: Phase contrast micrographs of cell attachment on chondroitin sulphate (CS) adsorbed onto 
polystyrene (PS) coverslips for 3 hour incubation at 37°C followed by a rinsing step.  CS did not encourage 
LEC attachment regardless of concentration.  This was the same response as untreated PS coverslips. 
  
110 
Chapter 3: Results 
To summarise, the cellular response for HA and CS adsorbed onto PEI, TCPS and PS 
coatings at “3 hour incubation at 37°C followed by a rinsing step”, was similar to 
uncoated controls, regardless of the basement substrate and GAG concentration.  The 
higher GAG concentrations (10mg and 5mg) proved difficult to dissolve in medium prior 
to coating substrates, therefore were not analysed further.   
 
3.4.2.2 3 Hour Incubation at 37°C without a Rinsing Step 
To explore if more GAG could be bound to the substrates to cause an effect on the LECs 
attachment the study was repeated at “3 hour incubation at 37°C without a rinsing 
step”.  Similar cellular attachment and growth was observed during cell culture of HA 
and CS adsorbed onto TCPS and PS coatings to the previous “3 hour incubation – 
followed by rinsing” study, therefore micrographs are not shown.   
 
When HA and CS were adsorbed onto PEI for “3 hour incubation at 37°C without a 
rinsing step” there was no cell attachment and growth on GAG adsorbed coatings, 
regardless of concentrations.  This was similar to the control (Figure 3.24),   therefore 
the experiment was stopped at day four as PEI in previous studies has been shown to 
encourage LEC attachment. 
 
 
 
 
 
  
Figure 3.24: Representative phase contrast micrographs of LECs growth on polyethylenimine (PEI) base 
polymer in the absence of any GAG, at days 1 and 4.  Cell attachment was the same for both hyaluronic 
acid (HA) and chondroitin sulphate (CS) concentrations and the untreated PEI control therefore the 
experiments were stopped at day four. 
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3.4.2.3 24 Hour Incubation at 37°C & 4°C without a Rinsing Step 
The incubation time was increased to 24 hours to examine if a longer incubation time 
produced more GAG adsorption onto the substrate to produce a cellular effect.  HA and 
CS were added to TCPS and PEI substrates for “24 hours incubation at either 37°C or 4°C 
without a rinsing step”.  Phase contrast micrographs were taken whilst in cell culture.  
The LEC response was similar to untreated TCPS and PEI controls regardless of GAG type, 
concentration and temperature (Figure 3.25).   
 
 
 
 
 
 
3.4.2.4 GAG Added to Cell Culture Medium 
A final method of including HA and CS in the culture medium was tested.  Cells were fed 
every 2 – 3 days with medium containing various concentrations of either HA or CS.   
LECs seeded on PEI substrates in the presence of “HA or CS containing medium” had a 
similar response to PEI control in the absence of GAG containing medium.  Cells 
attached and spread during the seven days in cell culture and near-confluent areas of 
LEC growth were observed by day 7, however there was a reduction in cell growth on 
1mg/ml CS throughout the seven days in cell culture (Figure 3.26).  
 
 
Figure 3.25: Representative phase contrast micrographs demonstrating cell attachment and growth on 
tissue culture polystyrene (TCPS) and polyethylenimine (PEI) controls in the absence of any GAG.  Cell 
attachment was the same when hyaluronic acid (HA) and chondroitin sulphate (CS) were adsorbed onto 
TCPS and PEI for “24 hours incubation at either 37°C or 4°C without a rinsing step”. 
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Figure 3.26: Phase contrast micrographs demonstrating LEC attachment and growth on 
polyethylenimine (PEI) in the presence of hyaluronic acid (HA) or chondroitin sulphate (CS) 
containing medium and control (PEI 0mg/ml). Some patchy growth was observed when LECs were 
seeded onto PEI in the presence of HA or CS containing medium compared to the control.  1mg/ml 
CS did not encourage cells to adhere. 
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Cells seeded on TCPS substrate in the presence of “HA or CS containing medium” had a 
reduced cell attachment and growth when compared to TCPS control (in the absence of 
GAG containing medium) (Figure 3.27).  By day 7 LEC attachment and growth on HA and 
CS coatings decreased with increasing GAG concentration. 
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Figure 3.27: Phase contrast micrographs demonstrating LECs attachment on tissue culture 
polystyrene (TCPS) in the presence of hyaluronic acid (HA) or chondroitin sulphate (CS) containing 
medium and TCPS control (0mg/ml).  Attachment and growth of cells seeded onto TCPS in the 
presence of HA or CS containing medium was similar to TCPS control, however the higher the 
concentration of GAG the less LEC attachment was observed, regardless of GAG type. 
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LECs seeded onto PS coverslips in the presence of “HA or CS containing medium” had a 
similar cellular response to PS control in the absence of GAG containing medium.  PS 
coatings did not support cellular attachment regardless of GAG type and concentration 
(similar to PS control), therefore phase contrast micrographs are not shown. 
 
3.4.2.5 Quantifying the Amount of GAG Present 
All adsorbed GAG coatings were stained with toluidine blue to demonstrate the 
presence of adsorbed GAG to PEI, TCPS and PS substrates.  Toluidine blue staining of HA 
and CS adsorbed onto TCPS substrates for “24 hours incubation at 37°C without a rinsing 
step”, demonstrated little positive staining regardless of GAG concentrations (Figure 
3.28).  
 
 
 
 
 
 
 
Figure 3.28: Photograph of a whole plate demonstrating toluidine blue staining of hyaluronic acid (HA) 
and chondroitin sulphate (CS) adsorbed onto tissue culture polystyrene (TCPS) for 24 hours at 37°C.  
There was little positive staining regardless of GAG.  Slight toluidine blue staining was observed on higher 
concentrations at 10mg/ml and 1mg/ml. 
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Toluidine blue staining of HA and CS adsorbed onto TCPS substrates for “24 hours 
incubation at 4°C without a rinsing step”, demonstrated slightly more toluidine blue 
staining present at 10mg and 1mg HA than CS, however results were inconclusive as it 
was not present in all the wells (Figure 3.29).  Lower concentrations had no positive 
staining. 
 
 
 
 
 
 
 
Toluidine blue did not prove successful at staining adsorbed GAG coatings regardless of 
method, substrate and GAG concentration, therefore toluidine blue photographs from 
other adsorbed GAG assays are not shown. 
  
Figure 3.29: Photograph of a whole plate demonstrating toluidine blue staining of hyaluronic acid (HA) 
and chondroitin sulphate (CS) adsorbed onto polystyrene (TCPS) for 24 hours at 4°C.  10mg/ml and 
1mg/ml HA showed a greater amount of toluidine blue staining.  Other concentrations did not positively 
stain for the presences of GAG. 
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3.4.3 Bound GAGs Coatings 
HA and CS were immobilised onto modified 13mm glass coverslips coated with amine 
functionality by silanisation.  GAGs were bound onto the amine coatings via 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC)/N-hydroxysuccinimide (NHS) reaction 
solution.   
 
3.4.3.1 Cell Growth Study 
N/N1003A LECs were seeded onto the bound GAG coatings for a total of seven days.  
Phase contrast micrographs were taken during this time of LECs seeded onto CS and HA 
bound coatings (Figure 3.31 and Figure 3.31 representatively). 
 
LECs seeded onto TCPS and glass controls had typical epithelial cuboidal appearance and 
by day 7 a confluent monolayer was observed (Figure 3.30).  Amine coated coverslips 
had less cell attachment than TCPS and glass controls and by day 7 a confluent 
monolayer was not observed.  LECs seeded onto 3mg/ml and 1mg/ml bound CS coating 
did not encourage LECs attachment and growth, cells remained rounded in morphology 
during the seven days and a lot of cell debris and floating cells was produced.  There was 
also some precipitation present from the coating.  Patchy LECs growth was observed on 
0.1mg/ml bound CS coating, cells that did adhere appeared epithelial in morphology.   
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Figure 3.30: Phase contrast micrographs demonstrating cell attachment and growth on tissue culture 
polystyrene (TCPS) control, glass coverslips, amine coated coverslips and 3mg/ml, 1mg/ml and 0.1mg/ml 
of bound chondroitin sulphate (CS) on amine coated coverslips, during the 7 days in cell culture.  TCPS and 
glass control had a similar growth pattern with LECs reaching confluency by day 7, both have a typical 
epithelial cuboidal appearance.  0.1mg/ml CS had patchy cell growth with some areas becoming near 
confluent and others areas with no cell growth.  Cells appeared epithelial in morphology.  1mg/ml and 
3mg/ml of bound CS did not encourage LEC attachment and growth.  Instead cells appeared rounded and 
produced a lot of cell debris and floating cells.   
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LECS seeded onto 3mg/ml and 1mg/ml bound HA coating did not encourage cell 
attachment and growth (Figure 3.31).  Patchy LEC growth was observed on 0.1mg/ml 
bound HA coating, similar to 0.1mg/ml CS, again cells that adhered appeared epithelial 
in morphology.   
 
 
 
 
 
 
 
 
  
Figure 3.31: Phase contrast micrographs demonstrating cell attachment and growth on 3mg/ml, 1mg/ml 
and 0.1mg/ml bound hyaluronic acid (HA) on coated amine coverslips, during the 7 days in cell culture.  
0.1mg/ml HA was similar to 0.1mg/ml of CS, cells grew in small patches with some areas becoming near 
confluent and others areas with no cell growth, and again cells appeared epithelial in morphology.  
1mg/ml and 3mg/ml of bound HA did not encourage LECs attachment and growth.   
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On day 7 cells were fixed with methanol and stained with methylene blue for 2 minutes 
to grossly visualise the LECs attachment and growth.  Methylene blue staining was 
similar for HA and CS (Figure 3.32 and Figure 3.33 representatively).  Few cells were 
visualised on bound HA and CS at 3mg/ml and 1mg/ml.  Some cell attachment was 
visualised on bound HA and CS at 0.1mg/ml concentration.  Amine, glass and TCPS wells 
all had relatively confluent areas of cell growth with amine having slightly less 
methylene blue staining. 
 
 
 
 
 
 
 
 
  
Figure 3.32: Photograph of the whole plate demonstrating methylene blue staining of LECs attached to 
hyaluronic acid (HA) bound to amine coated coverslips, amine coated coverslips, glass coverslips and 
tissue culture polystyrene (TCPS) control.  Amine, glass and TCPS all have good coverage of LECs with 
amine having slightly less cell growth.  3mg/ml and 1mg/ml HA showed few to no cell attachment.  
Some dye build-up can be seen around the edges of these wells.  Some methylene blue staining can be 
seen on 0.1mg/ml HA in small clusters. 
3mg/ml      1mg/ml      0.1mg/ml      Amine          Glass         TCPS    
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Figure 3.33: Photograph of a whole plate demonstrating methylene blue staining of LECs attached to 
chondroitin sulphate (CS) bound to amine coated coverslips, amine coated coverslips, glass coverslips and 
tissue culture polystyrene (TCPS) control.  Again amine, glass and TCPS all had good coverage of LECs with 
amine having slightly less cell growth.  3mg/ml and 1mg/ml CS showed no cell attachment.  Some dye 
build-up was noticeable on the CS coverslips also.  Some methylene blue staining can be seen on 
0.1mg/ml CS in small clusters. 
3mg/ml       1mg/ml     0.1mg/ml      Amine       Glass      TCPS  
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3.4.3.2 Quantifying the Amount of GAG Present 
To quantify if any bound GAG was present wells were again stained with toluidine blue, 
however the GAGs bound to the amine coated coverslips failed to stain (Figure 3.34).   
 
 
 
 
 
  
Figure 3.34: Photograph of a whole plate demonstrating toluidine blue staining of hyaluronic acid (HA) 
and chondroitin sulphate (CS) bound onto amine coated coverslips. Toluidine blue did not stain the 
bound GAG coverslips.   
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CA measurements were taken of bound GAG coated coverslips as an alternative to 
observe if any GAG was present (Figure 3.35).  The CA for TCPS represents the usual 
substrate used in cell culture to grow LECs.  Untreated glass CA was significantly more 
hydrophobic than TCPS.  The CA increased further when glass coverslips were 
functionalised with amine groups, however this increase was not significant.  When HA 
and CS were bound onto amine coated coverslips the CA decreased significantly, 
becoming more hydrophilic.  Data was analysed using Dunnett’s T3 post hoc test.  The 
results confirmed a change in CA indicating the surface of the glass coverslips had been 
modified. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.35: Graph demonstrating average contact angle measurements (CA) of controls (TCPS, glass and 
amine) and bound hyaluronic acid (HA) and chondroitin sulphate (CS) coated coverslips.  Error bars 
equal ± 1 standard deviations.   The CA of TCPS represents the usual substrate used to grow LECs in cell 
culture.  The CA changes when the glass coverslips were coated with amine and became slightly more 
hydrophobic.  However when HA and CS were bound onto the surface of amine coated the coverslips 
the CA decreased, making them more hydrophilic. The CA measurements were similar for HA and CS 
depending on the concentrations, 3mg/ml were more hydrophobic than 1mg/ml and 0.1mg/ml.  
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The CA measurement for bound GAG coatings and polymer GAG coatings provided by 
BioInteractions Ltd. were compared and statistically analysed using Dunnett’s T3 post 
hoc test (Figure 3.36).  Polymer HA and CS were not significantly different to 0.1mg/ml 
bound HA and CS.  Polymer HA was also not significantly different to 3mg/ml bound CS, 
however the p value (0.099) was close to the significance value of 0.05.  Some 
similarities between polymer HA and CS coatings and bound HA and CS coatings were 
observed.    
  
 
 
  
Figure 3.36: Graph demonstrating comparison of the average contact angle (CA) measurements between 
bound hyaluronic acid (HA) and chondroitin sulphate (CS) coating and polymer HA and CS coatings.  Error 
bars equal ± 1 standard deviations.  CA ranged from 19° - 28°.  Polymer HA and CS were not significantly 
different from 0.1mg/ml HA and CS, indicating some correlation in CA between polymer GAG coatings 
and bound GAG coatings. 
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3.5 Zwitterionic Polymers 
Six zwitterionic coatings (F-N) and three control coatings (L–N) were synthesized (Table 
2-5 pg.72).  Coatings were studied in cell culture for a total of seven days.  The cytoxic 
effect of the coatings was also examined along with time lapse microscopy.   Surface 
analyses of the coatings were performed using CA, SEM and white light interferometry.   
 
3.5.1 Cell Growth Study  
Phase contrast micrographs were taken throughout the study (Figure 3.37). LECs seeded 
onto TCPS wells produced a confluent monolayer by day 7, with typical epithelial 
morphology.  Cells did not adhere to coatings F, G, and I throughout the seven days in 
cell culture.  LECs settled and adhered to coating H and by day 7 patchy cell growth was 
observed.  
 
  
  
126 
Chapter 3: Results 
 
 
 
 
 
 
 
Phase contrast micrographs (Figure 3.38) representative micrographs from LECs on 
coatings J- N throughout the seven days in culture.  Coatings J, L and N were similar to 
Figure 3.37: Phase contrast micrographs demonstrating LECs attachment on tissue culture polystyrene 
(TCPS) and zwitterionic coatings F – I (F – 90% butyl methacrylate:10% novel zwitterionic monomer, G – 
80% butyl methacrylate:20% novel zwitterionic monomer, H – 70% butyl methacrylate:30% novel 
zwitterionic monomer and I – 58% hydroxypropyl methacrylate:31% hexyl methacrylate:11% novel 
zwitterionic monomer) during the 7 days in cell culture.  A monolayer of cells was present by day 7 on 
TCPS.  Coatings F, G and I behaved in a similar manner and did not support LEC attachment.  Coating H 
supported cell attachment and confluent areas of cell attachment were observed by day 7. 
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TCPS control.  All three coatings supported LEC attachment and produced a monolayer 
of cells by day 7.  Cells did not adhere to coatings K and M throughout the seven days in 
cell culture.  
 
 
 
 
  
Figure 3.38: Phase contrast micrographs demonstrating LECs attachment on zwitterionic coatings J – N (J 
– 58% hydroxypropyl methacrylate:31% hexyl methacrylate:11% novel zwitterionic monomer, K – 50% 
methoxyethyl methacrylate:30% hexyl methacrylate:20% novel zwitterionic monomer, L – 100% poly 
(butyl methacrylate), M – 90% butyl methacrylate:10% 2-methacryloyloxyethyl - phosphorylcholine 
(MPC) and N – 70% butyl methacrylate:30% 2-methacryloyloxyethyl – phosphorylcholine) during the 7 
days in cell culture.  Cell attachment on coatings J, L and N demonstrate a similar LEC response to TCPS 
control.  Cells did not adhere to coatings K and M throughout the seven days in cell culture. 
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3.5.2 Cell Staining 
After each time point cells were fixed and stained with phalloidin, and DAPI.  The cell 
nuclei were counted and the average number of cells per field of view was plotted 
(Figure 3.39).  Coatings F, G, I, and M did not support LEC attachment or growth. Coating 
K had an average cell count of 22 cells/field of view or less throughout the 7 days in cell 
culture.  On day 7 there was no significant difference between coatings F, G, I, K and M 
(p>0.05).  Coatings H, J, L and N did support LEC attachment and growth to various 
degrees, however coating J is believed to have dissolved in the medium so will not be 
taken any further.  There was no significant difference between coatings H, J, L and N at 
day 7.  On day 7 no significant difference was observed between coatings J and L 
compared to TCPS (p=0.55 and p=0.52 respectively).  This means out of the six novel 
zwitterionic coatings there is potentially a coating which could support the hypothesis 
for a monolayer of cells, coating H, and several coatings which could support the 
hypothesis for prohibiting cell growth, coatings F, G, and I.  Dunnett’s T3 post hoc test 
was used following one-way ANOVA.  
 
 
 
 
 
Figure 3.39: Graph demonstrating LEC attachment and growth on zwitterionic coatings F-N and control 
tissue culture polystyrene (TCPS) during 7 days in cell culture.  Error bars equal ± 1 standard deviations.  
The top purple line is the control (LECs grown on TCPSP) and represents the typical growth profile for 
this cell line.  Coatings N, J, H and L all supported cell attachment and growth to various degrees.  
Coating N and J had a linear profile, indicating LECs on these surfaces may carry on proliferating if they 
were left longer in culture.  Coatings K, F, G, I and M did not support the appropriate cell binding sites 
required for cell attachment and growth. 
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3.5.3 Cytotoxic Assay 
A cytotoxicity assay was performed, following BS EN ISO 10993-5:2009 using the 
extraction method.  After LECs had been incubated in the extracted medium for 1 and 3 
days the metabolic activity was measured using resazurin.  The results of the cytotoxicity 
assay confirmed that all coatings had a similar metabolic activity and were consistent 
with the negative controls (blank and TCPS) (Figure 3.40).  One way ANOVA was 
performed followed by Tukey’s or Dunnett’s T3 post hoc test on days 1 and 3, depending 
if variances were homogeneous or not, respectively.  The results demonstrate the novel 
zwitterionic coatings had no adverse effects, as the metabolic activity was not 
significantly different from cells seeded onto TCPS p<0.05. Positive control, 5% DMSO, 
was significantly different and induced toxicity.  The metabolic activity decreased on day 
3 as the cells became confluent and less metabolically active. 
 
 
 
 
 
 
 
Figure 3.40: Graph demonstrates cytotoxicity assay of zwitterionic coatings F–N and blank control (tissue 
culture polystyrene (TCPS) coverslips), negative control TCPS wells and positive control 5% DMSO.  Error 
bars equal ± 1 standard deviations.  * denote significant difference where P<0.05.  Metabolic activity was 
measured using resazurin.  There was no significant difference between coatings F-N & blank compared to 
TCPS control.  5% DMSO significantly induced cytotoxicity. 
Significance  p<0.01 
* 
* 
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3.5.4 Toxicity Assay 
LECs are adherent dependant cells, in culture they adhere to TCPS within half an hour 
(observed with time lapse microscopy analysis) and do not survive in the medium if they 
cannot settle and attach.  On the majority of the coatings F-N cells did not attach during 
the 7 days in cell culture, instead they clumped together and died.  Therefore a toxicity 
assay was performed to observe if unattached cells, initially seeded onto coatings F-N, 
could be aspirated and reseeded onto uncoated TCPS wells and attach, spread and 
proliferate.  The results illustrate the metabolic activity increased from day 1 to day 4 
across all coatings and TCPS control, indicating coatings F-N did not have a toxic effect 
on cell ability to attach, spread and proliferate (Figure 3.41).   Coatings J and L had a 
lower metabolic activity than the rest of the coatings, as most cells had attached to J and 
L coated wells within the 2 hours and is represented by columns, original J and original L.  
To some extent this was the same for coating N.  On day 1 there was significant 
difference in metabolic activity between TCPS and coatings F, J, L, N, original J, original L 
and original N (p<0.05).  On day 4 coatings F, J, K, M, N, original L and original N were 
significantly different to TCPS (p<0.05).  
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3.5.5 Time Lapse Microscopy 
The results from the time lapse microscopy were similar to the previous cell growth 
curve study (appendix B).  Coating F did not encourage cell attachment, cells initially 
clumped together and did not adhere to the coating. Coating G, I, K and M all produced 
a similar affect.  Coating H did support cell attachment to a certain degree, however cells 
took a while to settle and spread, approximately eight hours.  By day seven small 
patches of cell growth in the field of view were present.  Cells attached and settled onto 
coating J within 30 minutes to an hour.  By day 7 a sub-confluent monolayer was 
present.  Coating L encouraged cells to attach and settle within approximately an hour.  
LECs grew to a sub-confluent monolayer by day 7, however this was not as confluent as 
coating J and a lot of rounded cells were present.  Coating N encouraged settlement and 
attachment by two hours and by day seven a confluent monolayer had formed, similar 
Figure 3.41: Graph demonstrates cell toxicity assay of zwitterionic coatings F – N and tissue culture 
polystyrene coverslips (TCPS).  Error bars equal ± 1 standard deviations.  Metabolic activity of LECs was 
measured using resazurin.  On day four TCPS was significantly different to Coatings F, J, K, M, N, original L 
and original N (p<0.05). 
               = Cells moved to fresh TCPS wells                           = Cells attached to coatings within 2 hours 
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to TCPS control.  Cells settled and adhered to TCPS within 30 minutes and at day seven a 
fully confluent monolayer was present. 
 
3.5.6 Surface Analysis 
The wettability of coatings F-N was measured and plotted (Figure 3.42).  Coating F and I 
were more hydrophobic (64 and 50, respectively) than the other novel zwitterionic 
coatings (G, H, J and K).  Control coatings L and M were also had a higher CA, however 
the contact angle varied across all coatings from approximately 80° - 22° and were 
significantly different to TCPS (34°, p<0.05).   
 
 
 
Figure 3.42: Graph demonstrates the average contact angle measurements (CA) for zwitterionic coating 
F-N.  Error bars equal ± 1 standard deviations.  CA varied across the 6 novel zwitterionic coatings (F-K).  
Indicating cell growth was not related to the wettability of the coating. 
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SEM analysis indicated most surfaces to be smooth with some having micro features and 
cracks (Figure 3.43).  Coatings F and L both had fibrous honeycomb appearances.   
 
 
 
 
 
 
  
Figure 3.43: Representative scanning electron microscopy (SEM) micrographs, demonstrating zwitterionic 
coatings F- N.  Coatings F and L had a fibrous honeycomb appearance at x 5000 magnification which may 
have been caused by the processing.  Coatings G, H, I, J, K and M are relatively smooth apart from some 
cracks and ripples again believed to be artefacts of the chromium processing. 
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WLI results present the average surface roughness (Ra) across four areas measured at 
x100 magnification.  All coatings apart from F (Ra 149nm) and L (Ra 378nm) had an 
average surface roughness of below 35nm and were not significantly different.  This 
supports the SEM analysis (Figure 3.44).  Coatings F and L were significantly different 
from coatings G – K & M – N and TCPS p<0.05, measured using one way ANOVA and 
Dunnett’s T3 post hoc test. 
 
 
 
 
 
 
 
 
3.5.7 Preliminary Bulk Materials Assay 
Material F was copolymerised with pHEMA as a bulk contact lens to study the bulk 
material properties.  PHEMA contact lenses, gold standard Acyrsof® IOLs and untreated 
TCPS wells were used as controls.  Phase contrast micrographs were taken to monitor 
cell growth on substrates throughout the 7 days in cell culture (Figure 3.45).  Preliminary 
results demonstrate LECs seeded onto TCPS control produced a confluent monolayer by 
Figure 3.44: Graph represents average surface roughness values (Ra) for zwitterionic coatings F-N and 
tissue culture polystyrene (TCPS).  Error bars equal ± 1 standard deviations.  * denotes significant 
difference were p<0.05.    Coatings G, H, I, J, K and M are below 35nm.  Coating F (149nm) and L 
(378nm) had a rougher topography which was due to the fibrous topography.  Coatings F and L were 
significantly different to all other coatings and TCPS (p<0.05). 
* 
* 
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day 7 with cuboidal morphology.  No cells adhered to bulk material pHEMA of material 
F.  A large amount of LECs adhered and grew on Acrysof® IOLs, cells were observed at 
the edge of the IOL and in the centre and some rounded cells were also present. 
 
 
 
 
 
 
 
Figure 3.45: Phase contrast micrographs representative LEC attachment and growth on tissue culture 
polystyrene (TCPS), bulk material F, bulk material poly (hydroxyethyl methacrylate) (pHEMA) and 
Acrysof® IOL.  Typical epithelial morphology was observed on TCPS control.  Bulk material material F and 
pHEMA did not support LEC attachment and growth.  Floating dead cells were observed on these 
coatings.  A large proportion of LEC attachment and growth occurred on Acrysof® IOLs, cells appeared 
epithelial and reasonable well spread. 
  
136 
Chapter 3: Results 
LECs were fixed at day 7 with methanol and stained with methylene blue.  Photographs 
of the whole plate were taken, (Figure 3.46).  Bulk materials F and bulk material pHEMA 
absorbed the dye.  Some cell growth can be visualised on Acrysof IOLs and confluent 
areas can be observed on TCPS control wells. 
 
 
 
 
 
Figure 3.46: A. Photograph of the whole plate demonstrating cells stained with 
methylene blue on bulk material F, bulk material poly (hydroxyethyl methacrylate) 
(pHEMA), Acrysof® IOL and tissue culture polystyrene (TCPS).  Material F and 
pHEMA absorbed the dye due to their hydrogel-like properties.  B. Cells were 
visible on Acrysof® IOLs, close up photograph demonstrates cell attachment.  TCPS 
control had a near confluent coverage of LECs at day 7. 
A. 
B. 
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C-Flex (Rayner) pHEMA IOL was separately tested to compare it to bulk material pHEMA 
provided by BioInteractions Ltd.  LECs were again seeded on Acrysof® IOLs to confirm 
cellular response and uncoated TCPS wells were used as a control.  C-Flex did not 
encourage LEC attachment or growth (Figure 3.47).  Acrysof® IOL produced a similar 
cellular response to the previous study with LECs attaching and spreading throughout 
the duration of culture.  TCPS control was confluent by day 7 with typical epithelial 
morphology. 
 
 
 
 
 
 
 
Figure 3.47: Phase contrast micrographs representative LECs attachment and growth on Acrysof® IOL, C-
Flex IOL and tissue culture polystyrene (TCPS), during the 7 days in culture.  A similar cellular response 
was seen on Acrysof IOLs to the previous study, LECs attached and spread whilst in culture.  C-Flex did 
not enable LEC attachment or growth during the 7 days and was similar to bulk material pHEMA in the 
previous study. LECs seeded onto TCPS control were confluent by day 7 with typical epithelial 
morphology. 
 
  
138 
Chapter 3: Results 
Methylene blue staining can be observed on Acrysof IOLs indicating LEC attachment and 
spreading (Figure 3.48-A and Figure 3.48-B).  C-Flex IOL absorbed the dye in a similar 
way to the previous bulk material pHEMA due to its hydrophilic nature (Figure 3.48-C).   
 
 
 
 
 
 
Confluent areas of LEC growth was observed with methylene blue on TCPS control 
(Figure 3.49). 
 
 
 Figure 3.49: Photograph of the whole plate demonstrating methylene blue staining of, Acrysof IOL, C-Flex 
IOL, and tissue culture polystyrene (TCPS) control.  LECs were well spread and confluent by day 7 on TCPS 
control.    
A. B. C. 
Figure 3.48: Photographs of individual wells demonstrating cells stained with methylene blue on A. 
Acrysof® IOL, B. Acrysof® IOL and C. C-Flex IOL.  Cell attachment was observed on Acrysof® IOLs (A and 
B).  C-Flex IOL absorbed the dye similar to bulk material pHEMA due to its hydrogel-like nature. 
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3.6 Dedifferentiation Model and TGFβ3 Assay 
A dedifferentiation model was set up to control dedifferentiation of LECs and test 
TGFβ3’s ability to prevent or reverse the effect of dedifferentiation.  This was evaluated 
using αSMA as a marker for dedifferentiated cells. 
 
3.6.1 Serum Assay 
Two methods for reducing the rabbit serum (RS) concentration used with N/N1003A 
LECs were studied, first by reducing the serum concentration from the start of the 
experiment or secondly seeding LECs in optimum 8% serum for either 24 or 72 hours, 
prior to reducing or removing the serum completely.  The average number of cells per 
field of view for different serum concentrations at each time point was calculated and 
plotted (Figure 3.50).  Optimum 8% serum concentration is represented by the first blue 
(0 hours pre-treatment), red (24 hours pre-treatment) and green (72 hours pre-
treatment) bars of each time point, and represents the usual growth pattern for this cell 
line.  By day seven all 8% RS concentrations (0 hours, 24 hours and 72 hours pre-
treatment) fell within a similar range, and were not significantly different to each other.  
By day seven, the longer LECs were cultured in 8% RS prior to experimental conditions 
the greater the number of cells were counted, regardless of experimental serum 
concentration.  Some LECs did attach in 0% serum, however cell numbers were low, 
regardless of whether LECs were cultured in optimum 8% serum concentration first.  In 
0.5% RS LECs proliferated slightly during the seven days, with increasing cell 
proliferation the longer the LEC had been exposed to 8% serum.  A serum concentration 
of 2% RS encouraged cells to steadily proliferate but at a lower rate compared to the 8% 
control.  Cells seeded in 2% RS – 72 hours pre-treatment had the highest number of cells 
attached by day seven, compared to all other experimental serum concentrations.  
When cells were treated with 2% RS – 72 hours pre-treatment cell number was 
significantly different (p<0.05) to all other experimental serum concentrations, with the 
exception of 2% RS – 24 hours pre-treatment.  When cells were treated with 2% RS – 24 
hours pre-treatment, however, cell number was also not significantly different to 0.5% 
RS – 72 hours pre-treatment.  Due to this a serum concentration of 2% after pre-
treatment with 8% RS for 72 hours was chosen for future TGFβ3 studies. 
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Figure 3.50: Graph presents N/N1003A LECs attachment in 8%, 2%, 0.5% and 0% rabbit serum (RS) 
concentrations over time, error bars are 1± standard deviation.  Serum was either decreased from the 
start (0 hour treatment) or LECs were grown in optimum 8% serum for either 24 or 72 hours before 
serum starving for 24 hours then reducing the serum concentration thereafter.  8% RS represents the 
usual growth for these cells.  The longer LECs were cultured in 8% RS prior to experimental conditions the 
greater the cell attachment.  Some LECs did attach in 0% RS, however cell numbers were low during the 7 
days, regardless of the time treated in 8% serum prior to reduction. In 0.5% RS LEC did proliferate during 
the 7 days but cell number on day 7 in all 0.5% RS was significantly less than 2% RS (2% - 24 and 2% - 72 
hours treatment) (p<0.05).  2% RS concentration supported steady proliferate but at a lower rate 
compared to the control and LECs retained their epithelial morphology. 
Significance p<0.05 
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3.6.2 Dedifferentiation Model 
The results from the dedifferentiation model show αSMA expression in green and nuclei 
staining in red, therefore the more green cells the more dedifferentiation (Figure 3.51).  
PMMA had poor cell attachment and cells did not form a monolayer therefore was not 
quantifiable.  A small proportion of cells stained positive for αSMA when injury was 
induced, showing some dedifferentiation.  There was however no closure of the scratch 
in some wells, and αSMA expression was similar to control, showing insignificant 
amounts of dedifferentiation.   Dedifferentiation was observed in all concentrations of 
TGFβ2, with 10ng/ml having the most αSMA expression, therefore was chosen as a 
suitable model. 
 
 
 
 
 
 
Figure 3.51: Representative fluorescent micrographs demonstrating positive expression for 
αSMA (green) and PI staining (red) of N/N1003A LECs seeded on poly methylmethacrylate 
(PMMA) substrate, seeded on tissue culture polystyrene (TCPS) then scratched with a 1ml 
pipette tip when confluent, seeded onto TCPS and treated with 10ng/ml TGFβ2 (pre-treated in 
MEME containing 8% rabbit serum (RS) for 72 hours, serum starved for 24 hours then MEME 
containing 2%RS with 10ng/ml TGFβ2 for 7days) and seeded onto TCPS control.  PMMA had poor 
cell attachment and cells did not form a monolayer, there was no closure of the scratch and cells 
expressing αSMA were similar to TCPS control and TGFβ2 showed dedifferentiation in a dose 
dependant manner. 
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3.6.3 Optimisation 
Optimisation of the dedifferentiation model was carried out on TGFβ2.  The level of 
dedifferentiation increased in a dose dependant manner up to 6.5ng/ml (Figure 3.52).  
There was no difference in the level of dedifferentiation for higher doses.  An optimum 
concentration of 5ng/ml of TGFβ2 was chosen. 
 
 
 
 
 
Figure 3.52: Representative fluorescent micrographs demonstrating positive expression for αSMA 
in a TGFβ2 dose dependent study using N/N1003A LECs at day 7.  Micrographs demonstrate 
αSMA (red) and DAPI (blue) A. 2% serum no TGFβ2, B. 3ng/ml TG β2, C. 5ng/ml TGFβ2, D. 
6.5ng/ml TGFβ2, E. 8ng/ml TGFβ2, F. 10ng/ml TGF β2.  Level of dedifferentiation increased with 
dose of TGFβ2.  All cells have been pre-treated in MEME containing 8% rabbit serum (RS) for 72 
hours, serum starved for 24 hours then changed to MEME containing 2%RS with variations in 
TGFβ2 concentration for 7days. 
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3.6.4 TGFβ3 Dose Dependent Study 
The influence TGFβ3 had on LEC morphology and phenotype was investigated, again 
cells were fluorescently stained with αSMA in red, phalloidin in green and DAPI to stain 
the nuclei blue (Figure 3.53). 
 
 
 
 
 
  
 
 
  
 
Dedifferentiation was semi-quantitatively analysed by measuring the area of αSMA 
staining as a percentage of the total field of view, this was achieved by programming a 
macro on ImageJ.  TGFβ3 did dedifferentiate LECs to a certain extent (Figure 3.54) at all 
concentrations and time exposures, however to a lesser extent when compared to how 
much dedifferentiation was caused by TGFβ2 (approximately 40%).  When 10ng and 
10pg of TGFβ3 was added for 1 and 24 hours it gave a similar percentage of 
Figure 3.53: Fluorescent micrographs demonstrating positive expression for αSMA in a 10ng/ml TGFβ3 for 
1 hour treatment (pre-treated in MEME containing 8% rabbit serum (RS) for 72 hours, serum starved for 
24 hours then grown with MEME containing 2%RS with 10ng/ml for 1 hour followed by MEME 2%RS for 4 
days) and untreated LEC control (D, E and F), day 4.  αSMA (red), phalloidin (green) and DAPI (blue).  
Micrographs demonstrate some positive expression of αSMA in LECs that were treated with 10ng/ml 
TGFβ3 (A), and no positive expression in untreated control LECs (D) (this was not the case in all 
incidences).  Cytoskeleton staining of TGFβ3 LECs (B) appears to have some cuboidal morphology 
similarities with untreated control (E), however more unorganised actin fibres were present in small 
areas when LEC were treated with TGFβ3.  Nuclei staining demonstrated cells were attached and 
distributed well in both treated (C) and untreated (F) LECs at day 4. 
 
A. B. C. 
D. E. F. 
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dedifferentiation to the control (approximately 2%), which was LECs with no TGFβ3 
(Figure 3.54). 
 
There was a significant difference in the amount of dedifferentiation caused between 
TGFβ2 and 100pg/ml at 1 hour time exposure, 1ng/ml in cell culture medium and 2%.  
The other concentrations and time exposures of TGFβ3 were not significantly different 
to TGFβ2.  
 
 
 
 
 
 
 
 
 
  
Figure 3.54:  Graph demonstrating the percentage area of dedifferentiation quantified by αSMA 
expression in various TGFβ3 concentrations and time exposures, 5ng/ml TGFβ2 and untreated control 
(2 % rabbit serum (RS)).  Error bars equal ± 1 standard deviations.  * denote significant difference 
were p<0.05.  5ng/ml TGFβ2 was significantly different to all TGFβ3 concentrations and 2% RS 
control.  With the exception of 1ng/ml TGFβ3 in medium and 100pg/ml TGFβ3 at 1 hour time 
exposure all other concentrations were not  significant different compared to 2% RS control (p>0.05).  
 
Significance  p<0.05 
* 
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3.6.5 Dedifferentiation Model with TGFβ3 
Once 5ng/ml TGFβ2 was established as a dedifferentiation model and the effect TGFβ3 
had on LECs had been investigated, the dedifferentiation model and TGFβ3 were studied 
in conjunction with each other to examine TGFβ3s effect on reversing or preventing 
dedifferentiation. 
 
3.6.5.1 TGFβ3’s Ability to Reverse Dedifferentiation 
N/N1003A LECs were pre-treated in the reduced serum procedure before changing to 
experimental conditions.  LECs were dedifferentiated with 5ng/ml TGFβ2 followed by 
treatment with TGFβ3 (at the same concentrations and time exposures as previously 
studied) to reverse the effects of dedifferentiation.  Dedifferentiation was evaluated in 
the same way as before (explained in section 3.6.4).  The results indicate TGFβ3 had 
little effect at reversing dedifferentiation (Figure 3.55).  Due to the high standard 
deviations of TGFβ3 at all concentration and time exposure averages fell within a similar 
range to the control, 5ng/ml TGFβ2.  Cells treated with 2% serum had less than 5% area 
of dedifferentiation.  LECs treated pre-treated with 10ng/ml at 1 hour time exposure, 
1ng/ml at 1 hour time exposure, 100pg/ml at 24 hour time exposure, and 2% were 
significantly different to dedifferentiation levels of TGFβ2.  Untreated control 
dedifferentiation levels (2% serum) were significantly different to all TGFβ3 
concentrations and time exposures and TGFβ2 with the exception from 1ng/ml and 
100pg/ml in medium (analysed using Dunnett’s T3). 
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3.6.5.2 TGFβ3’s Ability to Prevent Dedifferentiation 
N/N1003A LECs were pre-treated with various concentration and time exposures of 
TGFβ3 then treated with 5ng/ml TGFβ2 to dedifferentiate cells to examine if TGFβ3 
could prevent the effects of dedifferentiation.  Cells were evaluated in the same way as 
before (explained in section 3.6.4).  There was a reduction in the level of 
dedifferentiation when cells were pre-treated with TGFβ3 prior to treatment with 
TGFβ2, at all concentrations and time exposures (Figure 3.56), however the level of 
dedifferentiation caused by 5ng/ml TGFβ2 was also reduced when compared to previous 
studies (Figure 3.55).  When cells were treated with 2% serum in the absence of any 
TGFβ the dedifferentiation level was fewer than 5%.  There was no significant difference 
Figure 3.55:  Graph to show TGFβ3 ability at reversing dedifferentiation.  The percentage area of αSMA 
dedifferentiation was quantified by αSMA expression in LECs treated with 5ng/ml TGFβ2 for 4 days 
followed by various concentrations and time exposures of TGFβ3, 5ng/ml TGFβ2 and untreated control 
(2% serum) for 4 days.  Error bars equal ± 1 standard deviations.  * denote significant difference where 
p<0.05.  There was only a small decrease in the level of dedifferentiation when dedifferentiated cells 
were treated with TGFβ3 regardless of dose and time exposures.  The percentage area of 
dedifferentiation for all treatments fell within a similar range to TGFβ2 control.  LECs treated with 2% 
serum (control) showed less than 5% area of dedifferentiation. 
* * 
Significance  p<0.05 
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from cells treated with TGFβ2 followed by TGFβ3 when compared to control TGFβ2 
levels, regardless of TGFβ3 concentration and time exposure (p>0.05).  In addition there 
was no significant difference between cells treated with TGFβ2 followed by TGFβ3 when 
compared to control 2% levels, with the exception of 10ng/ml for 24 hours time 
exposure (analysed using Dunnett’s T3).   
 
 
 
 
 
 
 
 
 
 
 
  
Figure 3.56: Graph demonstrating dedifferentiation prevention by TGFβ3 assay.  The percentage area 
of αSMA dedifferentiation was quantified by αSMA expression in LECs treated with 5ng/ml for 4 days 
followed by various concentrations and time exposures of TGFβ3 for 4 days, 5ng/ml TGFβ2 and 
untreated control (2% serum).  Error bars equal ± 1 standard deviations.  * denote significant 
difference where p<0.05.  There was a reduction in the level of dedifferentiation when cells were pre-
treated with TGFβ3, regardless of dose or time exposure.  The percentage area of dedifferentiation 
for all TGFβ3 treatments fell within a similar range.  Cells treated with 2% serum showed less than 5% 
area of dedifferentiation. 
Significance  p<0.05 
* 
  
148 
Chapter 3: Results 
3.6.6 Flow Cytometry 
Flow cytometry was evaluated as a method for quantifying the expression of αSMA in 
LECs incubated with 5ng/ml TGFβ2 or control LECs (no TGFβ2).  All LECs were gated to 
the same level based on the auto fluorescence of control, unstained cells.  Control 
unstained LECs had a low level intensity peak indicating some auto fluorescence, this 
was similar to unstained LECs incubated with 5ng/ml TGFβ2 (Figure 3.57-A and Figure 
3.57-B respectively).  When primary negative mouse IgG antibody and Alexa Fluor 488 
secondary were added to control LECs and LECs incubated with 5ng/ml TGFβ2 (Figure 
3.57-C and Figure 3.57-D) a defined peak was observed in similar area and a higher level 
of fluorescence occurred, meaning that the IgG caused some non-specific background 
stain.  When primary αSMA and Alexa Fluor 488 secondary antibodies were added to 
control LECs some positive expression was present (Figure 3.57-E).  This was expected as 
a small population of LECs naturally dedifferentiate whilst in culture.  When LECs were 
incubated with 5ng/ml TGFβ2 were stained with primary αSMA and secondary 
antibodies there was a higher increase of positive αSMA expression (Figure 3.57-F).  The 
histogram (Figure 3.57-F), had a wider spread meaning LECs were stained to different 
intensities, with some cells being brighter than others. 
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Figure 3.57: Histographs demonstrate αSMA expression measured by flow cytometry in: A. Control LECs – 
Unstained, B. LECs incubated with 5ng/ml TGFβ2 – Unstained, C. Control LECs – Negative IgG + Alexa Fluor 
488 and D. LECs incubated with 5ng/ml TGFβ2 – Negative IgG + Alexa Fluor 488.  When controls LECs and 
LECs incubated with 5ng/ml TGFβ2 were either unstained or stained with negative IgG a similar 
fluorescence peak was observed.   
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Control LECs – αSMA + Alexa 
Fluor 488 
LECs incubated with 5ng/ml 
TGFβ2 – αSMA + Alexa Fluor 
488 
E. F. 
Figure 3.58: Histographs demonstrate αSMA expression measured by flow cytometry (continued) in: E. 
Control LECs – αSMA + Alexa Fluor 488 and F. LECs incubated with 5ng/ml TGFβ2 – αSMA + Alexa Fluor 
488.  LECs incubated with 5ng/ml TGFβ2 had a high positive expression of αSMA with a wider spread of 
intensity (F) compared to control LECs (E). 
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The geometric mean was calculated from the forward and side scatter, to represent 
fluorescently stained cells and a bar chart of the geometric mean was plotted.  There 
was a high increase in positive αSMA expression in LECs incubated with 5ng/ml TGFβ2 
when they were stain with primary αSMA and Alexa Fluor 488 secondary antibodies, 
demonstrating that flow cytometry was a valid way of measuring αSMA expression 
within N/N1003A LECs (Figure 3.59).     
 
 
 
 
 
 
 
 
 
 
  
Figure 3.59: Graph demonstrating the geometric mean detection of αSMA fluorescence in control LECs 
and LECs incubated with 5ng/ml TGFβ2.  Unstained control and unstained LECs incubated with 5ng/ml 
TGFβ2 had little auto fluorescence.  When IgG control and Alexa Fluor 488 secondary were added to 
control LECS and LECs incubated with 5ng/ml TGFβ2 a slight increase in florescence was observed.  
Control LECs stained with primary αSMA antibody and Alexa Fluor 488 secondary showed positive 
expression of αSMA.  However when LECs were incubated with 5ng/ml TGFβ2 and stained with 
primary αSMA antibody and Alexa Fluor 488 secondary there was a 7-fold increase in the amount of 
fluorescence. 
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3.6.7 PCR Assay 
Real time PCR was performed on B3’s LECs, using extracellular matrix adhesions PCR 
arrays.  LECs were either incubated with TGFβ3, TGFβ2, a combination of TGFβ3 and 
TGFβ2 or LECs incubated with no TGFβ present (control LECs).  Each test sample was 
compared to a “control” sample (Table 3-3).  LECs incubated with TGFβ3 and TGFβ2 
were compared to control LECs sample.  LECs incubated with TGFβ3 followed by TGFβ2 
were compared to three different control samples. Firstly test sample 1.TGFβ3_TGFβ2 
was compared to TGFβ3, test sample 2.TGFβ3_TGFβ2 was compared to TGFβ2 and test 
sample 3.TGFβ3_TGFβ2 was compared to control LECs.   
 
Table 3-3: Detailing PCR test and control samples 
Test # Test Sample Control Sample 
1 TGFβ3 Control LECs 
2 TGFβ2 Control LECs 
3 1.TGFβ3_TGFβ2 TGFβ3 
4 2.TGFβ3_TGFβ2 TGFβ2 
5 3.TGFβ3_TGFβ2 Control LECs 
 
  
 
A shortened list of genes that were up or down regulated was created (Table 3-4).  
TGFβ3 up-regulated fibronectin 1 (FN1).  TGFβ2 and test sample 1.TGFβ3_TGFβ2, mainly 
up-regulated gene expression.  Test sample 2.TGFβ3_TGFβ2 down-regulated gene 
expression, and test sample 3.TGFβ3_TGFβ2, did a combination of up and down 
regulating gene expression within B3 LECs.  A group of the collagen, integrin and 
thrombospondin family genes were up and down regulate across the various test 
samples.  Two matrix metallopeptidase (MMP) and two laminin (LAM) genes were 
expressed, in addition the amount of fibronectin expression varied across test samples.  
These genes could all have a role to play within PCO.   
 
  
Table demonstrates test samples and control samples 
used to analyse PCR array plates. 
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Table 3-4: Demonstrating gene expression observed in B3 LECs when treated with various combinations 
of TGFβ3, TGFβ2, TGFβ3 followed by TGFβ2 and untreated LECs 
Genes 
TGFβ3- 
LECs 
TGFβ2- 
LECs 
1. TGFβ3_TGFβ2 
– TGFβ3 
2. TGFβ3_TGFβ2 
– TGFβ2 
3. TGFβ3_TGFβ2 
– LECs 
ADAMTS1 0 0 -2.69 -2.47 -2.78 
 COL14A1 0 -2.83 0 0 -2.52 
 COL16A1 0 3.31 2.37 0 2.76 
 COL1A1 0 2.73 0 0 0 
 COL4A2 0 2.29 0 0 0 
 COL5A1 0 3.36 0 0 2.14 
 COL6A1 0 2.17 0 0 0 
 COL6A2 0 3.83 3.08 0 4.30 
 COL7A1 0 4.65 2.35 0 3.52 
 COL8A1 0 0 0 0 -3.33 
 CTGF 0 2.64 0 0 2.40 
 FN1 2.12 4.34 0 0 2.82 
 HAS1 0 0 0 0 -5.29 
 ITGA3 0 0 0 -2.19 0 
 ITGA5 0 2.05 0 0 0 
 ITGA6 0 0 -2.03 -2.24 -2.66 
 ITGA7 0 3.48 2.45 0 2.88 
 ITGB3 0 2.58 0 -2.32 0 
 ITGB5 0 2.60 0 0 0 
 LAMB3 0 0 0 -2.57 -2.26 
 LAMC1 0 0 0 -3.23 -2.30 
 MMP14 0 8.62 2.27 -2.33 3.70 
 MMP2 0 3.50 2.32 0 3.45 
 SPARC 0 2.07 0 0 2.11 
 SPG7 0 2.31 0 0 0 
 THBS1 0 0 0 -2.38 0 
 TGFBI 0 3.29 2.40 0 3.72 
 THBS2 0 0 2.13 0 2.21 
 THBS3 0 0 2.54 0 0 
 
 
 
 
 
Gene expression showed a group of collagens (COL), Integrins (ITG) and thrombospondins (THBS) were up 
and down regulated dependent upon treatment.  Along with several other genes that may be associated 
with PCO, such as matrix metallopeptidases (MMP), laminins (LAM) and fibronectin (FN1). 
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4. Discussion 
 
The aim of this work was to evaluate surface coatings for potential intraocular lenses 
(IOLs), and the influence these coatings had on the postoperative scar reaction involved 
between residual lens epithelial cells (LECs) and the IOL surface. 
 
Sight is said to be our most dominant sense [169].  Cataracts are characterised by an 
opacification of the natural lens and render millions of people blind worldwide [43, 47].  
This blindness can be corrected by a simple ophthalmic operation [2, 31].  During 
cataract surgery the natural lens is removed, leaving the capsular bag in situ.  A polymer 
IOL is inserted inside this capsular bag to replace the natural lens.  The most common 
postoperative complication after implantation of this IOL is a type of scarring, known as 
posterior capsule opacification (PCO), which requires a second operation.  PCO is 
associated with capsular contraction and wrinkling, which distorts the light path [25, 52, 
60].  The clinical burden of PCO causes a significant cost factor on the health care 
system, and treatment is not necessarily available in developing countries.  This means 
the patient’s vision becomes compromised once again and the quality of life 
deteriorates, therefore efforts are needed to alleviate the problem of PCO.   
 
It is widely known that material properties such as the surface chemistry, wettability and 
roughness can affect the cellular response [170-173].  One method that has been 
investigated to alleviate PCO is surface modification of IOLs to tailor the cellular 
response [9, 46, 84, 174-175].  This could be achieved by modifying a surface to enable 
attachment of a LEC monolayer that maintains an epithelial phenotype.  Several groups 
have studied the effect of changing surface chemistry with the addition of various 
functional groups such as  amine, carboxyl, and hydroxyl groups onto surfaces to 
encourage cell attachment in various cell types, including kidney epithelial, 
keratinocytes and retinal pigment epithelial cells [124, 176-177].  The cellular response 
could also be controlled by incorporating extracellular matrix (ECM) molecules such as 
glycosaminoglycan [9, 139, 178].    
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BioInteractions Ltd. are a manufacturer of innovative biomaterials that are designed to 
minimise the human host response.  They specialise in the covalent binding of functional 
groups to biomaterial surfaces via a layer-by-layer technique, to tailor surface coatings 
of stents and catheters with non-thrombogenic properties [159, 179].  This PhD project 
has investigated various coatings for the potential use of new IOLs.  The surface charge 
and functional groups present on coatings has been varied to encourage a monolayer of 
LEC growth and maintain their epithelial morphology, or to inhibit LEC growth and 
migration.  Coatings have been produced and analysed in terms of their wettability, 
topography and evaluated in cell culture using established LEC lines.  
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4.1 Material Coatings and Techniques 
Seeding primary human LECs onto the various coatings tested may be beneficial as it 
would be a more representative model [180].  Methods for harvest primary human LECs 
from donor eyes were evaluated, however these techniques produced only small 
populations of LECs.  Donor age and time of cell extraction after post mortem time can 
affect the viability of the cells [181].  The average age for donor eyes is typically over 50 
and the time taken from post-mortem to tissue culture was typically between 24 – 48 
hours.  This could explain the low cell viability that was observed [181].  In addition 
primary cells typically have a low growth ability and limited life span [180].  This relates 
to clinical observations with variations in PCO rates and age.  Moisseiev et al reported 
PCO occurred in 47% of patients over the age of 40 and in 70% of patients under the age 
of 40 [182].  In addition it is known children suffer from severe PCO and capsulotomy is 
widely performed at time of IOL implantation to avoid future PCO, however this can lead 
to further complications [183-184].  This suggests there is an association between PCO 
rate and age, and the need for variations in treatment method.  Due to this primary cell 
cultures were not taken further and cell lines were used for subsequent experiments. 
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4.2 Anticoagulation Polymers Coatings – 1 and 2 
The coatings provided by BioInteractions Ltd. were designed as non-thrombogenic 
coatings for cardiovascular applications.  They have been shown to minimise protein 
adsorption and platelet activation in vivo.  It was hypothesised that these coatings could 
have a role in prohibiting cell attachment and growth on IOLs following cataract surgery, 
therefore these coatings were evaluated in cell culture as a starting point for this 
project.  Coatings were synthesised on a poly ethylamine (PEI) base polymer containing 
functional groups of heparin (HEP) sulphates and sulfonates and poly ethylene glycol 
(PEG), with the aim of reducing the initial protein and cell adhesion on the biomaterial 
surface.  HEP has extensively been used for its anticoagulation properties.  Sulphate and 
sulfonate groups are negative charged which aim to repel cell attachment and PEG is 
highly hydrophilic which aims to minimise the interaction between the coating and the 
biological environment [109, 159, 179, 185]. 
 
Fewer LECs were attached to coatings 001, 004 and pHEMA than TCPS control.  LECs that 
did attach onto these coatings were either rounded or elongated, showing a difference 
in morphology compared to cells adhered to TCPS wells.  Some cells initially attached to 
the pHEMA coating, at later time points the cells had become rounded.  This may have 
been due to the hydrogel-like material properties changing whilst in cell culture.  PHEMA 
coating was received dry and was not rehydrated prior to seeding cells, therefore the 
coating may have absorbed a high amount of water whilst in cell culture, causing the 
coating to swell and disrupt attached cells.  This coating may have benefited from being 
rehydrated after synthesis.  Alternatively this coating could have been rehydrated prior 
to seeding LECs.  Some defects were observed around the edge of coating 004, 
especially on the coated coverslips at later time points.   
 
Due to their hydrogel-like nature, all three coatings absorbed methylene blue dye, 
making it difficult to visualise the cells.  Cells that were present on the coatings prior to 
fixing appeared to have been washed off during the fixation and staining process, 
indicating cells were not strongly adhered to the surfaces.  As mentioned previously (0) 
cell binding is dependent upon the protein layer at the surface interface [7].  These 
proteins are made of mobile chains of amino acids that can change in orientation, and 
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enable cellular binding when specific sequences of amino acids are present in the 
correct orientation [7].  The removal of the weakly attached cells during washing may be 
the result of an unfavourable 3-D structure of the proteins, and thus amino acids, at the 
coating interface, preventing cell attachment.  Cells, therefore, could not settle and 
attach to the surface of the coating as the required cell binding sites were no longer 
available due to the folding of the protein.  Changes in the chemistry of a material can 
affect this protein conformation and thus the amino acid sequence, resulting in 
variations in the cellular response across the various coatings [3].  A live/dead assay 
showed the majority of cells on coatings 001, 004 and pHEMA were dead, however this 
does not necessarily indicate that the coatings were toxic, it is most likely the cells could 
not adhere to the coating therefore died as LECs are anchorage-dependent cells.  The 
methylene blue staining results showed LECs adhered and grew on the TCPS wells in the 
presence of coated coverslips, this supports the hypothesis that these coatings did not 
leach toxic materials into the medium.   
 
The decision was made to synthesise coatings directly onto TCPS wells for all future cell 
work, as some coated coverslips had noticeable imperfections when observed under the 
microscope.  In addition, multi-well plates were easy to use in cell culture and it was 
thought a better homogeneity of coating could be achieved.  Two slight variations to 
coating 001 (coatings 002 and 003) were also evaluated.  Coating 002 was cross-linked 
with glutaraldehyde, meaning the coating was more stable and PEG groups were less 
mobile.  Coating 003 had a total of five water-based layers, with the aim of incorporating 
more functional groups. 
 
More cells seemed to adhere to coating 001 in wells than in the previous study on 
coverslips, this may have been due to the coating procedure producing a more uniform 
coating.  The cell attachment and growth on coatings 001 and 002 were similar (p=0.15) 
with 002 having a higher incidence of cell attachment when cells were counted, 
however both coatings had large standard deviations due to heterogeneous growth.  
The cross-linking agent utilised in coating 002 may have fixed the polymer in a set 
orientation.  This may have caused protein adsorption that displayed more of the 
necessary amino acid sequences required for cellular attachment, compared to coating 
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001.  Coatings 001 and 002 had a wettability, 68° and 62° respectively.  Coating 003 had 
few, if any, cells attached during the 14 days in cell culture.  This may be attributed to 
the series of water based layers increasing the number of functional groups, such as 
hydrophilic PEG molecules, present on the surface.  This in turn may have affected the 
coatings wettability (35°).  Coating 003 was significantly more hydrophilic than coatings 
001 and 002 (p<0.01).  Scanning electron microscopy (SEM) analysis showed all three 
coatings to be featureless which is promising for future use as IOL coatings, as they 
should not scatter light and indicates the coatings were uniform.  In future work this 
along with other light transmission properties (for example, refraction and transmission) 
would be evaluated.  This also implies the varied cellular response seen in cell culture 
was not correlated to surface topography.  It is therefore believed that these differences 
are in relation to the surface chemistry and the presence of more functional groups on 
the surface.  Tognetto et al compared variations in cell response on pHEMA based IOLs 
manufactured with different methacrylate copolymers in vivo.  Results illustrated 
variations in the amount and type of cells attached, indicating cell attachment was 
dependant on material chemistry [89]. 
 
To summarise, this study demonstrated coating 004 and pHEMA did not support cell 
attachment, however the physical integrity of coating 004 was questionable.  
Complications arose with coatings 001 and 002: the coatings neither prohibited cell 
attachment nor enabled the growth of a LEC monolayer, therefore they did not support 
either hypothesis.  Coating 003 did not support LEC attachment or growth.   
 
Prior to experimentation on pre existing BioInteractions Ltd. coatings, LEC phenotype of 
FHL124 cell line was characterised, and cell culture conditions (seeding density and 
serum concentration) were optimised.  It is important LEC growth on coatings and TCPS 
control surfaces retain their epithelial morphology and phenotype.  Cytokeratin is a 
structural protein within the cytoskeleton.  This intermediate filament is often used as 
an epithelial cell marker [186-187].  FHL124 LECs were stained with pan cytokeratin, 
clone C11.  Positive expression of cytokeratin was observed following 
immunofluorescent staining.  Cells also had a cobblestone morphology typical of 
epithelial cells [162-163], visualised by F-actin fibre staining using phalloidin.   
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As LEC attachment and growth was routinely monitored throughout various cell culture 
studies, a reliable method to count cells and an optimum seeding density were required.  
Although a haemocytometer offers quick and easy analysis of cell number it proved to 
be an unsuitable method of counting cells, due to the low cell numbers at early time 
points.  Therefore it was deemed to be more accurate to fix, stain and micrograph cells.  
A seeding density of 1x104/cm2 provided both an exponential and stationary growth 
phase for analysis [180] within a convenient 7 day period. 
 
The protein concentration required to retain proliferation and epithelial morphology 
was also evaluated prior to coating analysis.  Serum present in cell cultures can add 
variability, induce contamination and also affect reproducibility from in vitro to in vivo, 
therefore the minimum amount of serum required for cells to retain typical morphology 
and proliferation should be used in cultures [188].  A serum concentration of 5% FCS was 
chosen to be the optimum level to culture FHL124 LECs, as this was the lowest serum 
concentration to encourage typical proliferation and morphology.   
 
This optimisation process gives confidence that the cell response seen in this study was 
due to the surface coatings of 001, 002, 003, 004 and pHEMA, rather than inappropriate 
cell culture conditions. 
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4.3 GAG Coatings  
Coatings 001, 002, 003 and 004 contained various amounts of HEP.  HEP is a highly 
negatively charged glycosaminoglycan (GAG) and was added to these coatings as a non-
thrombogenic molecule.  HEP has widely been used in the coatings of vascular 
prostheses such as, stents, catheters, vascular grafts and heart valves [179, 189-190].  It 
has been shown to prevent platelet adhesion and reduce restenosis of stents, and also 
has been administered as a drug for its anti-thrombogenic properties to prevent clotting 
[190-191]. GAGs interact with the extra cellular matrix (ECM), proteins and cells. They 
are also known to manipulate cell behaviours such as proliferation, migration and 
adhesion [126, 128-129], therefore the addition of other GAG molecules was 
investigated.  Hyaluronic acid (HA) is used in cataract surgery as the viscoelastic material 
injected between the cornea and the lens in the anterior chamber to allow surgeons 
room to operate [2].  HA is produced during embryonic development to provide space 
for new cells to grow [126], and has currently been used across multiple biological fields 
for its cell adhesion and proliferation properties [138, 178, 192].  Chondroitin sulphate 
(CS) has also been investigated for its potential to encourage cell adhesion and 
proliferation of stem cells [139].  It was hypothesised that by altering the amount of 
HEP, HA and CS present on a surface the LEC response could be controlled, either by 
encouraging a monolayer of cells to adhere or by prohibiting cell growth entirely. 
 
GAG-modified polymer coatings were provided by BioInteractions Ltd. HEP polymer 
coatings inhibited most cell attachment compared to HA and CS modified coatings.  The 
cell attachment and growth on HA and HEP polymer coatings was significantly different 
(p=0.03) at day 14.  This statistical difference was only observed as 0 cells/field of view 
were present on all micrographs of HEP coatings, and HA had a mean of 2 cells/field of 
view on day 14.  Therefore this difference is considered negligible.  Cell attachment was 
heterogeneous on both HA and CS, with areas of no cell attachment and areas of 
concentrated growth.  This sporadic growth resulted in large standard deviations.  
Variations in growth patterns were observed when polymer GAG coatings were 
examined using time lapse analysis in cell culture.  LECs were seeding onto HEP, HA and 
CS coated wells in the same method as the previous study.  HEP polymer coatings 
enabled a large amount of cells to attach during the 14 days in cell culture.  Cells 
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appeared elongated and not typical of epithelial morphology.  A mean of 1076 cells/field 
of view were counted on HEP coatings compared to 967 cells/field of view on TCPS 
control.  HA polymer coating had a mean of 375 cells/field of view and CS polymer 
coatings had a mean of 80 cells/field of view.  This result is in opposition to the previous 
studies, the cause of this is unknown.  One hypothesis may be due to insufficient coating 
process in this particular batch or degradation of the coatings.  This study would be 
repeated if materials and resources had allowed. 
 
SEM analysis for all GAG polymers showed featureless coatings, at 5000x magnification 
(micron scale).  Surface roughness analysis was measured using white light 
interferometry (WLI), results demonstrated TCPS and CS to be significantly different 
from HEP and HA, however this difference was only 2nm.  This difference in nanometre 
height is not believed to be associated with the cellular response, as it has been 
reported a change in the range of 10s of nanometres is required in order to observe a 
change in cell attachment [193-195]. 
 
Various methods to adsorb HA and CS onto substrates were evaluated, however little 
difference in cell attachment was observed between these adsorbed GAG substrates 
and controls (substrates in the absences of absorbed HA or CS).  Toluidine blue staining 
was used as a method to stain for the presence of GAGs [196]. Although this is 
commonly used no positive toluidine blue staining was observed on the adsorbed GAG 
substrates.  It was, therefore, concluded that GAGs were not successfully adsorbed onto 
base substrates.   
 
Covalent binding was considered as an alternative for depositing GAGs onto a surface.  It 
was hypothesised that utilising the carboxyl groups present at the end of HA and CS 
molecules would be a more reliable method for binding the GAGs onto amine coated 
surfaces.  Toluidine blue was again unsuccessful at confirming the presence of bound 
GAG, an alternative method for staining for the presence of GAGs is safranin O dye 
[139].  When covalently bound GAG coatings were immobilised onto their basement 
substrates the contact angle decreased, confirming surface modification and the 
presence of GAGs.  The same decease was seen when GAG polymer coatings (provided 
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by BioInteractions Ltd.) were added onto PEI base substrates (Figure 3.36).  Contact 
angle measurements for bound GAG coatings and GAG polymer coatings fell within a 
similar range (20 – 28°), however a difference was seen in the cellular response.  Whilst 
CS polymer coating provided by BioInteractions Ltd. supported patchy LEC growth, 
higher concentrations of bound CS coating (3mg/ml and 1mg/ml) did not support LEC 
attachment or growth, suggesting CS was orientated differently when covalently bound 
onto the amine base surfaces.  The base substrate layer could have also influenced the 
outermost GAG layer.  HA did not encourage cellular attachment in either polymer 
coatings provided by BioInteractions Ltd. or the covalently bound GAG coatings.  The 
same cellular responses was observed by D’Sa et al when B3 LECs were seeded onto HA 
coatings immobilised on plasma treated surfaces [9].  Uygun et al observed the opposite 
cellular attachment response with mesenchymal stem cells [139].  Orlidge et al 
examined attachment and proliferation of several cell types on HA and HEP coatings and 
reported that cell attachment and growth were dependant on cell type [178].  This 
Indicates cellular response to GAG coatings may be cell type dependant.  The cell 
response on the covalently bound GAG coatings was somewhat dose dependent.  At the 
lowest concentration of 0.1mg/ml of CS and HA few small patches of cell attachment 
and proliferation were observed.  As the dose increased cell attachment decreased [9, 
178].  Therefore covalent binding of higher concentrations of HA and CS to amine 
functionalised surfaces could be developed further as coatings to prohibit cell 
attachment on IOLs. 
 
To summarise, variations in the cell attachment and growth were observed depending 
on the GAG type and method utilised for depositing GAGs onto a surface.  This study has 
demonstrated that it is difficult to attach sufficient amount of GAGs to surfaces to have 
a significant influence on the cellular response.  The data suggested that covalent 
binding of GAG could be a possible route to prohibit LEC attachment and growth on 
IOLs, thus future work in this area could be justified 
 
As mentioned previously it is important to characterise cell phenotype, therefore prior 
to the use of N/N1003A LECs in this study various cytokeratin antibodies were used to 
test epithelial expression, however none of the cytokeratins tested proved successful in 
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staining N/N1003A LECs.  It should be noted that no references could be found in which 
cytokeratin was used as an epithelial marker to stain N/N1003A LECs.  Crystallins have 
previously been used to characterise LEC phenotype [160-166].  Reddan et al outlined 
the transformation of rabbit LECs into the N/N1003A LEC line, alpha A- and alpha B-
crystallins were used as a method for characterising LEC phenotype [162].  When Krausz 
et al repeated this characterisation, however, alpha A-crystallin was not detected in 
N/N1003A LECs [166].  Similar results were found by Meakin et al and Wang et al, in 
both N/N1003A and B3 LECs [160, 197].  Whilst alpha A-crystallin has been shown to 
diminish with cell maturity and is generally not present past passage 10, alpha B-
crystallin remains present as cells are passaged (until at least passage 26).  This was 
shown by Flemming et al in the B3 LECs [198].  Based on this N/N1003A LECs were 
stained for alpha B-crystallin and positive expression of alpha B-crystallin was 
immunofluorescently visualised.  This demonstrates the LEC used in this study were of 
epithelial origin.  
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4.4 Zwitterionic Polymers 
The charge on a surface can affect cellular attachment and growth [123, 172].  GAGs are 
negatively charged macro-molecules [127, 137].  In addition to how these negatively 
charged ECM molecules interact with LEC attachment, positively and negatively charged 
coatings with zwitterionic character were examined.  A zwitterionic molecule is a neutral 
entity that contains both positive and negative charges.  Several authors have reported 
their beneficial use to prevent adsorption of specific protein and cell attachment on 
surfaces [199-200].  It has previously been reported that changing the ratio of 
phosphorylcholine in a polymer can improve haemocompatibility [201-202].  Ueda et al 
demonstrated that protein adsorption deceased with increasing amounts of 2-
methacryloyloxyethyl phosphorylcholine (MPC) molecules in a copolymer [201].   These 
observations led to the advent of MPC being introduced into contact lenses [203].  Cell 
attachment has also been shown to be reduced on an IOL functionalised with MPC.  Cell 
attachment and migration beneath the IOL was monitored when the IOL was placed on 
a collagen IV membrane (imitating the capsular bag).  MPC-coated IOLs had reduced cell 
attachment compared to non-coated IOLs [204].  It was therefore hypothesised that by 
changing the amount of zwitterionic molecule present in a surface the cellular response 
could be controlled by preventing LEC attachment and growth.  The cells used in this 
study were N/N1003A LECs. 
 
Varying amounts of cell attachment were observed on the six novel zwitterionic 
polymers that differed in ratios between 10% to 30% zwitterionic compound 
copolymerised with acrylic-based monomer(s).  Following investigation of the surface 
properties it was concluded these results were more likely due to the chemistry of the 
surface coatings, rather than the surface properties such as wettability and roughness.   
 
With the exception of coating J, which contained 20% zwitterionic compound, coatings 
with 10 – 20% of zwitterionic compound in general did not support cell attachment.  It 
was assumed that proteins did not adsorb onto the surface of these zwitterionic 
coatings in the correct confirmation to provide the necessary amino acid sequence to 
facilitate integrin binding and cell attachment.  Coating K (20% novel zwitterionic 
monomer) had an average cell number of 22/field of view with the majority of 
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micrographs having 0 cells attached.  The cell attachment observed on coating K may be 
due to different acrylic-based monomers (methoxyethyl methacrylate and hexyl 
methacrylate) used in polymerisation.  It has been shown that the cellular response can 
be affected by the copolymer used in polymerisation (for example, butyl methacrylate 
and hexyl methacrylate), or the basement substrate [201, 205].  Coating J also was 
copolymerised with 20% zwitterionic monomer, however the coating was aqueous 
based and dissolved in solution, therefore the cellular response on coating J was 
believed to be a result of cells attached to the basement substrate, which was TCPS 
wells, rather than the coating.  When zwitterionic monomer content was increased to 
30% a change in cell attachment was observed.  Coating H, containing 30% zwitterionic 
monomer, was orientated to have appropriate cell binding site available for N/N1003A 
cell attachment and growth.  An Internal control, containing 30% MPC (coating N), 
similar to coating H also encouraged cell attachment, suggesting a higher zwitterionic 
component ratio in the copolymer may change the cellular response. 
 
To investigate if the cellular response was in relation to the surface properties and 
chemistry and not the toxicity of the coatings, a cytotoxicity test was performed 
following guidelines in ISO:10993-5:2009 [206].  The metabolic activity of cells seeded 
onto the six zwitterionic coatings was not significantly different from cells seeded onto 
TCPS wells, regardless of zwitterionic ratio and acrylic monomer.  This indicates the 
coatings were not cytotoxic to the cells and the cellular response must be the result of 
the surface chemistry. 
 
As LECs are adherent dependent, cell death will occur if they cannot settle and attach to 
a surface.  The majority of coatings did not support cell attachment, therefore a second 
toxicity test was conducted (Figure 3.41).  This investigated cell attachment and 
spreading on TCPS after cells had been in contact with zwitterionic and internal control 
coatings for two hours.  Two hours was chosen as it was a sufficient length of time for 
LECs to settle and attach to TCPS which typically occurs between 20 – 30 minutes, this 
was observed via time lapse microscopy.  A longer time period prior to seeding cells 
onto a surface may result in cell distress and changes in cell behaviour.  Some 
zwitterionic and internal control coatings had a chemistry that supported cell 
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attachment.  This meant that LECs initially attached to the coated wells within the first 
two hours, prior to the remaining unattached cells being aspirated and re-seeded in 
fresh TCPS wells.  This resulted in a lower number of cells attaching and proliferating 
across both plates, resulting in a lower metabolic activity.  This was the case for 20% 
zwitterionic coatings (J), and internal controls, 100% poly butyl methacrylate and 70% 
butyl methacrylate:30%MPC (L and N respectively), however these variations in 
metabolic activity were not due to toxicity of the coatings.  No significant difference was 
seen for coating L on day 4, even though the mean metabolic activity level was 
approximately half of the metabolic activity level for the control TCPS wells.  This may be 
due to the variability of cells metabolic activity in one well which resulted in a large 
standard deviation.  The metabolic activity of cells aspirated from 20% zwitterionic 
coating (K) and internal control 10% MPC coating (M) and reseeded onto fresh TCPS 
wells looked similar to TCPS control on day 4, however there was a significant difference 
when compared to TCPS control.  This was probably due to the metabolic activity of cells 
on these coatings having smaller standard deviations, compared to the metabolic 
activity of cells on other coatings, meaning there was less variation in the data.  The 
metabolic activity levels of cells aspirated from 10% zwitterionic coating (F) and 
reseeded onto fresh TCPS wells was significantly lower than TCPS control, at days 1 and 
4.  The cause of this is unknown, perhaps not all medium/cell solution was aspirated 
from the original coated wells. 
 
Surface analysis showed variations in contact angle, topography and surface roughness 
across zwitterionic coatings and internal controls.  The contact angle varied from 
approximately 80° to 22° and no correlation between wettability and cell attachment 
was observed.  The substrate used in cell culture to maintain a monolayer of LEC growth 
was TCPS and had a contact angle of approximately 34°.  This was significantly different 
to all other zwitterionic coatings and butyl methacrylate controls.  A contact angle of 
approximately 80° (100% poly (butyl methacrylate – coating L) and a contact angle of 29° 
(70% butyl methacrylate:30%MPC – coating N) both enabled cell attachment.  In 
addition coatings with a similar contact angle resulted in different cellular responses.  
The contact angle of coatings containing 70% butyl methacrylate:30%MPC (N) was not 
significantly different to 20% zwitterionic coating (K), however 70% butyl 
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methacrylate:30%MPC supported LECs attachment.  This was not the case for the 20% 
zwitterionic coating (K).  Similar a contact angle of 64° and 62° (coatings F and M 
respectively) did not enable the appropriate binding sites required for cell attachment.  
Likewise, a similar contact angle of 26° and 28° (coating G and K respectively) did not 
support LEC attachment.  The contact angle of these two groups was significantly 
different from each other yet the same cell response was observed, supporting the 
conclusion that there was no clear link between wettability and cell attachment.   
 
Coatings F and L had a fibrous honey comb appearance when the topography of the 
zwitterionic coatings were analysed using SEM.  Some similar micro features were 
present on 20% zwitterionic coating (G) and 10% MPC coating (M).  Cracks were also 
apparent in 30% zwitterionic coating (H) and ripples in the Y-axis of the image were 
present on 20% zwitterionic (K) at x5000 magnification (micron scale).  These features 
have been attributed to the drying and processing of these coatings prior to SEM 
analysis.  In future work surface topography would be examined via a method where 
additional processing steps are not required, for example atomic force microscopy 
(AFM).  This would mean samples could be examined in the same state they are used in 
cell culture, in addition the topography of wet samples can be examined which may be 
beneficial to hydrogel-like substrates.  This method could also be used to inspect cell 
attachment to the coatings.  SEM analysis showed coatings I, J and N to be featureless at 
x5000 magnification (micron scale).  There was also no significant difference in surface 
roughness between these coatings, however both the contact angle and the cellular 
response varied dramatically.  This indicates there is no link between topography and 
cell attachment and growth for these coatings.   
 
Coatings containing 90% butyl methacrylate:10%zwitterionic compound (F) and 100% 
poly butyl methacrylate (L) had a similar fibrous topography viewed using the SEM, this 
may be due to the high percentage of butyl methacrylate.  This was not observed, 
however, in coating M which equally had 90% butyl methacrylate, indicating the 
chemistry of coating M when copolymerised with MPC may affect the topography.  The 
contact angle for coatings F and L varied from approximately 64° - 79° respectively, and 
gave opposite cellular responses, with coating F not supporting LEC attachment and 
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growth.  In addition the average surface roughness for coatings F and L was 149nm and 
378nm respectively, these validate micrographs from SEM analysis.  Analysis of coatings 
F and L may appear to indicate there is a relation between surface topography, 
wettability and cell attachment.  Based on the results from all other zwitterionic and 
MPC coatings, however, it is clear this is not the case.  As coatings with opposite 
properties, i.e. smooth and more hydrophilic coatings also enable the attachment of a 
LEC monolayer.  
 
It would be advantageous to market an IOL as a bulk material as it would be more robust 
and easier to manipulate than coated IOLs, therefore following cell culture assays it was 
proposed that one or two coatings would be synthesised as bulk materials.  10% novel 
zwitterionic monomer was copolymerised with pHEMA and synthesised as a bulk 
contact lens as IOL moulds were not available.   Bulk 10% zwitterionic:pHEMA (material 
F) was compared to pHEMA control contact lenses, TCPS wells and the gold standard, 
Acrysof® IOLs, and, at a later experiment time point, pHEMA IOLs (C-Flex).  No cell 
attachment was observed on bulk material F, bulk material pHEMA and C-Flex IOLs.  
LECs adhered to Acrysof® IOLs: cells were observed at the edge of the IOL and in the 
centre, however some were rounded.  None of the pHEMA based materials enabled cell 
attachment and all absorbed methylene blue dye due to the hydrogel like properties.  
This preliminary study demonstrated the difference in cell attachment and growth 
between a hydrophobic acrylic (Acrysof® IOLs) and a hydrophilic acrylic (pHEMA contact 
lenses, bulk 10% zwitterionic:pHEMA and C-Flex IOLs). 
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4.5 Dedifferentiation Model and TGFβ3 Assay 
An alternative approach to reduce the incidence of PCO could be to control relevant 
cytokine release or activity following cataract surgery.  Transforming growth factor beta-
2 (TGFβ2) is secreted postoperatively by LECs as part of the natural wound healing 
response, which is known to cause dedifferentiation of LECs leading to PCO [147].  In 
addition the material used for IOLs can influence this wound healing response [52].  
Therefore a possible route to eliminate the effect TGFβ2 had on LECs was investigated.  
The future aim was to apply a coating that could “mop up” the secreted TGFβ2 or 
neutralise its effect.  
 
TGFβ3 is associated with wound healing and is currently being investigated in several 
studies to reduce scar tissue in the skin [153, 156-157, 207].  Jusitva™ is a 
pharmaceutical agent containing TGFβ3 aimed at reducing scarring in skin.  Successful 
results from phase I and II clinical trials have been reported [157].  There is, therefore, 
the possibility for its use elsewhere in the body to reduce scarring.  It was hypothesised 
if TGFβ3 was applied inside the capsular bag postoperatively or available on an IOL 
coating, it could potentially decrease scarring, and the number of dedifferentiation cells 
within the lens capsule.  The aim of this study was to establish a model to evaluate 
dedifferentiation of LECs and the possibility to reduce it with the addition of TGFβ3.   
αSMA was selected as a suitable marker for dedifferentiated LECs [208-214]. This 
provided a tool to evaluate the potential of TGFβ3 to prevent or reverse 
dedifferentiation. 
 
As serum is known to contain growth factors a serum concentration growth curve was 
performed on N/N1003A LECs prior the use of TGFβ3 in cell culture, to investigate the 
lowest serum concentration that could retain proliferation and typical morphological 
appearance.  Wormstone et al have previously grown primary capsular explants in 
serum and protein free medium for up to 28 days, however LEC were grown inside the 
capsular bag on their basement membrane [215].  Capsular bags have also been 
harvested in serum free medium but with the addition of TGFβ2 [67].  Wormstone et al 
also examined TGFβ2 signalling in LECs.  LECs were cultured in 5% serum for 3 days and 
serum starved for 2 days before exposure to experimental conditions for 24 hours.  
  
171 
Chapter 4: Discussion 
Experimental conditions were medium supplemented with various growth factors 
including TGFβ2 [147].  Marcantonio et al used a similar method when studying the 
influence of TGFβ2 on α5β1 integrin.  Cells were cultured in 5% serum until confluent, 
serum starved for 24 hours, then changed to experimental medium for a further 24 
hours.  Experimental medium was again serum free with the addition of various growth 
factors [216].  Based on the literature two methods were studied.  Firstly by reducing 
the serum concentration from the start of the experiment or secondly seeding LECs in 
optimum 8% RS for either, 24 or 72 hours then serum starving for 24 hours prior to 
experimental conditions.  The first method of reducing serum concentration from the 
start resulted in significantly less cell attachment compared to the second method of 
seeding cells in optimum 8% rabbit serum (RS) for 24 and 72 hours.  Morphological 
changes were observed when serum was reduced from 8% RS to 0%.  LECs appeared to 
decrease in size and round up, this may have been due to withdrawing the proteins and 
growth factors required to maintain typical growth and epithelial morphology.  Pre-
treatment with 8% RS for 72 hours then reducing serum to 2% RS provided the 
appropriate culture conditions needed to retain epithelial morphology and proliferation, 
a similar technique has widely been used in cell culture when evaluated growth factors 
or cell signalling pathways [67, 147, 215-216].   
 
Three potential dedifferentiation models were evaluated, seeding LECs onto poly(methyl 
methacrylate) (PMMA) substrate, scratching a confluent monolayer of LECs and treating 
LECs with various concentrations of TGFβ2.  A PMMA model was investigated as this 
material has been shown to induce contraction in LECs and PCO in vivo [50, 52].  This 
was a simple method using a substrate to examine dedifferentiation, however the time 
needed for PMMA to cause dedifferentiation in vitro is not known.  Cells may need to be 
cultured for a long time given how long dedifferentiation takes to occur in vivo.  The 
scratch model was examined to replicate the physical injury caused to LECs during 
phacoemulsification and clean up of residual LECs [60, 217].  This was a quick method 
using a 1ml tip to create a scratch through the centre of a monolayer, however this may 
be difficult to replicate on material coatings provided by BioInteractions Ltd.  Depending 
upon the number of layers and how the coating has been applied the scratch could 
inevitably cause damage to the coating.  LECs were maintained in medium containing 
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various concentrations of TGFβ2 (MEME, 2% RS) due to its association with scarring and 
PCO.  In normal aqueous TGFβ2 is between 1 – 2ng/ml, and in eyes with cataracts it is 
increased to 3 – 4ng/ml [218-220].  As the level of TGFβ2 is increased postoperatively 
this model tries to mimic the natural environment, however the influence of TGFβ2 on 
LECs may vary from in vivo to in vitro.  A dedifferentiation model using 5ng/ml TGFβ2 
was chosen as it is clinically relevant.   
 
TGFβ3 did dedifferentiate LECs to some extent regardless of time exposure or 
concentration, which was not expected.  When TGFβ3 was studied in conjunction with 
the dedifferentiation model TGFβ3 seemed to have little effect at reversing already 
dedifferentiated LECs, regardless of time exposure and concentration.  A higher dose of 
TGFβ3 may have been more effective.  Wormstone et al observed long term fibrotic 
response up to 28 days quantified by αSMA expression when LECs had been treated 
with TGFβ2 for a short time period [74].  Indicating TGFβ3 was not sufficient at reversing 
TGFβ2 long lasting fibrotic response.      
 
TGFβ3 seemed to offer some protection against dedifferentiation when added prior to 
dedifferentiating LECs.  This was observed by a reduction in the level of dedifferentiation 
at all TGFβ3 concentrations and time exposures, when compared to the amount of 
dedifferentiation caused by TGFβ2.  The level of dedifferentiation caused by TGFβ2, 
however, was reduced by approximately 22% when compared to the level of 
dedifferentiation caused in the previous study.  One reason to explain this may be due 
to the short shelf life of TGFβ2 meaning optimum dedifferentiation did not occur.  To 
validate this result the study would be repeated with fresh TGFβ2 to examine if the 
decrease in dedifferentiation after pre-treatment with TGFβ3 was still present.  The 
results seen in this study could also be correlated to the results observed in the phase III 
clinical trial using “Juvista”.  The primary and secondary end points were not met 
therefore the trial was stopped and funding was withdrawn [158].  The failure to meet 
the end points placed doubt on “Juvista” ability to reverse scarring, however this leads 
to more questions as to what is happening at the gene level in association with wound 
healing. 
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As the method for analysing dedifferentiation was semi quantitative, flow cytometry 
was evaluated for its potential to provide a quantitative method to evaluate LEC 
expression of αSMA.  This method has previously been used to obtain quantitative data 
for reliable cell labelling expression [221].  Positive expression of αSMA labelled cells 
was apparent when LECs were incubated with 5ng/ml of TGFβ2.  The histogram had a 
wide spread meaning some cells were stained more intensely than others.  This reflects 
what was observed immunocytochemically in earlier studies and verifies flow cytometry 
as a method for quantifying αSMA expression.  This method could have proved a more 
quantifiable method for examining the dedifferentiation model in conjunctions with 
TGFβ3.  If more time was available the dedifferentiation study would have been 
repeated using flow cytometry as a quantitative method for examining dedifferentiation 
levels. 
 
To examine if there was a difference in gene expression between un-dedifferentiated 
LECs, dedifferentiated LECs (TGFβ2) and LECs incubated with TGFβ3 polymerase chain 
reaction (PCR) was performed.  As gene arrays were specific to human species, B3 
human LEC line was used in this study.  B3 LECs were characterised with pan cytokeratin, 
clone C11, prior to use.  Each test sample was compared to a control sample (Table 3-3).  
If the expression of a gene was low in both the control and test sample the result was 
not evaluated further, due to question of reliability of the gene expression.  If more time 
and resources had allowed this would have been repeated to validate these results. 
 
TGFβ is associated with induction of dedifferentiation and detected by αSMA expression 
in several cell types throughout the body [24, 57, 74, 222].  TGFβ2 has been shown to 
increase the expression of collagen and fibronectin [59].  Fibronectin is associated with 
contraction and scarring [24, 52].  Fibronectin was up-regulated by a fold increase of 4.3 
when LECs incubated with TGFβ2 were compared to untreated LECs (control LECs).  
Additionally, a fold increase of 2.1 was observed when LECs incubated with TGFβ3 were 
compared to untreated LECs (control LECs).  The up-regulation of fibronectin may be 
directly correlated to the positive αSMA expression observed immunocytochemically, 
and could be a possible reason for the unexpected αSMA staining seen in LECs treated 
with TGFβ3.  In addition LECs incubated with TGFβ2 had a higher up regulation of 
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fibronectin and therefore a higher expression of αSMA staining.  When cells were 
incubated with TGFβ3 prior to dedifferentiation with TGFβ2 a similar fold increase to 
LECs incubated with TGFβ3 alone (2.8 and 2.1 respectively) was observed.  This may 
indicate TGFβ3 offers some protective properties against up-regulation of fibronectin, 
and thus dedifferentiation.  This may validate αSMA expression quantified by the 
previous immunocytochemistry study. 
 
Matrix metallopeptidase are a family of enzymes involved in ECM degradation [223].  
TGFβ2 treatment up-regulated the expression of matrix metallopeptidase 14 (MMP14, a 
member of the MMP membrane bound sub-family) by an 8.6 fold-increase when 
compared to control LECs.  Hodgkins et al observed MMP14 had the highest expression 
in LECs when screening the entire MMP family [224].  MMP14 is associated with the 
activation of MMP2 [223-225].  MMP2 was also observed when LECs were incubated 
with TGFβ2 compared to untreated LECs (control LECs) but not when cells were 
incubated with TGFβ3.  Richiert and Ireland also did not see any MMP2 expression in 
chick LECs unless they were incubated with TGFβ2 [226].  Eldred et al also demonstrated 
MMP-14 and MMP-2 were up-regulated in FHL124 LECs incubated with TGFβ2.  In 
addition TGFβ2 induced capsular wrinkling was reduced in the presence of a MMP2 
inhibitor.  Suggesting that MMP-2 plays an important role in capsular wrinkling seen in 
PCO [225].  The true involvement with MMP14 and MMP2 in terms of dedifferentiation 
in relation to PCO is not fully understood therefore the results observed here would 
need to be examined further.  
 
Several In vivo and in vitro studies have illustrated the presence of collagen expressed by 
dedifferentiated LECs [24, 102, 227-228].  Saika et al observed deposition of collagen 
types I, III, IV, V, and VI, on the capsular bag after implantation of an IOL [227-228].  
These specific collagen genes were observed in the PCR results when LECs were 
incubated with TGFβ2.  Several integrin genes were up and down regulated across 
treatments.  Integrins β5 and integrin α5 were both up-regulated when LECs were 
incubated with TGFβ2, also shown by Dawes et al [59].  Dawes et al and Marcantonio et 
al have examined α5β1 integrin (a receptor for fibronectin) expression in LECs [24, 59-
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60, 216].  The role integrins plays on dedifferentiation could therefore be examined 
further.  
 
This technique was used as a method to highlight genes that may be of interest, the 
understanding of these results would require further detailed work.  If more time and 
resources had allowed this would be repeated to validate the results.  Specific genes 
such as fibronectin 1, MMP14, MMP2, groups of collagens and groups of integrins would 
be examined further by several techniques including PCR, enzyme-linked 
immunosorbent assay (ELISA) and western blotting.   
 
As we know reducing the incidence of PCO is a multi and cross disciplinary process, the 
up and down regulation of these genes should be related to IOL material.  In future work 
a more iterative process for screening potential IOL materials could be the combination 
of examining materials in cell culture, via surface analysis, and the expression of these 
genes.  This may lead us one step closer to understanding the complexity of scarring in 
PCO, and a possible route to prevention of this disease.  
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5. Conclusions 
 
Investigations were carried out on an array of surfaces designed to control the LEC 
attachment and growth response, to reduce the incidence of PCO.  The following 
conclusions were drawn: 
 
1. Pre-existing BioInteractions Ltd. coatings 
a. Coating 001 and 002 were not suitable as IOL coatings as they did not support 
either hypothesis, to prevent cellular attachment or to enable the growth of a 
LEC monolayer. 
b. Coating 003 supported the hypothesis to prevent cell attachment and growth 
and was further analysed in terms of its GAG properties. 
c. Further work was not conducted on coating 004 as there were concerns over 
the coatings integrity. 
2. GAG coatings 
a. On average HEP and HA coatings prevented cellular attachment, and whilst 
some cells attached to CS it did not enable the growth of a LEC monolayer.  
There were, however, inconsistencies with these cellular responses, therefore 
future work would be required to confirm HEP’s and HA’s ability to prevent 
cellular attachment. 
b. Adsorbed GAGs did not successfully attach to the base substrate.  Which 
resulted in no noticeable cellular difference from control coatings to HA and CS 
adsorbed coatings.  
c. HA and CS were successfully covalently bound onto amine coated glass 
coverslips.  Covalently bound GAG coatings, at higher concentrations (3mg/ml 
and 1mg/ml), did not provide the correct binding sites for LECs to attach and 
grow.  These could be appropriate coatings to prevent LEC attachment and 
growth, thus reducing the incidence of scarring and the postoperative fibrotic 
response.  Further work using a capsule bag model could be investigated [229].    
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3. Zwitterionic coatings 
a. The ratio of zwitterionic:monomer can be varied to control the cellular 
response. 
b. Zwitterionic coating proved non-cytotoxic following ISO:10993-5:2009 
protocol. 
c. There was no clear link between wettability and cellular attachment.  In 
addition there was no correlation between surface roughness and the cellular 
response.  Therefore it was concluded that the cellular response seen on the 
zwitterionic coatings was the result of surface chemistry.   
d. The confirmation of the protein adlayer on novel zwitterionic bulk material F 
may not have presented appropriate binding sites required for cellular 
attachment, therefore LECs did not settle and attach on this material.  This 
material could possibly be synthesised as an IOL bulk material to prevent cell 
attachment.  Future work examining the bulk material properties and protein 
adsorption could be investigated.  
4. Dedifferentiation 
a. The effect TGFβ2 has on dedifferentiating LECs is a problem associated with 
PCO.  A model for successfully dedifferentiated LECs using 5ng/ml TGFβ2 was 
developed. 
b. TGFβ3 had little effect at reversing dedifferentiation, however, it may offer 
some protection against dedifferentiation, although this would need to be 
examined further. 
c.  The regulation of collagens, integrins, matrix metallopeptidase and fibronectin 
1 gene expression differed in dedifferentiated and un-dedifferentiated LECs.  
These genes play important roles with cell attachment, proliferation, scarring 
and fibrosis within PCO.  In future work these genes should be explored further 
in terms of their expression profile with IOL material.  This could inevitable 
lead to tailoring a material to provide optimum gene expression, to achieve a 
monolayer of LEC growth retaining epithelial phenotype, or prohibiting LEC 
growth, alleviating the incidence of PCO. 
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6. Appendices 
 
Appendix – A 
Glycosaminoglycan time lapse microscopy of N/N1003A LECs seeded onto GAG polymer 
coatings (heparin, hyaluronic acid and chondroitin sulphate).  Please find the CD 
attached, folder name is GAG time lapse sub-folders are named according to coatings. 
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Appendix – B 
Zwitterionic time lapse microscopy of N/N1003A LECs seeded onto zwitterionic coatings 
(F-J) and methacryloyloxyethyl phosphorylcholine controls (L-N).  Please find the CD 
attached, folder name is zwitterionic time lapse sub-folders are named according to 
coatings. 
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Appendix – C 
 
PCR Array Catalogue #: PAHS-013 
 
Position Symbol Description RefSeq ID 
A01  ADAMTS1 
 ADAM metallopeptidase with thrombospondin type 
1 motif, 1 
NM_006988 
A02 ADAMTS13 
 ADAM metallopeptidase with thrombospondin type 
1 motif, 13 
NM_139025 
A03  ADAMTS8 
 ADAM metallopeptidase with thrombospondin type 
1 motif, 8 
NM_007037 
A04  CD44  CD44 molecule (Indian blood group) NM_000610 
A05  CDH1  Cadherin 1, type 1, E-cadherin (epithelial) NM_004360 
A06  CNTN1  Contactin 1 NM_001843 
A07  COL11A1  Collagen, type XI, alpha 1 NM_080629 
A08  COL12A1  Collagen, type XII, alpha 1 NM_004370 
A09  COL14A1  Collagen, type XIV, alpha 1 NM_021110 
A10  COL15A1  Collagen, type XV, alpha 1 NM_001855 
A11  COL16A1  Collagen, type XVI, alpha 1 NM_001856 
A12  COL1A1  Collagen, type I, alpha 1 NM_000088 
B01  COL4A2  Collagen, type IV, alpha 2 NM_001846 
B02  COL5A1  Collagen, type V, alpha 1 NM_000093 
B03  COL6A1  Collagen, type VI, alpha 1 NM_001848 
B04  COL6A2  Collagen, type VI, alpha 2 NM_001849 
B05  COL7A1  Collagen, type VII, alpha 1 NM_000094 
B06  COL8A1  Collagen, type VIII, alpha 1 NM_001850 
B07  VCAN  Versican NM_004385 
B08  CTGF  Connective tissue growth factor NM_001901 
B09  CTNNA1 
 Catenin (cadherin-associated protein), alpha 1, 
102kDa 
NM_001903 
B10  CTNNB1 
 Catenin (cadherin-associated protein), beta 1, 
88kDa 
NM_001904 
B11  CTNND1  Catenin (cadherin-associated protein), delta 1 NM_001331 
B12  CTNND2 
 Catenin (cadherin-associated protein), delta 2 
(neural plakophilin-related arm-repeat protein) 
NM_001332 
C01  ECM1  Extracellular matrix protein 1 NM_004425 
C02  FN1  Fibronectin 1 NM_002026 
C03  HAS1  Hyaluronan synthase 1 M_001523 
C04  ICAM1  Intercellular adhesion molecule 1 NM_000201 
C05  ITGA1  Integrin, alpha 1 NM_181501 
C06  ITGA2 
 Integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 
receptor) 
NM_002203 
C07  ITGA3 
 Integrin, alpha 3 (antigen CD49C, alpha 3 subunit of 
VLA-3 receptor) 
NM_002204 
C08  ITGA4 
 Integrin, alpha 4 (antigen CD49D, alpha 4 subunit of 
VLA-4 receptor) 
NM_000885 
C09  ITGA5 
 Integrin, alpha 5 (fibronectin receptor, alpha 
polypeptide) 
NM_002205 
C10  ITGA6  Integrin, alpha 6 NM_000210 
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C11  ITGA7  Integrin, alpha 7 NM_002206 
C12  ITGA8  Integrin, alpha 8 NM_003638 
D01  ITGAL 
 Integrin, alpha L (antigen CD11A (p180), lymphocyte 
function-associated antigen 1; alpha polypeptide) 
NM_002209 
D02  ITGAM 
 Integrin, alpha M (complement component 3 
receptor 3 subunit) 
NM_000632 
D03  ITGAV 
 Integrin, alpha V (vitronectin receptor, alpha 
polypeptide, antigen CD51) 
NM_002210 
D04  ITGB1 
 Integrin, beta 1 (fibronectin receptor, beta 
polypeptide, antigen CD29 includes MDF2, MSK12) 
NM_002211 
D05  ITGB2 
 Integrin, beta 2 (complement component 3 receptor 
3 and 4 subunit) 
NM_000211 
D06  ITGB3 
 Integrin, beta 3 (platelet glycoprotein IIIa, antigen 
CD61) 
NM_000212 
D07  ITGB4  Integrin, beta 4 NM_000213 
D08  ITGB5  Integrin, beta 5 NM_002213 
D09  KAL1  Kallmann syndrome 1 sequence NM_000216 
D10  LAMA1  Laminin, alpha 1 NM_005559 
D11  LAMA2  Laminin, alpha 2 NM_000426 
D12  LAMA3  Laminin, alpha 3 NM_000227 
E01  LAMB1  Laminin, beta 1 NM_002291 
E02  LAMB3  Laminin, beta 3 NM_000228 
E03  LAMC1  Laminin, gamma 1 (formerly LAMB2) NM_002293 
E04  MMP1  Matrix metallopeptidase 1 (interstitial collagenase) NM_002421 
E05  MMP10  Matrix metallopeptidase 10 (stromelysin 2) NM_002425 
E06  MMP11  Matrix metallopeptidase 11 (stromelysin 3) NM_005940 
E07  MMP12  Matrix metallopeptidase 12 (macrophage elastase) NM_002426 
E08  MMP13  Matrix metallopeptidase 13 (collagenase 3) NM_002427 
E09  MMP14  Matrix metallopeptidase 14 (membrane-inserted) NM_004995 
E10  MMP15  Matrix metallopeptidase 15 (membrane-inserted) NM_002428 
E11  MMP16  Matrix metallopeptidase 16 (membrane-inserted) NM_005941 
E12  MMP2 
 Matrix metallopeptidase 2 (gelatinase A, 72kDa 
gelatinase, 72kDa type IV collagenase) 
NM_004530 
F01  MMP3 
 Matrix metallopeptidase 3 (stromelysin 1, 
progelatinase) 
NM_002422 
F02  MMP7  Matrix metallopeptidase 7 (matrilysin, uterine) NM_002423 
F03  MMP8  Matrix metallopeptidase 8 (neutrophil collagenase) NM_002424 
F04  MMP9 
 Matrix metallopeptidase 9 (gelatinase B, 92kDa 
gelatinase, 92kDa type IV collagenase) 
NM_004994 
F05  NCAM1  Neural cell adhesion molecule 1 NM_000615 
F06  PECAM1  Platelet/endothelial cell adhesion molecule NM_000442 
F07  SELE  Selectin E NM_000450 
F08  SELL  Selectin L NM_000655 
F09  SELP 
 Selectin P (granule membrane protein 140kDa, 
antigen CD62) 
NM_003005 
F10  SGCE  Sarcoglycan, epsilon NM_003919 
F11  SPARC  Secreted protein, acidic, cysteine-rich (osteonectin) NM_003118 
F12  SPG7 
 Spastic paraplegia 7 (pure and complicated 
autosomal recessive) 
NM_003119 
G01  SPP1  Secreted phosphoprotein 1 NM_000582 
G02  TGFBI  Transforming growth factor, beta-induced, 68kDa NM_000358 
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G03  THBS1  Thrombospondin 1 NM_003246 
G04  THBS2  Thrombospondin 2 NM_003247 
G05  THBS3  Thrombospondin 3 NM_007112 
G06  TIMP1  TIMP metallopeptidase inhibitor 1 NM_003254 
G07  TIMP2  TIMP metallopeptidase inhibitor 2 NM_003255 
G08  TIMP3  TIMP metallopeptidase inhibitor 3 NM_000362 
G09  CLEC3B  C-type lectin domain family 3, member B NM_003278 
G10  TNC  Tenascin C NM_002160 
G11  VCAM1  Vascular cell adhesion molecule 1 NM_001078 
G12  VTN  Vitronectin NM_000638 
H01  B2M  Beta-2-microglobulin NM_004048 
H02  HPRT1  Hypoxanthine phosphoribosyltransferase 1 NM_000194 
H03  RPL13A  Ribosomal protein L13a NM_012423 
H04  GAPDH  Glyceraldehyde-3-phosphate dehydrogenase NM_002046 
H05  ACTB  Actin, beta NM_001101 
H06  HGDC  Human Genomic DNA Contamination SA_00105 
H07  RTC  Reverse Transcription Control SA_00104 
H08  RTC  Reverse Transcription Control SA_00104 
H09  RTC  Reverse Transcription Control SA_00104 
H10  PPC  Positive PCR Control SA_00103 
H11  PPC  Positive PCR Control SA_00103 
H12  PPC  Positive PCR Control SA_00103 
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